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4ABSTRACT
Liver ischaemia-reperfusion (I/R) injury occurs in a number o f clinical settings, 
including liver surgery, transplantation and haemorrhagic shock with subsequent fluid 
resuscitation. It is well recognised as a significant cause o f morbidity and mortality and 
characterised by oxidative stress accompanied with depletion o f antioxidants. Its 
pathophysiology is complex.
This thesis investigates the effect o f lobar liver I/R injury on liver microcirculation, 
hepatic oxygenation, cellular energetics and nitric oxide (N O ) metabolism. It evaluates 
also the hypothesis that the antioxidant N-acetylcysteine (NAC) ameliorates liver I/R 
injury.
Initially an experimental rabbit model was established where both phases (early and 
late) o f liver I/R injury could be studied. New Zealand white rabbits underwent 60 min 
of lobar ischaemia followed by 7 h of reperfusion. It was found that cannulation of the 
femoral artery, for monitoring of the arterial blood pressure, induced remote liver 
injury, which could be avoided by use of the ear artery.
Lobar liver I/R caused significant decrease in hepatic microcirculation, liver tissue 
oxygenation and cellular energetics. It also caused significant alterations in NO 
metabolism during the late phase (increase in plasma nitrites and plasma S-nitrosothiols, 
decrease in liver tissue nitrotyrosine) and significant oxidative stress.
Intravenous administration o f NAC (150 mg/Kg/h over the 15 min before reperfusion 
and maintenance at 10 mg /Kg/h during the 7 h reperfusion period) had a clear 
protective effect during the late phase of reperfusion injury in rabbits with normal and 
steatotic liver. This effect was associated with improved cellular energy metabolism 
(maintenance o f cytochrome oxidase activity, increased acetates and decreased lactates
in bile) and altered NO metabolism (reduced plasma nitrites, S-nitrosothiols and 
reactive nitrogen species).
In conclusion, this thesis has shown that lobar hepatic I/R induces significant alterations 
on cellular energetics and NO metabolism. It provides also significant new information 
about the timing and the possible mechanism of the protective effect o f NAC. It could 
form the basis for the performance of large scale prospective randomised clinical trials 
where the effect o f thiols in clinical settings o f liver I/R injury will be investigated.
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THESIS DESCRIPTION
Chapter 1 is an overview o f the clinical significance o f hepatic ischaemia-reperfusion 
(I/R) injury, the pathophysiology of liver I/R and the role of reactive oxygen and 
nitrogen species in I/R injury.
Chapter 2 reviews the role of antioxidant therapy on liver I/R with special emphasis on 
the role of thiols.
In chapter 3, materials and methods used in this study are described.
In chapter 4 the establishment and refinement of an experimental rabbit model of lobar 
liver I/R is described. This model allowed the study of both the early and late phases of 
liver I/R injury. The cannulation of the ear artery for continuous monitoring of the 
arterial blood pressure, instead of the femoral artery, was found to avoid remote liver 
injury.
Chapter 5 describes the application of proton nuclear magnetic resonance ( 1HNMR) 
spectroscopy in analyzing the changes in bile composition during liver I/R.
In chapter 6 , the effect of N-acetylcysteine (NAC) administration on liver function 
following hepatic I/R injury in normal liver is investigated and discussed.
In chapter 7 the effect o f NAC administration on liver function during hepatic I/R injury 
in steatotic liver has been studied.
Chapter 8  investigates the possible mechanism of the protective effect o f NAC in liver 
warm I/R injury. It has been demonstrated that NAC administration preserves cellular 
energetics and modulates nitric oxide metabolism.
Chapter 9 is a general discussion o f the thesis and the directed future research.
References and an appendix listing the presentations and publications arising out o f the 
work described appear at the end o f the thesis.
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1.1 Clinical significance of liver ischaemia - reperfusion (I/R) injury
Liver I/R injury is well recognized as a significant cause o f morbidity and mortality in 
two principal settings. Firstly, it occurs in major liver resections (Liu et al. 1996) and 
transplantation (Caldwell-Kenkel et al. 1991; Deschenes et al. 1998; Silva et al. 2006) 
where anoxic or ischaemic liver injury takes place. Secondly, it happens as a 
consequence o f systemic hypoxia or with conditions which cause low blood flow to the 
liver resulting in insufficient perfusion. The latter occurs in haemorrhagic, cardiogenic 
or septic shock with subsequent fluid resuscitation (Yamakawa et al. 2000), in 
cardiovascular surgery with extracorporeal circulation (Okano et al. 2002), in 
laparoscopic surgery (Glantzounis et al. 2001; Glantzounis et al. 2005b) and in 
abdominal compartment syndromes (Rezende-Neto et al. 2003).
Severe warm liver I/R can lead to liver or even to multiple organ failure (Helling 2006). 
The extent of hepatic injury caused by I/R depends primarily on the condition of the 
liver prior to the ischaemic insults and its duration (Isozaki et al. 1995). In liver surgery 
new techniques have been applied to increase the resectability rate o f liver tumours such 
as down staging chemotherapy and portal vein embolisation. However, these techniques 
can make the liver more susceptible to ischaemic insults (Pocard et al. 2001). 
Furthermore, the commonest primary liver cancer, hepatocellular carcinoma usually 
develops on the background of liver cirrhosis, which increases the risk of liver failure 
during any subsequent surgery (Kaibori et al. 2003).
In the field o f liver transplantation I/R injury is closely related to the development of 
primary graft non-function (occurs in < 5 % of grafts) and primary graft dysfunction
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(occurs in 10-30 % o f grafts) (Clavien et al. 1992). Both conditions are associated with 
high rates o f morbidity and mortality. I/R injury also increases the incidence of 
subsequent graft rejection (Fellstrom et al. 1998) and of non-anastomotic biliary 
strictures o f transplanted livers (Lemasters et al. 1995).
Another field where I/R injury affects outcome is hepatic resection or transplantation 
with steatotic livers. It is reported that 25 % of the western population has some degree 
of hepatic steatosis (Selzner et al. 2001) which is the result of the abnormal 
accumulation of triacylglycerol within the cytoplasm of hepatocytes, attributed to the 
effects o f alcohol excess, obesity, diabetes or drugs. Furthermore, hepatic steatosis is 
associated with an impaired microcirculation (Seifalian et al. 1998; Ijaz et al. 2003), 
increased postoperative morbidity and mortality and poor graft function (Selzner and 
Clavien 2001).
It is obvious that liver I/R occurs in many diverse clinical settings and has a major 
impact on clinical outcome. Reoxygenation of the ischaemic liver causes the generation 
of numerous reactive oxygen (ROS) and nitrogen species (RNS). Although ROS and 
RNS in low concentrations play an important role as mediators in normal cellular 
metabolism and signal transduction (Czaja 2002; Haddad 2002) in higher 
concentrations they can be damaging. In light o f this a complex defence network, the 
antioxidant system, developed in mammals, to prevent or reduce the injury caused by 
high concentrations o f ROS or RNS. Free radical scavenging or administration of agents 
that enhance the endogenous antioxidant system could reduce post ischaemic tissue 
injury and so be useful in clinical settings against hepatic I/R damage.
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1.2 Pathophysiology of liver I/R 
Ischaemic injury
When oxygen supply to cells becomes insufficient as a direct result o f reduced blood 
flow or hypoxia the mitochondrial respiratory chain function alters and the reduction- 
oxidation (redox) state of the mitochondrial enzymes becomes reduced. This results in 
the inhibition o f the oxidative phosphorylation process with a subsequent reduction in 
ATP (Adenosine Triphosphate) synthesis (Gonzalez-Flecha et al. 1993). Reduction of 
cellular ATP causes disturbances in membrane ion translocation by inhibition of the 
ATP-dependent sodium (Na+) / potassium (K+) ATPase, resulting in sodium influx and 
intracellular sodium accumulation with corresponding cell swelling and death (Blum et 
a l 1991).
Intracellular calcium accumulation is also strongly implicated in the development of 
ischaemic injury and is thought to be a crucial step in the transition to irreversible 
damage (Dhar et al. 1996). The increased cytosolic calcium level causes activation of 
cell membrane phospholipases resulting in phospholipids degradation and cell 
membrane disruption (Farber 1981). Prior to cell death hepatocytes and other cells 
develop a state characterized by mitochondrial permeability transition (Kim et al. 
2003), lysosomal disruption, bleb formation and growth, cell swelling and leakage of 
small molecular mass solutes (Nishimura and Lemasters 2001; Zahrebelski et al. 1995). 
Calcium also activates xanthine oxidoreductase (XOR) which has a role in oxygen free 
radical production following reperfusion (Ishii et al. 1990; Glantzounis et al. 2005c). 
Although the basic mechanisms of ischaemic injury after warm and cold liver ischaemia
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share several similarities, there are also significant differences. In liver transplantation 
the liver undergoes cold ischaemic storage followed by rewarming ischaemia and 
reperfusion (Selzner et al. 2003). Cold ischaemia is associated with reduced oxidative 
phosphorylation, lower cellular ATP levels and increased glycolysis (Churchill et al. 
1994), while warm ischaemia leads to greater oxidative stress and mitochondrial 
dysfunction (Baumann et al. 1989; Mochida et al. 1994). The main site of injury in cold 
ischaemia are non-parenchymal cells (Kupffer, sinusoidal endothelial cells (EC), Ito 
cells and biliary epithelium) whereas in warm ischaemia are hepatocytes (Ikeda et al. 
1992).
Reperfusion injury
Although ischaemia causes significant injury to tissue and cells; the injury during 
reperfusion is more severe. A complex network of hepatic and extra hepatic 
mechanisms is involved in the pathophysiology of hepatic I/R. Experimental evidence 
shows that there are two distinct phases of liver reperfusion injury. The early phase 
covers the first two hours after reperfusion. During this phase the main event is the 
activation o f Kupffer cells (Jaeschke and Farhood 1991). Complement activation and 
the recruitment and activation of CD4+ T lymphocytes are factors that enable the 
activation o f the Kupffer cells (Jaeschke 2003; Fondevila et al. 2003).
Kupffer cell activation leads to structural changes, formation o f vascular ROS and 
production o f cytokines such as tumour necrosis factor (TNF-a) and interleukin 1 (IL-1) 
(Lentsch et al. 2000; Liu et al. 2001). These ROS and cytokines have a direct cytotoxic 
effect on EC and hepatocytes; can induce changes in cell membrane receptors in 
hepatocytes and release of cytokines. TNF-a acts as the central mediator in the hepatic 
response to I/R. The production o f TNF-a induces the expression o f adhesion molecules
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on vascular EC and stimulates the production and release of neutrophil-attracting 
chemokines. The final result is the recruitment o f neutrophils. These activated 
neutrophils release ROS and proteases that are responsible for the induced oxidative 
stress during the late phase of reperfusion injury (Jaeschke 2000; Weiss 1989) which is 
much more severe compared to the early phase.
Recent evidence suggests that the T-lymphocytes can also be important mediators in 
short and long term liver I/R injury. Their role seems to be a multifactorial one. There is 
evidence that systemic immunosuppression attenuates hepatocellular injury following 
I/R (Matsuda et al. 1998; Shen et al. 2002; Suzuki et al. 1993). The adherence of CD4+ 
T-lymphocytes in hepatic sinusoids occurs during the early phase o f reperfusion and is 
mediated by TNF-a and IL-1 (Clavien et al. 1993). These T-lymphocytes can increase 
Kupffer cell activation and can act as cellular mediators in polymorphonuclear (PMN) 
cell recruitment through the release of substances such as granulocyte colony 
stimulating factor and interferon y (Zwacka et al. 1997).
The basic pathophysiological mechanisms in hepatic I/R injury are summarized in 
figure 1 .
25
Late
Phase
Early
Phase
CD4+T-cell
activation
Ischaemia / Reperfusion 
i
Complement
activation
Hepatocyte
Kupffer cell activation activation
ROS, TNFa, IL-1B
Expression of liver derived chemokines, 
Cellular adhesion molecules, 
________Hepatocvte / EC injury________
Neutrophil activation and accumulation
I
Production of ROS / proteases, 
Hepatocellular injury
Figure 1.1. Schematic presentation o f the pathophysiology o f liver ischaemia / 
reperfusion injury. Keys: ROS, reactive oxygen species; TNFa, tumour necrosis factor 
a; IL -ip, inteleukin lp ; EC, endothelial cells.
1.3 Reactive oxygen species and I/R injury
A “radical” is defined as any atom or biomolecule that contains unpaired electrons 
(Halliwell B and Gutteridge JMC 1999). These unpaired electrons influence the 
chemical reactivity making the radical more reactive than the corresponding non­
radical. Although oxygen (O2) is the most important biological molecule for sustaining 
life, it is also the main source for free radical formation due to its high availability.
The biologically relevant radicals are the superoxide anion (O 2 "), the hydroxyl radical 
( OH) and nitric oxide (NO ). Under normal conditions around 1-3 % o f the oxygen 
metabolized in the mitochondria is converted to the radical 0 2  ’ (Nohl et al. 2003). Some
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other species are intermediate in the metabolism of O2 or NO but are not radicals as 
they do not contain unpaired electrons. These intermediate species along with the 
radical species are called ROS and RNS respectively. The most representative examples 
of non radical ROS are hydrogen peroxide (H2 O2) and hypochlorous acid (HOC1). The 
most representative o f non radical RNS is peroxynitrite (ONOO") (Ischiropoulos et al. 
1992). Peroxynitrite is formed when there is simultaneous production o f NO with 
superoxide anion (eq. 1 ):
NO  + 0 ~  >ONOO~ (1)
Tissue toxicity from superoxide generation is based on its direct reactivity with 
numerous types of biological molecules (typically lipids, DNA, RNA, catecholamines 
and steroids) and from its dismutation to form H2O2 (Cuzzocrea et al. 2001). Trace 
amounts o f metals ions (principally iron or copper) react with H2O2 in what is known as 
the Fenton reaction to produce the toxic radical OH (Sutton and Winterbourn 1989). 
This radical can cleave covalent bonds in proteins and carbohydrates and destroy cell 
membranes.
Liver injury induced by I/R is caused, at least partially, by ROS and RNS. There is 
evidence that during hepatic I/R there is generation and release o f ROS and RNS with 
concomitant consumption of endogenous antioxidants and apoptotic or necrotic cell 
death (Bilzer et al. 1999; Giakoustidis et al. 2002; Jaeschke 2000; Rauen et al. 1999; 
Rudiger and Clavien 2002).
Although the exact sources of ROS generation in liver I/R are still under investigation, 
the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, the xanthine /XOR 
system and the mitochondria have been suggested to play key roles (Fan et a l 1999).
Although XOR was regarded as the principal source o f post ischaemic oxidant stress in 
the liver, recent evidence suggests that XOR plays a minor role as compared to the 
mitochondria (Jaeschke 2002). Mitochondria are the site o f the production of large 
amounts o f superoxide, under conditions of oxidative stress. It is this stress that finally 
leads to the formation of membrane permeability transition pores and the breakdown of 
the mitochondrial membrane potential that can cause cellular death (Nieminen et al. 
1997).
ROS and RNS can have an important role in signal transduction pathways coordinating 
the body inflammatory response after liver I/R injury (Zwacka et al. 1998a; Jaeschke 
2000; Harada et al. 2003; Jaeschke 2003). They are involved as mediators in the 
production o f substances regulating liver blood flow (Paxian et al. 2001) and 
regeneration (Nakatani et al. 1997; Pannen 2002). Transgenic mice with over 
expression o f antioxidant enzymes have decreased cellular ploidy during liver 
regeneration suggesting that ROS are involved in cell cycle control (Nakatani et al. 
1997). ROS also induce stress genes such as haem oxygenase-1 (HO-1) (Bauer and 
Bauer 2002). The induction o f HO-1 leads to formation of the antioxidant biliverdin, the 
vasodilator carbon monoxide (CO) and iron. The multiple roles o f ROS in liver I/R are 
summarised in table 1 .
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Table 1.1 Role o f  reactive oxygen species (ROS) in liver ischaemia-reperliision (I/R) 
injury.
Function References
Enhance pro-inflammatory gene expression (TNF-a, EL-1, IL-8 ,
cellular adhesion molecules) Lentch, 2000
Induce expression o f the transcription factors NF-kB and activator Zwacka, 1998
protein- 1 Harada, 2003
Direct cellular damage through protein oxidation and degradation, Jaeschke, 2000
lipid peroxidation and DNA damage
Direct induction and regulation o f apoptotic and necrotic cell Rauen, 1999
death Rudiger, 2002
Inactivation o f antiproteases Weiss, 1989
Jaescke, 2000
Induction of protective stress genes in hepatocytes Bauer, 2002
Formation o f mediators involved in regulating sinusoidal blood Nakatani, 1997
flow & liver regeneration Paxian, 2001
Keys: TNF-a, tumor necrosis factor-a; IL-1, interleukin-1; IL-8, interleukin-8; NF-kB, 
nuclear factor-kappa B.
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1.4. Role of nitric oxide in liver I/R injury
NO is a radical synthesized via the oxidation o f L-arginine by NO synthetase (NOS) 
(Moncada and Higgs 1993). There are two major isoforms o f NOS in the liver, 
endothelial NOS (eNOS) and inducible NOS (iNOS). eNOS is expressed constitutively 
and its activity is dependent on Ca2+ and calmodulin (Vasquez-Vivar et al. 1998). iNOS
94-is synthesised by EC, hepatocytes and Kupffer cells and its activity is Ca independent. 
NO is a lipophilic biomolecule that diffuses to adjacent cells and enters the cytosol, 
where it activates soluble guanylyl cyclase by binding to the iron in the haem centre 
resulting in an intracellular increase of cyclic guanosine monophosphate (cGMP) levels 
(Schmidt et al. 1993). Many of the biological actions o f NO are mediated through the 
guanyl cyclase/cyclic GMP system.
Under physiologic conditions only constitutive eNOS is present in the liver and the low 
level of NO produced regulates hepatic perfusion, prevents platelet adhesion, 
thrombosis, PMN cell accumulation and secretion o f inflammatory mediators (Gauthier 
et al. 1994; Mittal et al. 1994) . NO also induces vasodilatation at the level o f the 
sinusoid and at presinusoid sites (McCuskey 2000; Ming et al. 1999), this in order to 
keep a balance with vasoconstrictors such as endothelin (Pannen 2002). Induction of 
iNOS may have either toxic or protective effects. The effects are dependent on the type 
of insult, the level and duration of iNOS expression and the simultaneous production of 
superoxide anion (Cuzzocrea et al. 2001).
In liver I/R iNOS mRNA expression starts 1 h post reperfusion with increased iNOS 
activity at 5 h post reperfusion (Hur et al. 1999). The literature concerning the effect of
iNOS in liver I/R injury is still ambivalent. Some studies suggest that iNOS expression 
has detrimental effects (Kimura et al. 2003; Meguro et al. 2002; Serracino-Inglott et al.
2001) to liver function whilst others suggest that it is beneficial (Hsu et al. 2002; Wang 
et al. 1998) or has no effect at all (Hines et al. 2002; Rivera-Chavez et al. 2001). One 
study with mice deficient in iNOS showed a moderate reduction in reperfusion injury 
(Lee et al. 2001). The toxic effects o f NO are linked with the production of 
peroxynitrite which is the product of O2 " and NO'. Peroxynitrite can cause cell injury 
through multiple pathways: initiation o f lipid peroxidation, direct inhibition of 
mitochondrial respiratory chain enzymes, inhibition of membrane Na+ / K+ ATP-ase 
activity, or oxidative protein modification such as formation of nitrotyrosine (Doulias et 
al. 2001; Hon et al. 2002; Szabo 2003). However, whether NO will act as a 
cytoprotective or cytotoxic agent depends on a number o f factors such as N O - 
superoxide radical ratios, hepatic stores of reduced glutathione and the duration of 
ischaemia.
1.5 Therapeutic strategies for amelioration of liver I/R injury
Understanding the mechanisms of liver I/R injury allows therapeutic strategies to be 
developed. The current strategies are either mechanical (e.g. ischaemic preconditioning 
or remote preconditioning) or pharmacological. Ischaemic preconditioning is the 
application o f short periods of ischaemia and reperfusion to an organ prior to prolonged 
ischaemia whereas in remote preconditioning cycles o f brief ischaemia are applied to a 
remote organ (e.g. lower limb) prior to prolonged ischaemia of the target organ (e.g. 
liver, heart). Preliminary studies with both techniques have shown a reduction in liver 
I/R injury although further studies and refinement of technique are required (Banga et 
al. 2005; Kharbanda et al. 2002; Koti et al. 2003). Mechanical methods of reducing I/R
injury are worthwhile but are limited in their application whereas pharmacological 
modulation may have universal application.
One o f the main group of pharmacological agents which can enhance the antioxidant 
defence system is thiols. Thiols are molecules containing sulfydryl (-SH) groups and 
have an important role in maintaining the body’s redox balance and defence against 
oxidants (Sen 1998; Wlodek 2002). N-acetylcysteine is a synthetic thiol used currently 
as the drug o f choice in the management of fulminant liver failure due to paracetamol 
overdose (Chyka et al. 2000; Cotgreave 1997). It has been used in different 
experimental settings linked to oxidative stress showing mainly beneficial effects. 
However, its application in small clinical trials has shown inconsistent results (Aitio 
2006). Its role in warm liver I/R injury is still ambivalent (Chavez-Cartaya et al. 1999; 
Koeppel et al. 1996). Progress in the use of protective strategies such as antioxidant 
therapy in liver I/R requires well designed experimental and clinical studies, in order to 
gain a better understanding of the basic mechanisms o f I/R injury, o f the mechanism of 
protective action and timing of any beneficial effects.
1.6 Aim and objectives of this thesis
1. To investigate further the pathophysiology o f warm liver I/R injury
2. To investigate the effect of the administration o f the antioxidant NAC on liver 
function and the mechanism of action. NAC was chosen as a classical 
representative of thiols, which had already been tested in experimental studies of 
liver I/R, producing conflicting results.
The next chapter provides an overview of the endogenous antioxidant system and 
reviews the experimental and clinical evidence on the role o f antioxidant therapy on 
liver I/R, with special emphasis on the role of thiols.
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CHAPTER 2
THE ANTIOXIDANT SYSTEM AND THE ROLE OF 
ANTIOXIDANT THERAPY IN LIVER I/R INJURY WITH 
EMPHASIS ON THIOLS
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2.1 The antioxidant system
The body has developed major antioxidant defence mechanisms to protect it from 
damage due to free radicals. An antioxidant is any substance that when present at low 
concentrations compared with those of an oxidizable substrate, significantly delays or 
prevents oxidation o f the substrate (Gutteridge 1995). The endogenous antioxidants 
mainly are small molecular weight substances that are able to prevent initiation of 
oxidative damage or to limit its propagation and enzymes that convert and detoxify 
ROS and RNS. Cellular redox balance is in normal circumstances under tight control. 
However, when ROS and RNS are produced at levels that cannot be counteracted by 
endogenous antioxidant systems, an imbalance takes place that is called oxidative 
stress (Sies H 1991). This condition can lead to the damage of lipids, proteins, 
carbohydrates and nucleic acids. Hepatocytes tend to be resistant to injury by ROS and 
RNS since they contain high intracellular concentrations o f glutathione (GSH), 
superoxide dismutase (SOD), catalase and lipid soluble antioxidants.
The antioxidant system is very important for the living species and has allowed them to 
use oxygen (O2) for energy production, without being exposed to the deleterious effects 
of O2 . The composition o f antioxidant defences differs from tissue to tissue and from 
cell to cell in a given tissue. Also, different organs contain different concentrations of 
antioxidants and for this reason there is variability in organ resistance to I/R. However, 
there is evidence that the antioxidants operate as a balanced and coordinated system and 
each relies on the action of the others (Marczin et al. 2003; Vertuani et al. 2004).
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Antioxidants are a heterogenous family of molecules. Several classifications have been 
used in the past taking into account the origin (natural or synthetic), nature (enzymatic 
or non-enzymatic), properties (hydrophilic or lipophilic), mechanism (catalytical 
removal o f ROS, metal chelation, scavenging o f ROS) and site of action (intracellular; 
membrane and extracellular). This review is presented according to the site of action of 
the antioxidants.
Intracellular antioxidant defences include: the superoxide dismutase; catalase;
glutathione peroxidase and reductase enzymes, the tripeptide glutathione, the 
polypeptide thioredoxine, the enzyme haem oxygenase (HO) and peroxidases of the 
peroxiredoxin family.
SOD catalyses the dismutation of superoxide to hydrogen peroxide and oxygen (eq.
1):
2 0 2 + 2H + SOD >H 20 2 + 0 2 (1)
Three forms o f SOD exist with different subcellular localizations. Those containing 
copper and zinc (Cu/ZnSOD) are located in the cytosol (Sherman et al. 1983), 
manganese (MnSOD) in the mitochondria (Ho and Crapo 1988) and the extracellular 
form usually located on the outside of plasma membrane interacting with matrix 
components. The product o f reaction 1, H2 O2 , is a weak oxidant and is relatively stable. 
However, unlike superoxide, H2O2 can rapidly diffuse across cell membranes and in the
presence o f transition metal ions it can be converted to toxic hydroxyl radicals via
Fenton chemistry (eq. 2):
Fe*2 + H 20 2------>Fe*2+ O H  + OH~ (2)
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Three main systems can break down H2O2 . One o f them is the haemoprotein catalase. 
Catalase is present in all major body organs being especially concentrated in liver. It
catalyzes the breakdown of hydrogen peroxide to oxygen and water (eq. 3):
2 H 20 2 ------ >02 + 2 H 20  (3)
The second system consists of the glutathione peroxidases. This group includes four
different isoforms such as cellular, gastrointestinal, extracellular and phospholipids 
(Dufaure et al. 1996). They have a major role in removing hydrogen peroxide generated 
by superoxide dismutase with the oxidation of GSH to its oxidized form glutathione 
disulphide (GSSG) (eq. 4):
2GSH + H 20 2 — >GSSG + 2 H 20(4)
Glutathione reductase is also an important enzyme in this system. It expresses its action 
through the regeneration o f GSH from GSSG using NADPH (Meister 1988).
The third system consists of peroxidases o f the peroxiredoxin (Prx) family that reduce 
hydrogen peroxide and alkyl hydroperoxides to water and alcohol respectively using 
reducing equivalents. These equivalents are derived specifically from thiol-containing 
donor molecules, such as thioredoxin. They are located in the cytoplasm (Prx I and II) 
and in mitochondria (Prx III) (Kang et al. 1998; Seo et al. 2000).
HO is an enzyme found in the endoplasmic reticulum that catalyses the breakdown of 
haem to biliverdin with the release o f iron ions and CO. Three isoforms of HO have 
been characterized: HO-1 that is highly inducible in conditions of inflammation and 
oxidative stress and HO-2 and HO-3 that are constitutively expressed (Guo et al. 2001).
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Induction of HO-1 protects the cell against oxidative injury by controlling intracellular 
levels o f free haem (a prooxidant), producing biliverdin (an antioxidant) and improving 
microcirculation via CO release (Bauer and Bauer 2002). Recent evidence suggests that 
HO-1 expressed early after intermittent porta hepatis clamping and possibly contributes 
to the early protective effects of ischaemic preconditioning (Patel et al. 2004)
Major extracellular antioxidant defences include the metal-binding proteins (Betteridge 
2000). Free metals iron and copper can promote free radical damage, accelerating lipid 
peroxidation and catalyzing hydroxyl radical formation. The body is protected against 
these potentially adverse effects by metal- binding proteins which ensure that these 
metals are maintained in a nonreactive state (Halliwell and Gutteridge 1990). 
Transferrin and lactoferrin bind iron while caeruloplasmin and albumin bind copper. 
Haemoglobin and myoglobin are normally intracellular proteins. When these proteins 
are exposed to a large amount of oxidative stress such as H2 O2 , they are degraded 
releasing both haem and iron ions that can then stimulate lipid peroxidation. 
Haemoglobin binding proteins known as haptoglobins and haem binding proteins such 
as haemopexin decrease the effectiveness of these substances in stimulating lipid 
peroxidation (Gutteridge 1989).
In addition to the major protective role of the metal-binding proteins, various low- 
molecular-weight molecules that are synthesised in vivo have antioxidant properties 
(Ames et a l  1981; Frei et al. 1988; Layton et al. 1996). The most important of these 
substances are bilirubin, melatonin, lipoic acid, coenzyme Q, uric acid and the 
melamins. Recent evidence suggests that uric acid has an important role in the 
endogenous antioxidant system (Glantzounis et al. 2005c; Reyes and Leary 2003) and
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that exogenous administration of uric acid could have beneficial effects in situations 
associated with oxidative stress (Chamorro et al. 2004; Waring et al. 2003).
A large number o f dietary constituents exert antioxidant effects in vivo. The most 
important are hydrophilic ascorbic acid (vitamin C) and lipophilic a-tocopherol (the 
most active form of vitamin E) that are important components o f the human antioxidant 
system. Ascorbate is required in vivo as a cofactor for many enzymes, o f which the best 
known are proline hydroxylase and lysine hydroxylase both involved in the biosynthesis 
of collagen. Its main chemical property is its ability to act as a reducing agent. It can 
scavenge most radicals such as O2 ’, OH, peroxyl, thiyl, oxysulphur radicals and 
peroxynitrite (Halliwell and Gutteridge 1990; Birlouez-Aragon and Tessier 2003). The 
lipophilic a-tocopherol is a highly effective antioxidant when incorporated in the lipid 
core o f cell membranes. It has the ability to scavenge intermediate peroxyl radicals and 
therefore interrupt the chain reactions of lipid peroxidation (Traber 1994).
Carotenoids are a group of coloured pigments that are widespread in plant tissues. They 
serve as a precursor o f vitamin A and are the principal dietary source of vitamin A in 
humans. They exert their antioxidant action as free-radical scavengers (Liebler and 
McClure 1996). Another group of antioxidants are the plant phenols. Plants contain a 
huge range o f phenols including tocopherols, tocotrienols, flavonoids, anthocyanidins 
and phenylpropanoids. They inhibit peroxidation by acting as chain-breaking peroxyl- 
radical scavengers. In addition, they scavenge ROS and RNS such as OH, ONOO' and 
HOC1 and they act as metal chelators (Rice-Evans et al. 1996; Shahidi and 
Wanasundara 1992).
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There is synergism among the different antioxidants and they are linked to each other in 
a systematic relationship as part o f the antioxidant network (Vertuani et al. 2004). 
Recent studies in myocardial I/R injury suggest that the hydrophilic agents (ascorbic 
acid, GSH) are consumed first followed by the lipophilic species (Vitamin E ) 
(Haramaki et al. 1998; Marczin et al. 2003) . It has also been shown that ascorbate can 
recycle a-tocopherol (Vertuani et al. 2004).
Figure 2.1 summarizes the main antioxidant mechanisms.
A ctiv a ted  . - t r  ^
PMN -  •  # N A D P H <
o x id a s e
Kupffer
c e l l s
A T P  'schaem la _ H y p 0 x a n t h i n e  +  Q 2  X O R — q . _
Allopurinol
G SS G  + 2 HzO GSH
Peroxidase
Desferrioxamine
Mitochondria
GSH + HoO 2 H .0  + O
DNA d a m a g e
Protein  d a m a g e
a-Tocopherol  
C o en zy m e Q
/ L \ p \ 4 \
V p e r o x id a t io n /
Figure 2.1. Basic mechanisms o f  the endogenous antioxidant system. Xanthine 
oxidoreductase (XOR) and mitochondria are the main intracellular sources o f 
production o f reactive oxygen species (ROS). Kupffer cells (KC) and activated 
neutrophils (act PMN) are the main extracellular sources for production o f ROS during 
the early and late phase o f  reperfusion respectively. The main intracellular antioxidant 
enzymes are superoxide dismutase (SOD), catalase and glutathione (GSH) peroxidase. 
A-tocopherol and coenzyme Q are the main antioxidants in cellular membranes.
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2.2 Antioxidant therapy
There is a large number o f antioxidant agents which have been shown experimentally or 
clinically to be of benefit in the treatment of liver I/R injury. Table 2.1 summarises the 
effects o f these agents in liver I/R injury.
2.2.1 Membrane and extracellular antioxidants
a-tocopherol is the most important inhibitor of the free radical chain reaction of lipid 
peroxidation. It acts as a direct free radical scavenger, increases GSH levels and has 
other non-antioxidant properties such as the inhibition o f protein kinase C (Brigelius- 
Flohe et al. 2002; Calfee-Mason et al. 2002; Masaki et al. 2002; Ricciarelli et al.
2002). A significant reduction in liver a-tocopherol levels was observed during the first 
hour o f reperfusion in a rat model of liver ischaemia (Marubayashi et al. 1984). 
Pretreatment with high and very high doses o f a-tocopherol (30 and 300 mg/kg of body 
weight i.m, respectively) improved ATP levels, prevented the increase in lipid 
peroxidation products such as thiobarbituric acid reactive substances and attenuated the 
loss o f hepatic glutathione during the early phase of reperfusion after warm ischaemia in 
rats (Giakoustidis et al. 2002). High doses of a-tocopherol (1000 U/kg) also increased 
the survival o f rats with steatotic liver which underwent warm liver ischaemia (Soltys et 
al. 2001). A-tocopherol has also shown beneficial effects in cold I/R injury (Gondolesi 
et al. 2002). Trolox C, the hydrophilic analog of a-tocopherol has shown beneficial 
effects in experimental liver I/R injury (Eum et al. 2002). The combination of a- 
tocopherol and pentoxyphilline, a drug that affects microcirculation as used in the 
treatment of peripheral vascular disease, reduces experimental warm liver I/R injury 
(Vardareli et al. 1998).
Ascorbic acid in low doses (<100 mg/kg) has also shown protective effects in hepatic 
function in an experimental study of liver I/R injury. However high doses of ascorbic 
acid (1000 mg/kg) aggravated the injury. This harmful effect could be due to the 
increased reduction o f ferric iron to the ferrous form under high ascorbic acid 
concentration (Seo and Lee 2002). A prospective randomized clinical study in patients 
undergoing liver resection used an antioxidant multivitamin infusion containing 1 0  mg 
a- tocopherol acetate and one g ascorbate administered prior to reperfusion. In the 
treated group less plasma lipid peroxidation occured and less acute liver damage as 
assessed by measurement of the prothrombin time and transaminase levels. The treated 
group also had fewer postoperative complications (postoperative liver failure and 
infections) (Cerwenka et al. 1999).
Melatonin is a hormone produced by the pineal gland that helps regulate circadian 
rhythms and exhibits antioxidant activity. In an experimental study with rats that 
underwent 60 minutes of total liver ischaemia and 2  h reperfusion, melatonin 
administration preserved functional and energetic status, reduced TNF-a production and 
inhibited expression o f iNOS (Rodriguez-Reynoso et al. 2001). One recent clinical 
study in patients undergoing liver resections suggested that the protective effect of 
melatonin may be through the enhancement of neutrophil apoptosis (Chen et al. 2003).
Pretreatment with coenzyme Q prevented the post ischaemic loss of hepatic a- 
tocopherol and glutathione (Marubayashi et al. 1984) and also attenuated the increase 
in lipid peroxidation and the decrease in mitochondrial respiration in rats submitted to 
partial hepatic ischaemia (Genova et al. 1999). Also the administration of idebenone 
that is an analog o f coenzyme Q-10, in isolated perfused pig livers reduced significantly
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the neutrophil mediated reperfusion injury (Schutz et al. 1997). The combination of 
coenzyme Q and pentoxyphylline had a protective effect in warm I/R injury by 
maintaining GSH levels and by inhibiting lipid peroxidation (Portakal and Inal-Erden 
1999).
As mentioned before free iron in its ferrous state can catalyze the formation of hydroxyl 
radical from hydrogen peroxide (Fenton reaction). In this way it can initiate lipid 
peroxidation. Desferrioxamine is an iron chelator used for the treatment of iron loading 
diseases such as Thalasaemia. Pretreatment with desferioxamine in vivo protected in 
experimental settings with warm and cold hepatic ischaemia (Omar et al. 1989; Bailey 
and Reinke 2000; Park et al. 2003).
There is a number o f experimental studies using biomolecules principally trimetazidine 
(Tsimoyiannis et al. 1993) or trimetazidine analogs (Elimadi et al. 2001) that have 
shown beneficial effects after warm liver ischaemia. The mode of action has been 
postulated to be through the chelation of metals mainly Copper (Tselepis et al. 2001). In 
addition, plant phenols (Su et al. 2003; Tsuda et al. 2002) or herbal medicines (Nagai et 
al. 1992; Chiu et al. 1999; Singh et al. 2000; Topp et al. 2001; Zhong et al. 2002; 
Sanchez et al. 2003) have shown beneficial effects (Table 2.1).
From the above it is clear that substantial experimental evidence exists about the 
protective effects of extracellular antioxidants in hepatic I/R injury. However, the 
majority of these antioxidants have not as yet been evaluated in clinical trials.
2.2. 2 Intracellular antioxidants
Thiols
Sulphydryl groups exert their antioxidant action through the oxidation o f the thiol (-SH) 
group of cysteine. Furthermore, they have a central role as mediators to the majority of 
redox-sensitive cell signaling mechanisms (Moran et al. 2001; Vertuani et al. 2004) . 
Due to their significance the role of thiols in I/R injury is presented separately at the end 
of this chapter.
Superoxide dismutase
The rational behind using SOD is to accelerate the detoxification of the superoxide 
anion, thus preventing the generation of the highly reactive OH radical. In vivo 
experimental studies in hepatic I/R have reported protective effects with SOD pre­
treatment (Atalla et al. 1985; Nauta et al. 1990). However, some other studies failed to 
show a protective effect with SOD administration (Lambotte et al. 1988; Minor et al.
1992). In order to detoxify effectively intracellular ROS the SOD molecule has to enter 
the cells intact or superoxide has to leave the cell to be metabolized extracellularly. 
There is no evidence in the liver that superoxide moves through cell membranes. The 
main problems with SOD administration are the short half-elimination life (about 6  
min) and the lack o f uptake of the intact protein into cells (Jaeschke 1991). Inadequate 
delivery to target sites could be the cause for the mixed results reported to date in the 
literature.
In order to improve the intracellular availability of SOD new derivatives have been 
developed. These include the conjugation of SOD with carbohydrate structures which 
facilitate the uptake into liver nonpenchymal cells. The techniques that have been 
developed are: mannosylation, succinylation (Yabe et al. 1999b) and pegylation
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(Veronese et al. 2002). Kupffer and sinusoidal endothelial cells have receptors that 
recognize and internalize ligands containing mannose, succinylated and pegylated 
proteins. Targeted SOD derivatives showed beneficial effects in preventing 
experimental warm liver I/R injury (Fujita et al. 1992; Nguyen et al. 1999).
Catalase
The results in the literature are ambivalent concerning the role of catalase in liver I/R 
injury (Nordstrom et al. 1988; Tanaka et al. 1990). The main problems are the same as 
with SOD, the short half-elimination life in plasma and the difficulty of protein uptake 
into cells. In order to bypass these difficulties catalase targeted derivatives have been 
developed from conjugation with carbohydrates. The initial results appear promising 
(Yabe et al. 1999a), and the administration of a combination o f both enzymes (catalase 
and SOD) has been tried and the results were found to be effective (Yabe et al. 2001). 
Among the different combinations Man-SOD and Suc-catalase have shown the greatest 
efficacy in preventing liver injury. This combination reduced significantly ICAM-1 
expression and neutrophil infiltration.
Allopurinol
Allopurinol is a XOR inhibitor. Low doses (5-10 mg/kg) are sufficient to inhibit hepatic 
activities o f xanthine oxidase and xanthine dehydrogenase almost completely, but these 
doses were not protective of liver I/R (Jaeschke 1991). On the other hand, an 
experimental study where allopurinol was administered ip, before ischaemia, at high 
doses (50 mg/kg) showed a clear protective role in rats subjected to liver I/R injury 
(Jeon et al. 2001). There is experimental evidence that allopurinol has a protective role 
in acetaminophen-induced toxicity (Knight et al. 2001) The most likely mechanism for 
this protective effect is the prevention of mitochondrial oxidative stress. An alternative 
mechanism is the action as a free radical scavenger and most probably as a scavenger of
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peroxynitrite (Knight et al. 2001). Table 2.1 summarises substances with extracellular 
and intracellular antioxidant action that have shown beneficial effects in liver I/R injury.
2.2. 3 Antioxidants that modulate NO' metabolism
NO can have either beneficial or detrimental effects in liver I/R injury. Recent evidence 
has shown that during the reperfusion period eNOS is down regulated despite iNOS 
expression in both hepatocytes and inflammatory cells during the late phase (Serracino- 
Inglott et al. 2003). The expression of iNOS is associated with evidence of ONOO' 
formation, although the exact role of peroxynitrite in liver I/R is not clear (Jaeschke 
2003). It has been postulated that when the endogenous amount o f SOD or GSH is not 
enough to inhibit ONOO' formation cellular damage can occur. Pharmacological 
intervention to block ONOO' formation could have a protective role against the toxic 
effects o f massive ONOO' production (Cuzzocrea et al. 2001). This intervention could 
act either at the level o f the reactant (NO and O2 ' )  or the product (ONOO'). Blocking 
the action o f O2 ' can be achieved by the use o f SOD or its derivatives. There are reports 
in the literature that showed beneficial effects with use o f selective inhibitors of iNOS 
in both warm and cold liver I/R injury (Isobe et al. 1999; Kimura et al. 2003).
Strategies that aim at decreasing the intrinsic life time o f ONOO' could be either 
competitive stoichiometric trapping of ONOO' or catalysis o f ONOO' decomposition to 
benign products (e.g. isomerization to nitrate). Such ONOO' decompositors have been 
developed and have as their base iron porphyrin complexes (Cuzzocrea et al. 2001). The 
search for other redox-active complexes that will accomplish catalysis of the 
peroxynitrite isomerization to nitrate still continues.
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Table 2.1 List o f  antioxidant agents w ith beneficia l effects in liver ischaem ia /  reperfusion injury.
Antioxidant C ategoiy Species Injury
Type
Mode of 
Adm.
Dose Main protectiv e 
effect
Authors (first)
A-Tocopherol Vitamin-diet Rat WI im 30 and 300 mg kg Survival, Histology Giacoustidis. 2002
A-Tocopherol Vitamin-diet Rat CI/WI iv 50 IU Kg Histology Gondolesi. 2002
A-Tocopherol
Ascorbate
Vitamins-diet Clinical WI iv 2 mg 
1000 mg
Better PT
ipostop. complications
Cerwenka. 1999
Ascorbate \'itamin-diet Rat WI iv 30 and 100 mg kg i  lipid peroxidation Seo. 2002
Coenzyme Q 
Pentoxifylline
In vivo LMM agent Rat WI In ip 10 mg kg 
50 mg kg
i lipid peroxidation 
t GSH levels
Portakal. 1999
Idebenone Coenzyme Q deriv Pig Cl Schutz. 1997
Lipoic acid In vivo LMM agent Rat Cl iv 500 pM Histology Muller. 2003
Deferrioxamine Iron chelator Dog CIWI iv 20 mg kg i AST activity Park. 2003
Trimetazidine Metal chelator Rat WI iv ip 2.5 mg kg Histology Tsimoyiannis. 1993
Quercetin Plant phenol Rat WI po 0.13 mmol kg I ALT. AST Su. 2003
Cyanidin Plant phenol Rat WI po 0.9 mmol kg I lipid peroxidation Tsuda. 2002
Green Tea Extracts Plant extracts 
(Catechines)
Rat WI po 0.1 °o Histology Zhong. 2002
Magnifera indica Plant extracts Rat WI po 250 mg kg i AST. .ALT 
i lipid peroxidation
Sanchez. 2003
Glutathione
(GSH)
In vivo LMM agent Rat WI iv 100 pM h kg i ALT 
t survival
Schauer-a. 2004
Glutathione hi vivo LMM agent Rat CIWI iv 100 pM h/kg i ALT. f bile flow Schauer-b, 2004
N-acetylcysteine Thiol compound 
GSH precursor
Rabbit WI iv 150 mg kg 1 .ALT
t microcirculation
Glantzounis. 2004
N-acetylcysteine
Melatonin
Thiol compound Rat WI ‘P 150 mg kg 
10 mg kg
i  AST. .ALT 
i lipid peroxidation
Sener. 2003
N-acetylcysteine Thiol compound Clinical Cl WI iv 150 mg kg i ICAM. 1 a-GST Weigand. 2001
Bucillamine Thiol compound Rat Cl WI Ipr
iv
15 mg kg 
10 mg kg
Survival Amersi. 2002
SOD derivatives Intracellular enzyme Rat WI iv 5000 IU Kg 1 lipid peroxidation Nguyen. 1999
CAT derivatives Intracellular enzyme Rat WI iv 0.1 mg kg I .ALT. AST Yabe. 1999
.Allopurinol XO Inhibitor Rat WI ip 50 mg kg 1 AST Jeon. 2001
Aminoguanidine iNOS inhibitor Pig Cl Wl iv 10 mg kg Survival, histology Kimura. 2003
Keys: Admin, administration; Wl, warm ischaemia; im, intramuscular; Cl, cold ischaemia; iv, intravenous; PT, 
prothrombin time; LMM, low molecular molecule; deriv, derivatives; In, Intragastric; ip, intraperitoneal; AST, 
aspartate transaminase ; ALT, alanine transaminase; ICAM-1, intercellular adhesion molecule-1; a-GST:a- 
glutathione S-transferase; ipr, intraportally; XO, xanthine oxidase
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2.2. 4 Antioxidant gene therapy
Gene therapy has recently been applied as a therapeutic strategy against I/R injury. Two 
categories o f vector systems have been used, viral and non viral. The advantages of 
virus based systems include higher infection efficiencies and the ability to encode 
multiple large genes (Engelhardt 1999). The disadvantages include immunogenicity and 
vector production issues. For these reasons non-viral vector systems using lysosomes 
and DNA-protein complexes have been developed.
In liver I/R injury predominantly to date viral vectors typically recombinant virus have 
been used. High doses of mitochondrial SOD administered via viral vector in rats 
prevented liver I/R injury via inactivation of the transcription factors nuclear factor -  
kappa B (NF-kB) and activator protein-1 (AP-l)(Zwacka et al. 1998b). Experimental 
studies in a rat liver transplantation model with normal and steatotic livers have shown 
that cytosolic and mitochondrial SOD markedly improved survival whereas 
extracellular SOD was not protective (Lehmann et a l 2000;Lehmann et al. 2003). In 
another experimental study (Wheeler et al. 2001) overexpression of the three SOD 
isoforms were all shown to protect against an increase in serum transminases and 
hepatocellular necrosis following I/R injury. They also reduced significantly the 
production o f lipid derived free radicals. The extracellular form was protective when 
administrated in high doses.
A recent in vitro study has shown that the induction o f human genes expressing the 
peroxidase peroxiredoxin, can protect murine cells effectively from oxidative stress 
(Shau et al. 2000). Gene therapy therefore has potential for amelioration of the effects 
of liver I/R. Although its value to cadaveric liver transplantation may be limited by the
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emergency nature o f the procedure, it could have application to elective liver surgery 
such as liver resection for tumours or living donor liver transplantation. However, the 
future success of gene therapies requires better understanding of the pathophysiology of 
I/R. Although ROS can cause cell injury during I/R they may also have a significant 
role in the normal cell growth and proliferation. The targets should be ROS that are 
responsible for cell injury, in addition the subcellular compartments that produce 
detrimental ROS should be identified. A recombinant adenoviral vector has been used 
to inhibit NF-kB activation in a model of partial hepatectomy (Iimuro et a l 1998), 
resulting in massive apoptosis and also delaying the regeneration process. This study 
showed that NB-kB is important in preventing apoptosis and also in enabling liver 
regeneration.
2.2.5 THIOLS
Thiol compounds contain sulphydryl (-SH) groups and exert their protective effect 
against I/R injury by reacting with ROS and RNS. They undergo one-electron oxidation 
with the formation o f thiyl radicals (R S) and exert their antioxidant properties through 
scavenging o f free radicals, chelation of metal ions and the thiol/disulfide component of 
redox buffer (Laragione et al. 2003). There is significant in vitro and in vivo evidence 
showing the consumption of thiols in conditions associated with oxidative stress (Bilzer 
et a l  1999; Haramaki et a l 1998; Leichtweis and Ji 2001; Schauer et a l 2004a; Sirsjo 
etal. 1996).
Thiols are central to cellular antioxidant defence in mammals. Glutathione and 
thioredoxin are thiols which act as substrates for the enzymes glutathione peroxidases 
and peroxyredoxines respectively . These molecules are the main part o f the endogenous
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antioxidant system responsible for removal of the H2 O2 generated under conditions of 
oxidative stress (Halliwell and Gutteridge 1999).
Thiols also play an important role in most redox-sensitive signalling mechanisms. 
Recent evidence suggests that thiols can act as redox sensitive switches providing a 
common trigger for a variety of ROS and RNS mediated signalling events. Under 
normal conditions they use ROS as a mediator to regulate their protein activity 
(Leichert and Jakob 2004; Linke and Jakob 2003; Moran et al. 2001). A typical 
example is the reversible redox state of cysteine, an amino acid that plays an important 
role in the structure, function and regulation of proteins. The active element is the thiol 
(-SH) group o f cysteine which when performing its antioxidant activity is oxidised to 
cystine or cysteine disulfide (Leichert and Jakob 2004).
The endogenous thiols thioredoxin and glutathione are also o f central importance in 
redox signalling (Droge et al. 1994; Nakamura et al. 1997). The oxidation and 
enzymatically catalysed reduction of methionine is a novel molecular mechanism for 
cellular regulation. Methionine sulfoxide reductase is an enzyme that reduces 
methionine sulphoxide to methionine in a thioredoxin-dependent manner. There is 
evidence that it plays an important role in the repair o f age- or degenerative disease - 
related protein modification (Hoshi and Heinemann 2001).
However, antioxidant reactions of thiols yield thiyl radicals (R S ) that can be toxic. 
Under normal conditions thiyl radicals can react with thiolate anion (RS') producing 
disulfide radical anions (RSSR *) as an intermediate and then disulfides and superoxide 
anion (O2 ') which can have also toxic effects. Winterboum proposed in 1993 ‘the
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radical sink hypothesis’ which suggests a coordinated antioxidant action between GSH 
and SOD. According to this hypothesis SOD will catalyze the dismutation of superoxide 
anion terminating the biologically generated free radical (Winterboum 1993; 
Winterbourn and Metodiewa 1994). More recent evidence suggests that vitamin C plays 
a very important role in the detoxification of thiyl radicals and that reaction of thiyl 
radicals with ascorbate with the formation of the low activity ascorbyl radical is the 
most probable mechanism associated with detoxification o f thiyl radicals (Sturgeon et 
al. 1998). Figure 2.2 summarises the reactions between thiols, oxidants and 
antioxidants.
RSH + R RH + RS
RS + RS‘ RSSR-
RSSR + 0 2 *  RSSR + O ,'
2 0 /  + 2YC SOD O? + H2O2
RS + Asc- -------- ► RSH + Asc'
Figure 2.2: Reactions o f thiols with oxidants yield thiyl radicals first, then disulfide 
radical anion and finally disulfides and superoxide anion, which is believed to be 
inactivated in the reaction catalysed by the enzyme superoxide dismutase. An 
alternative pathway that probably plays a more important role in the detoxification of 
thiyl radicals is the reaction with ascorbate (vitamin C). Keys: RSH: thiol, R : free 
radical, RS : thiyl radical, RSSR* : disulfide radical anion, O2 '" : superoxide anion, 
SOD: superoxide dismutase, H2 O2 : hydrogen peroxide, A sc -: ascorbate, Asc : ascorbic 
radical.
Another recent study showed that the copper, zinc superoxide dismutase isoenzyme 
(Cu, Zn-SOD) catalyses autoxidation of thiols such as cysteine and cysteamine, 
generating substantial amounts of hydrogen peroxide which may contribute to the 
toxicity o f thiols (Winterboum et al. 2002). This data shows that the metabolic 
pathways o f thiol reactions with oxidants are not yet fully elucidated and that a 
coordinated action is required between the major endogenous antioxidants for the toxic 
effects of thiyl radicals to be eliminated.
THIOREDOXIN
Thioredoxin is a polypeptide especially concentrated in the endoplasmic reticulum 
(Trxl) but it is also found in mitochondria (Trx2). It is used as an electron donor by the 
antioxidant enzymes peroxyredoxins for the reduction o f hydroperoxides and 
peroxynitrite (Rhee et al. 2005). Thioredoxin contains two adjacent -SH  groups in its 
reduced form, which are converted to a disulphide in the oxidized form of thioredoxin. 
Because o f its dithiol/disulfide exchange activity, thioredoxin determines the oxidation 
state o f many protein thiols. Therefore it plays important roles in antioxidant defence, 
redox regulation of protein function and signal transduction. While GSH has one 
cysteine, thioredoxin has two cysteins in its active site. Thioredoxin together with 
thioredoxin reductase and peroxyredoxins forms a complete redox system similar to 
GSH system. GSH and thioredoxin often have complementary if  not overlapping roles 
in cytoprotection.
Antioxidant properties o f thioredoxin include removal o f hydrogen peroxide (Spector et 
al. 1988), free radical scavenging (Schallreuter and Wood 1986), and protection of cells 
against oxidative stress (Nakamura et al. 1994; Tanaka et al. 1997). In the current
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literature, there is indirect evidence on the effect o f thioredoxin on liver I/R. An 
experimental study from Japan showed that the agent geranylgeranylacetone (GGA), an 
acyclic polyisoprenoid, which is used as an antiulcer drug, showed protective effects in 
a rat model undergoing warm liver I/R (Fudaba et al. 1999). Subsequently another study 
showed that GGA induces expression of m-RNA and protein o f thioredoxin suggesting 
cytoprotective effects through thioredoxin (Hirota et al. 2000).
There are more data on the efficacy of thioredoxin in the myocardium. A recent study 
demonstrated a reduction of thioredoxin-1 , in the ischaemic reperfused myocardium. 
There was an increased induction of thioredoxin-1 expression when the heart was 
adapted to ischaemic stress by ischaemic preconditioning. Inhibition of thioredoxin-1 
expression resulted in reduced postischaemic ventricular recovery and increased 
myocardial infarct size in the preconditioned heart. Corroborating these findings, 
transgenic mouse hearts overexpressing thioredoxin were resistant to I/R injury as 
compared with the hearts from wild-type mice (Das and Maulik 2003; Das 2004; 
Turoczi et al. 2003). Thus, it appears that thioredoxin plays a crucial role in 
cardioprotection induced by preconditioning. A recent study has shown that 
exogenously applied thioredoxin reduced myocardial I/R injury in mice likely through 
its antiapoptotic effects (Tao et al. 2004).
Thioredoxin has also been shown to have a protective effect in lung I/R injury 
(Nakamura et al. 2005). The role of human thioredoxin and L-cysteine in I/R lung 
injury has been studied in isolated rat lungs. Thioredoxin and L-cysteine added to the 
pulmonary artery flush solution before ischaemia significantly reduced the wet to dry 
lung weight ratio and the albumin concentration in the bronchoalveolar lavage fluid
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(Wada et al. 1995). In another experimental study, rats underwent lung I/R and treated 
with thioredoxin had significant better survival rate compared with controls. 
Thioredoxin also increased arterial oxygen tension and reduced lipid peroxide, 
superoxide dismutase, and glutathione peroxide levels. Histology showed less 
thickening and oedema o f the alveolar walls in the thioredoxin group than in controls 
(Fukuse et al. 1995). The thioredoxin administered during reperfusion significantly 
increased arterial oxygen tension after reperfusion (Okubo et al. 1997). Human 
thioredoxin also reduced reperfusion injury in a canine lung transplantation model (Yagi 
etal. 1994).
Thioredoxin has also been investigated in the kidney, in C57BL/6 and transgenic mice 
overexpressing thioredoxin during renal I/R (Kasuno et al. 2003). With I/R, endogenous 
murine thioredoxin was rapidly depleted from the cytosol in the cortical proximal 
tubules and detected in the urinary lumen. The urinary excretion of thioredoxin 
increased transiently after I/R. These transgenic mice with overexpression of 
thioredoxin were more resistant to I/R injury compared with wild-type mice, suggesting 
that exogenous application of thioredoxin may reduce renal I/R injury.
Thioredoxin can permeate the blood-brain barrier in cerebral ischaemia, which has an 
important biological role in the regulation of various intracellular molecules. Exogenous 
thioredoxin exerts distinct cytoprotective effects on cerebral I/R injury in mice by 
means o f its redox-regulating activity (Hattori et al. 2004). Expression o f thioredoxin in 
transgenic mice decreased ischaemic neuronal injury, after focal brain ischaemia, in 
comparison to wild-type mice. This shows that thioredoxin and the redox state modified
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by thioredoxin play a crucial role in brain damage during I/R injury (Takagi et al. 
1999).
The role o f thioredoxin in redox signalling and amelioration of I/R injury in the 
ischaemic liver is a promising field for research.
LIPOIC ACID
Lipoic acid is a dithiol (8 -carbon open or cyclic disulfide) that is found as a prosthetic 
group in a-keto acid dehydrogenase complexes o f mitochondria and has an important 
role in cell metabolism (Packer 1998) . It is a cofactor in the multi-enzyme complexes 
that catalyse the oxidative decarboxylation o f a-keto acids, such as pyruvate and a- 
ketoglutarate (Takaoka et al. 2002). It has antioxidant properties due to direct radical 
scavenging and metal chelating by both lipoic acid and its reduced form dihydrolipoate 
(DHLA). It also has regulatory action on signal transduction processes. Levels of free 
lipoic acid in tissues and body fluids are very low, so it is unlikely to have antioxidant 
effects in vivo. However, exogenous administration of lipoic acid could have beneficial 
effects in conditions associated with oxidative stress, since it has a wide range of 
antioxidant properties and also the ability to promote the synthesis of other endogenous 
antioxidants such as a- tocopherol and GSH (Packer et al. 1995). When administered to 
cells, lipoate is reduced rapidly to DHLA and released outside the cell. DHLA released 
from cells reduces extracellular cystine to cysteine, and thus promotes cellular cysteine 
uptake and through this GSH synthesis. It can also reduce GSSG to GSH.
The administration of a-lipoic acid has been shown to be beneficial in various organ 
oxidative stress injury. It has potential applications both in the prevention and treatment
of diabetic complications such as diabetic neuropathy (Packer et a l  1995) where 
oxidative stress is regarded as main pathogenetic factor (Pacher et a l 2005). a-lipoic 
acid (thioctic acid) is available in Germany and has been used extensively in clinical 
trials for the treatment o f diabetic neuropathy. A previous review of 15 clinical trials 
(Ziegler et al. 1999) and subsequent meta-analysis (Ziegler et a l  2004) involving the 
use o f a-lipoic in the treatment of diabetic neuropathy showed promising improvement 
in neuropathic symptoms and neuropathic deficits in patients with diabetic 
polyneuropathy. A small case series suggests that a-lipoic acid may also ameliorate 
chemotherapy-induced neuropathy caused by docetaxel and cisplatin (Gedlicka et a l  
2003). In vitro and in vivo experimental models of I/R injury have shown a beneficial 
role for a-lipoic acid administration in protection to heart (Coombes et a l 2000; Scheer 
and Zimmer 1993), brain (Packer et a l  1997), kidney (Takaoka et a l 2002) and retina 
(Chidlow et a l  2002). In liver I/R injury, pre-treatment with a-lipoic acid decreased the 
indices o f I/R injury both in isolated perfused livers and in vivo (Muller et a l 2003). In 
the latter study (Muller et a l  2003) the authors observed that inhibition of the 
phosphatidylinositol PI3-kinase/Akt pathway, blocked the protective effect o f a-lipoic 
acid on I/R injury. In another experimental study with rat hearts, phosphatidylinositol-3- 
kinase activation upstream of protein kinase C has been proposed as a signalling 
pathway in the mechanism of ischaemic preconditioning (Tong et a l 2000). Although 
the cellular contents of a-lipoic acid were not measured in M uller’s study (Muller et a l
2003) and the evidence for liver protection is indirect through pharmacological 
manipulation, this study provides encouragement to further studies in order to explore 
the potential role for a-lipoic acid as a therapeutic agent in liver I/R injury. Clinical 
trials regarding pharmacological benefits of a-lipoic acid in liver I/R injury are lacking. 
There are no reports o f serious side effects with a-lipoic acid administration in animal
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or human studies and this should encourage clinical trials with a-lipoic acid in liver I/R 
injury.
GLUTATHIONE
Glutathione (GSH) is an endogenous molecule present in all animal cells, in millimolar 
concentrations. It has multifaceted physiological functions (Smith et al. 1996; Wu et al.
2004) such as antioxidant defence, detoxification o f xenobiotics, modulation of redox- 
regulated signal transduction, regulation of cell proliferation, synthesis o f deoxy- 
ribonucleotides, regulation of the immune response and regulation of leukotriene and 
prostaglandin metabolism. The cysteine sulfhydryl (-SH) side chain o f glutathione 
accounts for most o f its physiological properties.
The antioxidant function of GSH occurs through two mechanisms of reaction with 
ROS: direct or spontaneous and glutathione peroxidase (GPX) catalysed. As a major by­
product o f such reactions oxidised glutathione (GSSG) is produced (reaction 4). GSSG, 
can then be again reduced to GSH with the participation of glutathione reductase and 
NADPH (reaction 5):
GSSG + NADPH + H  + ------> 2 GSH  + NADP (5)
Depletion of reduced GSH indicating a decrease in the antioxidant capacity of the cell, 
has been associated with aging (Droge 2002; Thomas and Mallis 2001; Suh et al. 2005), 
inflammation (Villa et al. 2002), I/R injury (Leichtweis and Ji 2001) and 
neurodegenerative diseases (Drake et al. 2002; Bharath et al. 2002).
In liver I/R injury, two experimental studies with a rat model o f liver transplant 
(Schauer et al. 2004b) and liver I/R (Schauer et al. 2004a), have used a continuous 
intravenous administration of GSH during reperfusion. This decreased sinusoidal 
endothelial cell and hepatocellular injury, improved postischemic bile flow and restored 
sinusoidal flow. The GSH-mediated protection o f the liver grafts was associated with an 
increase o f GSSG in plasma, suggesting detoxification o f ROS by the intravenously 
administered GSH. Previous studies from the same group showed that continuous 
infusion o f GSH during reperfusion of cold preserved livers (Bilzer et al. 1999) and 
after warm I/R (Bilzer et al. 2002) prevented Kupffer cell-related reperfusion injury. 
Continuous infusion o f GSH has been used in another experimental study and protected 
the liver from endotoxin induced liver injury during I/R (Liu et al. 1994). These studies 
show a therapeutic potential for GSH in ROS- mediated reperfusion injury.
A similar finding with GSH administration was found with myocardial I/R. In an 
experimental study where pigs underwent coronary I/R the use o f a glutathione 
monoethylester reduced reperfusion-induced myocardial damage (Guamieri et al.
1993). The infusion with glutathione monoethylester decreased the depletion of tissue 
GSH and improved the GSH/GSSG ratio. Moreover, the drug decreased mitochondrial 
dysfunction at the level of pyruvate utilization and partially prevented the fall in ATP in 
reperfused tissue. GSH administration has also been shown to improve the recovery of 
myocardial function after I/R in perfused hearts. This protective effect could be through 
detoxification of peroxynitrite and the stimulation o f soluble guanylate cyclase (Cheung 
et al. 2000). Addition o f GSH in crystalloid cardioplegia detoxifies ONOO' and forms 
cardioprotective nitrosoglutathione, resulting in attenuated neutrophil adherence and
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endothelial protection through the inhibition of neutrophil-mediated damage (Nakamura 
et al. 2 0 0 0 ).
Overall, the evidence suggests that exogenous GSH administration is associated with 
reduction o f I/R injury in experimental settings associated with extracellular oxidative 
stress. Also, GSH has low toxicity in humans (Aebi et al. 1991), low cost and appears to 
be an attractive agent for use in clinical settings. However, we should bear in mind that 
GSH is a large molecule that is not transported efficiently into cells and exogenous 
GSH administration may not exert significant antioxidant effects in situations associated 
mainly with intracellular oxidative stress(Amersi et al. 2002; De Flora et al. 2001; 
Jaeschke 1991).
N-ACETYLCYSTEINE
As mentioned above, exogenous GSH administration has limited cellular uptake due to 
its large molecular size and this may limit its value in situations associated with severe 
intracellular oxidative stress. Also a common limiting factor in GSH synthesis is the 
bio-availability of cysteine inside the cell. Cysteine per se is highly unstable in its 
reduced form. As a result, considerable research has focused on alternative strategies for 
cysteine delivery. In the N-acetylated form, i.e. N-acetylcysteine (NAC) the redox state 
of cysteine is markedly stabilized. After free NAC enters a cell, it is rapidly hydrolysed 
to release cysteine (Cotgreave 1997). NAC (figure 3) has a much smaller molecular size 
compared to GSH and was initially introduced for the treatment o f congestive and 
obstructive lung diseases, primarily those associated with hypersecretion of mucus (e.g. 
chronic bronchitis and cystic fibrosis) (Boman et al. 1983). NAC is currently the drug
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of choice for the management o f fulminant liver failure due to paracetamol overdose 
(Cotgreave 1997). The diversity in the pharmacological uses o f NAC is due to the 
multiple chemical properties o f the cysteinyl thiol o f the molecule. These include its 
nucleophilicity and redox reactions. The main mechanism o f  action o f NAC is through 
the metabolism to cysteine in vivo and synthesis o f  GSH (Winniford et al. 1986). 
However, some effects o f NAC are not mediated by an increase o f GSH, as suggested 
by experiments with inhibitors o f GSH synthesis or the D-stereoisomer o f  NAC (D- 
NAC) that cannot be converted to GSH. These effects include direct scavenging o f  ROS 
and RNS, inhibition o f apoptosis (Yan et al. 1995), antiproliferative effects (Kim et al.
2001) and direct reduction o f functional protein thiols at the cell surface (Laragione et 
al. 2003).
o
OH
HS
C
O
Figure 2.3: Chemical structure of N-acetylcysteine
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The clinical benefit o f NAC in liver I/R is still ambivalent (Chavez-Cartaya et al. 1999; 
Koeppel et al. 1996). This probably relates to differences in the method of NAC 
administration and the duration of follow up.
In the field o f liver transplantation, there are six published small (9-30 patients in each 
group) clinical trials (5 randomised controlled trials and one open label pilot study) that 
assessed the effect o f intravenous NAC administration and patient outcome. In the first 
study NAC improved oxygen delivery and consumption but had no effect in 
postoperative graft function, morbidity or mortality (Bromley et al. 1995). The second 
failed to show any clear protection on postoperative graft function (Steib et al. 1998). 
The third clinical study showed that NAC administration was associated with better 
liver function, less hepatocellular injury and lower incidence o f primary graft 
dysfunction (Thies et al. 1998). The fourth study showed that NAC attenuated the 
increase in a-glutathione S-transferase, circulating ICAM-1 and VCAM-1 after liver 
transplantation, indicating cytoprotective effects (Weigand et al. 2001). In the fifth 
study NAC was used in combination with prostaglandin Ei in pediatric liver transplant 
recipients. In this pilot study peak serum ALT was lower and median postoperative in- 
hospital stay was shorter in the treated group, while rejection was less severe 
(Bucuvalas et al. 2001). The most recent published study (Khan et al. 2005) is a small 
study (9 patients each group), where NAC was administered (intravenously and via the 
portal vein) only to the donors. NAC administration did not affect peak transaminases 
or episodes o f acute rejection in the recipients.
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It is obvious that there is a significant variability in the results o f these clinical trials. 
This could be due to differences in methodology, time and length o f administration and 
primary end points. No large scale randomised trial has been performed as yet.
Another interesting effect of NAC administration is the reversal of the effects o f 
ischaemic preconditioning. Ischaemic preconditioning is the application o f short periods 
of I/R prior to major ischemic insult and is associated with a protective effect in 
different I/R settings (Koti et al. 2002; Koti et al. 2003; Murry et al. 1986; Peralta et al. 
1997). ROS are thought be essential for the preconditioning response against I/R injury 
(Jaeschke 2003; Sindram et al. 2002) suggesting a role for ROS in redox signalling. 
Two studies found that the inhibition of ROS by NAC was detrimental to liver 
protection from ischaemic preconditioning. Sindram et al (Sindram et al. 2002) found 
that pre-treatment with NAC reversed the beneficial effects of ischaemic 
preconditioning on sinusoidal endothelial cell detachment and apoptosis in rat livers 
subjected to cold preservation and reperfusion injury. Tejima et al (Tejima et al. 2004) 
found that scavenging of ROS with NAC treatment reversed the protective effects of 
ischaemic preconditioning in rat livers subjected to warm I/R injury. These findings 
suggest that small amounts of ROS are acting as signalling molecules for the body’s 
response against I/R injury.
NAC has been investigated extensively in the treatment o f I/R in other organs. Animal 
studies utilising NAC in myocardial I/R injury showed that NAC administration 
reduced the extent of infarction and limited oxidative stress with enhanced contractile 
recovery (Fischer et al. 2003; Sochman et al. 1990; Tang et al. 1991). A pilot clinical 
study (Arstall et al. 1995) showed that the combination of NAC, nitroglycerin and
streptokinase in the treatment of myocardial infarction, produced less oxidative stress, 
more rapid reperfusion and better preservation of left ventricular function. The ISLAND 
(Infarct Size Limitation: Acute N-acetylcysteine Defense) a randomized angiography- 
and echocardiography-controlled study (Arstall et al. 1995; Sochman et al. 1995; 
Sochman et al. 1996; Sochman 2002) showed that a combination of NAC and 
streptokinase reduced infarct size and improved left ventricular (LV) function, in 
comparison to patients with reperfusion induced by streptokinase alone or in 
comparison to patients with failed reperfusion.
In a small prospective randomised clinical trial (Andersen et al. 1995) the perioperative 
administration of N-acetylcysteine in patients undergoing coronary artery bypass 
grafting significantly reduced the postoperative neutrophil oxidative burst response, an 
indicator o f oxidative stress. Subsequently Tossios et al (Tossios et al. 2003) studied the 
effect o f NAC administration on oxidative stress markers, in LV biopsy specimens, 
taken from patients who underwent coronary artery bypass surgery. They found that in 
the NAC group the levels of 8 -iso-prostaglandin-F2a (a marker o f lipid peroxidation) 
and of nitrotyrosine (a marker of nitrosative stress) were significantly lower compared 
with the placebo group, at the end o f the cardiopulmonary bypass. The same group 
(Fischer et al. 2004) also studied the effect of NAC on myocardial apoptosis in the same 
patient group. They found that cardioplegic arrest initiates the apoptosis signal cascade 
in human LV cardiac myocytes (as expressed by caspases -3  and -7). NAC prevented 
the cardioplegia-induced apoptosis. Despite these promising small-scale trials, no large- 
scale trial has been conducted to confirm a clear benefit o f NAC in reducing reperfusion 
injury in the treatment o f acute myocardial infarction or surgically induced I/R during 
cardiac surgery (Marczin et al. 2003; Sochman 2002).
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In a recent study NAC ameliorated lung reperfusion injury in dogs after deep 
hypothermia and total circulatory arrest (Cakir et al. 2004). Renal I/R injury is of 
clinical interest because of its role in renal failure and renal allograft rejection. 
Experimental studies have shown that NAC administered prior to ischaemia and 
immediately before the reperfusion period reverses I/R induced nephrotoxicity, as 
evidenced by decreases in blood urea nitrogen and creatinine and better histology 
(Sehirli et al. 2003). This protective effect is associated with less oxidative stress as 
indicated by less lipid peroxidation and maintenance o f GSH levels. NAC has also been 
shown to ameliorate ischaemic acute renal failure in experimental models of kidney 
transplantation. Donor pretreatment with NAC preserved renal metabolism and 
improved outcomes o f I/R injured kidney transplants (Fuller et al. 2004; Lin et al. 
2004).
Administration o f NAC before ischaemia attenuated cerebral I/R injury in a rat model of 
experimental cerebral ischaemia (Cuzzocrea et al. 2000b; Sekhon et al. 2003). Animals 
treated with NAC showed significant reductions in brain infarct volume and the 
neurological score as compared to the untreated animals. NAC treatment also 
maintained GSH levels and reduced apoptotic cell death in ischaemic brain. NAC 
treatment also blocked the I/R-induced expression of TNF-a and inducible nitric oxide 
synthase (Khan et al. 2004).
A newly designed amide form of NAC, N-acetylcysteinamide (AD4), in which the 
carboxylic group is neutralized, is more lipophilic and cell-permeating. This compound 
was shown to cross the blood-brain barrier, scavenge free radicals, chelate copper ions
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and protect mice from experimental autoimmune encephalomyelitis, a condition used as 
a animal model o f multiple sclerosis and characterized by significant oxidative stress 
(Offen et al. 2004). Also AD4 protected human red cells from oxidative stress more 
efficiently than NAC (Grinberg et al. 2005).
BU CILL AMINE
Bucillamine is a low molecular weight thiol, containing two sulphydryl groups. Along 
with its antioxidant properties it has anti-inflammatory properties and is used for the 
treatment of rheumatoid arthritis (Horwitz 2003). Bucillamine is fourfold more potent 
than NAC in in vitro studies (Whitekus et al. 2002) and in mice 20 mg /kg i.p o f 
bucillamine had similar effects to a 16-fold greater dose o f NAC (320 mg/kg i.p.).
Similar to other cysteine derivatives such as NAC, bucillamine has the ability to 
replenish intracellular GSH, prevent decrease in intracellular GSH and thus maintain the 
antioxidant line o f defence against oxidative stress. Its effects in I/R injury have only 
been evaluated in experimental studies so far. Amersi and colleagues (Amersi et al.
2 0 0 2 ) conducted the first study investigating the effect o f bucillamine on oxidative 
stress and I/R injury in a rat model of liver transplantation. This was a well conceived 
and executed study, involving ex vivo perfusion o f normal and fatty livers and an in 
vivo model of syngenic orthotopic liver transplants in rats. In these models bucillamine 
treatment resulted in significantly decreased I/R injury and increased survival after 
transplant, increased levels of GSH in the liver and decreased levels of oxidized 
glutathione in both liver and blood. These findings suggest that this agent may be a 
useful target in liver protection against I/R injury. In a phase I human study in normal
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volunteers, bucillamine at doses up to 25 mg/kg/h i.v. for 3 h elicited no serious drug- 
related adverse effects (Horwitz 2003).
Regarding cardiac I/R injury Horwitz and Sherman (Horwitz and Sherman 2001) 
demonstrated in isolated rat cardiac myocytes that it is a potent antioxidant; bucillamine 
(125-500 pM) prevented lactate dehydrogenase (LDH) release in cardiac myocytes 
exposed to hydrogen peroxide or a xanthine/xanthine oxidase system. Further, in dogs 
subjected to 90 min o f coronary artery occlusion and 48 h of reperfusion, bucillamine, 
administered during reperfusion decreased myocardial infarct size by 41% (Horwitz and 
Sherman 2001).
2.2.6 CONCLUSIONS
Liver I/R injury occur in a number of clinical settings in general surgery and is 
associated with increased morbidity and mortality. ROS and RNS play a major role in 
the pathophysiology o f I/R injury. The antioxidant defence system is a complex system 
that includes intracellular enzymes, non-enzymatic substances that act as scavengers 
and dietary components. It normally controls the production of ROS and RNS. 
Oxidative stress occurs when there is significant imbalance between production and 
removal o f ROS and RNS. This occurs principally when antioxidants are depleted or 
oxidants are overproduced.
Antioxidant therapy is a promising therapeutic strategy to ameliorate liver I/R injury. 
Drug therapy has distinct advantages when compared to surgical strategies such as 
ischaemic preconditioning and intermittent clamping, since it can be applied in 
conditions where the surgical strategies can not be applied (typically transplantation or
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haemorrhagic shock) and at the same time avoid the detrimental effects that the surgical 
techniques possess. In recent years new strategies have been developed using for 
example SOD and CAT derivatives, thiol compounds, selective NOS inhibitors, 
peroxynitrite decompositors, and gene therapy. Although the results are still not entirely 
clear; there is accumulative evidence, mainly from in vitro and in vivo experimental 
studies, that the administration o f antioxidant substances can reduce the post reperfusion 
liver injury.
However important parameters have to be taken in account before antioxidant therapy is 
applied: a) Free radical pathways are very complex and more studies are needed for an 
in depth understanding of the mechanisms involved. ROS and RNS at low 
concentrations have an important role as signal, trigger and messenger molecules in 
cellular growth and metabolism (Gutteridge and Halliwell 2000; Olthoff 2002). The 
understanding o f the signal transduction mechanisms and the role o f ROS and RNS in 
them enables us to develop therapeutic strategies that will then target detrimental 
oxidative stress but without affecting the pathways that are responsible for normal cell 
growth, repair and regeneration after liver I/R. b) Free radicals are very reactive with 
extremely short half lives. Timing of intervention is critical, c) Certain antioxidants can 
also exert prooxidant effects under specific conditions (Vertuani et al. 2004). d) 
Differences between species, duration of ischaemia, dose, timing and mode of drug 
administration, distribution problems and different end points may account for the 
inconsistency found in the results.
Regarding thiols antioxidant action is determined by both, efficient detoxification o f 
free radicals and inactivation of the concurrently created thiyl radicals. Determining
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which signalling pathways lead to alterations in thiol metabolism is critical for 
understanding the mechanisms of and developing therapies for exogenous oxidative 
stress.
In choosing a thiol for a specific action the global effects should be considered. It has 
been found that large increases in free thiols in the circulation are associated with toxic 
effects. This could be the results of thiyl radical mediated reactions. The changes also in 
the thiol redox gradient across cells could affect transport or cell signalling processes 
which are dependent on formation and rupture of disulphide linkages in membrane 
proteins.
In the next chapter the experimental model, along with the methodology used in this 
thesis is described.
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2.3 Chapter summary
Oxidative stress is an important factor in many pathological conditions such as 
inflammation, cancer, ageing and organ response to ischaemia-reperfusion. Humans 
have developed a complex antioxidant system in order to eliminate or attenuate 
oxidative stress. Liver ischaemia-reperfusion injury occurs in a number of clinical 
settings, including liver surgery, transplantation and haemorrhagic shock with 
subsequent fluid resuscitation; leading to significant morbidity and mortality. It is 
characterized by significant oxidative stress and accompanied with depletion of 
endogenous antioxidants. The administration of antioxidant agents could provide 
protection from the harmful effects of I/R injury.
Thiol-containing compounds have an essential role as antioxidants and signalling 
molecules. They participate in many biochemical reactions due to their ability to be 
easily oxidised and then quickly regenerated. Main representatives are glutathione, 
lipoic acid and thioredoxin which are synthesised de novo in mammalian cells. N- 
acetylcysteine and Bucillamine are synthetic thiols which have been administered in 
experimental and clinical studies for treatment of conditions associated with oxidative 
stress.
This review-chapter had two aims: firstly, to describe the main pathways by which the 
antioxidants function. Secondly, to highlight the new developments that are ongoing in 
antioxidant therapy and to present the experimental and clinical evidence about the role 
of antioxidants in modulating hepatic ischaemia-reperfusion injury with particular 
emphasis on thiols.
CHAPTER 3
MATERIALS AND METHODS
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3.1 Animal model of lobar liver I/R injury
The study was conducted under a project license granted by the Home Office in 
accordance with the Animals (Scientific Procedures) Act 1986. New Zealand white 
rabbits were used for the experiments. All animals were kept in temperature controlled 
environment with 12 h light-dark cycle. Animals were kept without food overnight prior 
to the experiments. Experimental research protocols were approved by the hospital 
ethics committee.
Anaesthesia was induced by intramuscular injection o f 0.5 ml/kg Hypnorm™ (fentanyl 
citrate and fluanisone; Janssen Animal Health, High Wycombe, Buckinghamshire, UK). 
Following tracheostomy, anaesthesia was maintained with 0.5-3 % isoflurane through 
an anaesthetic circuit. Body temperature was maintained at 37-38.5°C by a warming 
blanket (Harvard Apparatus, Southmatick, Massachusetts, USA) and monitored with 
rectal temperature probe. Haemoglobin saturation and heart rate were recorded 
continuously by a pulse oximeter (Ohmeda® Biox 3740 pulse oximeter; Ohmeda, 
Louisville, Colorado, USA). A radio-opaque catheter 20 gauge (GA) was inserted into 
the right femoral artery or into the right ear marginal artery and connected to a pressure 
transducer for monitoring of mean arterial blood pressure. Ear marginal veins were 
cannulated with radio-opaque catheters (22 GA) for the administration of anaesthetics, 
fluids and medication.
Laparotomy was performed through a midline or transverse subcostal incision. The 
ligamentous attachments from the liver to the diaphragm were divided and the liver was 
exposed. Lobar ischaemia was induced by clamping the vascular pedicles o f the median 
and left lobes of the liver, using an atraumatic microvascular clip. This method produces
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a severe ischaemic insult without mesenteric venous hypertension (Koo et al. 1992). 
After 60 min of ischaemia, the vascular clip was removed and reperfusion was allowed 
for up to 7 h. At the end of the experiment the animals were killed by exsanguination.
Hepatic microcirculation was continuously measured via a probe placed on a fixed site 
on the median lobe o f the liver and held in place by a retort holder during ischaemia and 
reperfusion period. Hepatic tissue oxygenation was continuously measured via optodes 
placed on the surface o f the left liver lobe during ischaemia and reperfusion period.
Blood samples (1 ml each) were collected from the arterial line at different time points 
during the experiment for blood gases, serum transminases, CK, LDH, plasma nitrite, 
nitrates and nitrosothiols.
Liver tissue at baseline and at the end of the experiment was taken from the ischaemic 
liver lobe, placed immediately in liquid nitrogen and stored in -80 °C for nitrotyrosine 
measurement. Also liver tissue samples fixed in 10% formalin for histological study.
3.2 Hepatic microcirculation
3.2.1 Basic principles
Hepatic microcirculation (HM) was measured by a surface laser Doppler flowmeter 
(LDF) (DRT4, Moor Instruments Limited, Axminster, UK) in flux units. Measurement 
is easy to perform and provides a continuous signal without interference with tissue 
blood flow (Almond and Wheatley 1992; Shepherd et al. 1987; Wheatley et al. 1993).
Briefly, a monochromatic laser light from a 2mV-helium neon laser operating at 632 nm 
is guided to the tissue via optical fibres. The back-scattered light from the tissue is
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transmitted through optical fibres to photodetectors. Only the photons which are 
scattered by moving red blood cells will have a Doppler frequency shift, whereas those 
from the static tissue matrix will not be Doppler shifted. Mixing o f these components at 
the photo detector surface produces an electrical signal containing all o f the Doppler 
frequency shift information. Further processing o f the signal produces an output voltage 
that varies linearly with the product of total number o f moving red blood cells in the 
measured volume of a few cubic millimetres multiplied by the mean velocity of these 
cells.
Linearity o f the LDF signal from the liver with total organ perfusion has been 
demonstrated and the technique has been shown to be sensitive to rapid changes in 
organ blood flow (Almond and Wheatley 1992; Hewett and Murray 1993; Shepherd et 
al. 1987; Wheatley et al. 1993). The LDF measurements are expressed in arbitrary 
perfusion units (flux). Due to the problems associated with variation in signal across the 
surface o f the liver, it is not possible to apply a conversion factor so that the LDF signal 
can be expressed in absolute flow units (Almond and Wheatley 1992; Hewett and 
Murray 1993; Wheatley et al. 1993).
The application and reproducibility of LDF measurement for assessment o f liver 
microcirculation has been validated in both experimental animals (Hewett and Murray 
1993; Wheatley et al. 1993) and human liver transplantation (Seifalian et al. 1997).
3.2.2 LDF application in the rabbit, data collection, analysis
The hepatic microcirculation in this study was assessed using a commercially available 
dual channel surface laser Doppler flowmeter (DRT4, Moor Instruments Ltd., Devon,
UK) (Figure 3.1). The LDF was calibrated before each study against a standard 
reference (Brownian motion of polystyrene micro spheres in water) provided by the 
manufacturer. The LDF probe was placed on a fixed site on the median lobe of the liver 
in order to avoid any error due to anatomical variation in the microcirculation. It was 
held in place by a probe holder in order to minimise any disturbance to blood flow by 
the LDF probe pressure on the tissue. Data were collected continuously. Data from the 
continuous measurement by LDF was collected via the near infrared spectroscopy 
(NIRS) program that can accept the input of 4 different clinical monitors. After 
conversion o f the NIRS data to excel sheets, the LDF data at the relevant points in each 
experiment was calculated as a mean of 2 -min data.
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Figure 3.1. Dual channel surface laser Doppler flowmeter and its probes 
(DRT4, Moor Instruments Ltd., Devon, UK).
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3.3 Intracellular oxygenation / mitochondrial activity
Cytochrome oxidase activity as a reflection of hepatic intracellular oxygenation was 
continuously measured using near infrared spectroscopy (NIRS). In all tissues a number 
of colour-bearing compounds (chromophores), namely oxyhaemoglobin (H b02), 
deoxyhaemoglobin (Hb) and cytochrome oxidase (Cyt Ox) are present in variable 
concentrations. They have different absorption spectra in the near infrared (NIR) light 
and their absorption characteristics are oxygen dependent (Jobsis FF 1992).
Cytochrome oxidase (Cyt Ox) is the terminal complex o f the mitochondrial respiratory 
chain (Figure 3.2). It takes electrons from cytochrome c and catalyses the reduction o f 
oxygen to water with the concomitant synthesis of ATP through the oxidative 
phosphorylation process (Capaldi 1990; Edwards et al. 1991). In hepatocytes, 
approximately 90 % of the oxygen is consumed by mitochondrial cytochrome oxidase. 
Cyt Ox contains four redox-active metal sites: two haem iron (haem a and haem a2) 
centres, the copper-copper dimer (C ua), and the binuclear haem-copper coupled centre 
(haem as/Cue). These four metal centres accept or donate electrons during the electron 
transfer through the respiratory chain, changing their redox state. The oxygen-binding 
site of the enzyme is the binuclear unit formed of the Cub and haem a3 . The donation of 
electrons from this unit to oxygen accounts for the majority of oxygen consumption in 
the tissues. The Cua and haem a centres donate electrons to the binuclear unit and 
therefore are not directly involved in oxygen reduction (Capaldi 1990; Nicholls and 
Ferguson 1982). In the absence of oxygen, electron transfer to oxygen cannot take 
place. Electrons accumulate on the haem and copper atoms and Cyt Ox becomes 
reduced. With oxygen availability the electrons are transferred rapidly from the metal 
centres to oxygen and Cyt Ox becomes oxidised. Many factors can affect the Cyt Ox
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redox state in vivo, but the most significant factors are the oxygen concentration 
(Capaldi 1990; Cooper et al. 1994); nitric oxide in physiological circumstances (Cleeter 
et al. 1994; Cooper 2002) and oxidants such as ROS and RNS in oxidative stress 
situations (Shiva and Darley-Usmar 2003; Shiva et a l  2005).
All 4 centres exhibit different absorption characteristics depending on their redox state. 
The copper centres are optically sensitive in the NIR region in contrast with the haem 
centres that absorb visible light (Capaldi 1990; Cooper 2002; Edwards et al. 1991; 
Jobsis et al. 1976). Absorption o f the NIR light by Cyt Ox occurs primarily at the CuA 
centre within Cyt Ox. The oxidised Cu A centre has a characteristic shape spectrum with 
a broad peak centred around 845 nm (Cooper et al. 1994; Jobsis FF 1992). The signal 
intensity decreases on reduction o f this centre. The contribution o f haem iron centres to 
absorption o f NIR is less than 10 % of the total signal in the reduced -  oxidised 
spectrum (Boelens and Wever 1980; Cooper et al. 1994).
The redox state o f Cyt Ox CuA is dependent on cellular oxygen availability (Capaldi 
1990; Cooper 2002; Edwards et al. 1991; Takashima et al. 1995). In the presence of 
oxygen electron transfer occurs and the enzyme becomes oxidised whereas lack of 
oxygen results in a decreased flow o f electrons and Cyt Ox becomes reduced. The 
increase in the reduction state o f Cyt Ox reflects severe cellular hypoxia.
Another synthetic chromophore that can be measured by NIRS is Indocyanine green 
(ICG). ICG is an anionic dye that has been used for many years to measure hepatic 
blood flow and as a test o f liver function (Caeser et al. 1961; Grainger et al. 1983). It 
has a characteristic maximum absorption peak at 805 nm in the NIR light region
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allowing its absorption coefficient to be incorporated in the NIRS algorithm to measure 
directly its concentration in the hepatic tissue (Shinohara et al. 1996).
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Figure 3.2. Schematic presentation o f the mitochondrial respiratory chain
3.3.1 Basic principles of NIRS
Light interactions with the tissue involve the combination o f  reflectance, scattering and 
absorption which depends upon many factors including the light wavelength and the 
illuminated tissue type (Jobsis FF 1992). In the visible region o f  the spectrum (450-650 
nm) light is strongly attenuated due to the intense absorption by haemoglobin and light 
scattering in tissues, which increases with decreasing the wavelength. Therefore, light
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fails to penetrate more than 1 cm o f tissue (Sterpetti et al. 1988; Jobsis FF 1992; Kitai 
et al. 1993). However, the NIR region o f the electromagnetic spectrum (700-1000 nm) 
represents an optical window of relative transparency and a significant amount of 
radiation can be effectively transmitted through biological materials over distances of 
up to 8  cm (Jobsis FF 1992; Kitai et al. 1993; Sterpetti et al. 1988).
The technique o f NIRS relies upon two main physical properties: (1) the relative 
transparency o f biological tissue to light in the NIR region o f the spectrum and (2) the 
existence o f different tissue chromophores with characteristic absorption spectra in the 
NIR light spectrum (Elwell et al. 1994; Ojha et al. 1993; Wray et al. 1988). In tissue 
with homogeneous scattering the calculation o f light attenuation and the relationship 
between the optical absorption and chromophore concentration may be described by a 
modified Beer - Lam bert’s law. The law modifications include (a) an additive term, G, 
due to scattering losses and (b) a multiplier, to account for the increased optical 
pathlength due to scattering. This law can be used to convert the obtained optical 
densities to concentration changes o f Hb, HbC>2 , and Cyt Ox in pmole/L per optical 
pathlength (Ojha et al. 1993; Wray et al. 1988): A = a . c. d. B + G; where A is the 
attenuation o f light (optical density), a  is the absorption coefficient o f the chromophore 
(pm ole^.cm '1), c is the concentration o f the absorbing compound (pmole/L) and d is the 
geometrical distance between the points where light enters and leaves the tissue (cm). B 
the differential pathlength factor (DPF) which accounts for the increase in optical 
pathlength due to light scattering (which causes the optical pathlength to be greater than 
d) and G is a constant geometrical factor which accounts for loss o f photons by 
scattering. As G cannot be quantified in vivo and is dependent upon the scattering 
coefficient o f the tissue interrogated, it is not possible to measure the absolute
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concentration o f the chromophore in the tissue from measurement o f the absolute 
attenuation. If  a ,  B, and d are known and G assumed to remain constant during 
measurement, we can measure the change in the chromophore concentration (Ac) from 
measuring the change in attenuation (AA) from the following formula:
Ac = AA / a . d. B.
Since the absolute concentration o f tissue chromophores are unknown and cannot be 
calculated due to the effect o f light scattering within the tissue, all NIRS measurements 
are expressed as absolute concentration changes (pmole/L) from an arbitrary zero at the 
start o f the measurement. The absorption coefficient o f Cyt Ox was obtained in vivo 
from the brains o f experimental animals whose blood had been replaced by a blood 
substitute (fluorocarbon) with exposure to 1 0 0 % O 2 or N 2 to obtain the oxidised and 
reduced Cyt Ox spectra (De Blasi et al. 1997; Ojha et al. 1993; Williams et al. 1990; 
Wray et al. 1988)
For simultaneous computation o f the changes in concentration o f a number of 
chromophores from changes in attenuation at a number o f wavelength, a mathematical 
operation (algorithm) can be used which incorporates the relevant absorption coefficient 
for each chromophore at each wavelength (Cooke et al. 1991; Cope 1991; Ojha et al. 
1993; Wray et al. 1988).
3.3.2 Near infrared spectrophotometer
The NIR spectrometer used in this study is the NIRO 500 (Hamamatsu Photonics K.K., 
Hamamatsu, Japan) (Figure 3.3). This spectrometer is the commercial version o f an
instrument developed by colleagues in the Department o f Medical Physics and 
Bioengineering, University College London (Cope 1991). In the NIRO 500, the light 
source is monochromatic light generated from semiconductor laser diodes (LD). The 
light is produced at four wavelengths (774, 826, 849, and 906 nm). The choice of the 
wavelengths is based on 765 nm, the absorption maximum for Hb; 810 nm, the isobestic 
wavelength at which the extinction coefficients o f Hb0 2  and Hb are equal which can be 
used to calculate haemoglobin concentration independent o f oxygen saturation; 845 nm, 
the absorption maximum for oxidised Cyt Ox; and 900 nm, a reference wavelength 
(Jobsis FF 1992; Ojha et al. 1993; Wray et al. 1988).
The light is produced by laser diodes and carried to the liver via a bundle o f optical 
fibres in sequential pulses. The optical fibres are covered by a light proof protective 
sheath and its distal end terminated in a very small glass prism which reflects the light 
through 90° to direct it into the tissue (Elwell et al. 1994). Photons emerging from the 
liver are collected by the second bundle o f optical fibres and detected by a 
photomultiplier tube (PMT) light detector (Elwell et al. 1994) (Figure 3.4). The incident 
and transmitted light intensities are recorded and from these the changes in the 
concentration o f tissue chromophores (pmol/L) are calculated using an algorithm 
incorporating the known chromophores absorption coefficients and an experimentally 
measured optical pathlength.
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Figure 3.3: Near infrared spectrometer (NIRO 500, Hamamatsu Photonics KK, 
Hamamatsu, Japan).
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Figure 3.4: Schematic diagram o f the NIRO 500 spectrometer. Four laser diodes (LD) 
are used as the monochromatic light source and a photomultiplier (PMT) is used to 
detect transmitted light from the tissue. Data from other monitors can be recorded 
simultaneously via the data input channels.
The standard NIRO 500 algorithm was developed using the wavelength dependant- 
pathlength for the brain tissue (Essenpreis et al. 1993). As a part o f this study, 
modification o f  the NIRO 500 algorithm has been carried out in the Department o f 
Medical Physics and Bioengineering, University College London for its hepatic 
application (Cope 1991). The absorption coefficient o f a freshly dissected and viable 
blood free pig liver was measured. The absorption coefficient was found to be 0.04 mm' 1 
at 800 nm which is some four times larger than that o f normally perfused brain tissue 
although the transport scattering coefficient was similar near 1.0 mm"1. When the 
absorption coefficient o f blood in a normally perfused liver was added to the blood free
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absorption coefficient the overall absorption coefficient was near 0 . 1  mm ’ 1 with the 
scattering coefficient essentially unchanged. The optical pathlength as a function of 
wavelength for normally perfused liver was then calculated incorporating the measured 
absorption coefficient and the scattering coefficient mathematically corrected for the 
contribution o f haemoglobin absorption. The average blood content o f the liver was 
assumed to be 12% by volume (Lautt and Greenway 1987) at an average haemoglobin 
saturation o f 60%.
3.3.3 NIRS application in the rabbit, data collection, analysis
NIRS probes were mounted inside a probe holder and placed on the liver surface at a 
fixed site o f the left lobe o f the liver in all the animals in each experiment to avoid any 
anatomical variation which could influence in tissue oxygenation and blood volume. As 
a part o f the modification o f this instrument for use on the liver, a flexible rubber holder 
was made to hold the NIRS probes at a fixed spacing over the liver surface. This probe 
holder ensured that the sites o f light entry and exit are maintained at a constant and 
known spacing distance which minimises the possibility o f artefact due to changes in 
the distance between the probe ends. Also, it allows a satisfactory contact between the 
liver surface and the probe ends.
The NIRS includes the facility to set the attenuation and therefore chromophore 
concentration changes to zero with the NIRS initial setting. Since all the measurements 
are changes from an arbitrary initial zero, this function is important to ensure that 
artifacts such as system drift, optode movement, and excessive light having a minimal 
effect on the data. The NIRS data were continuously collected in a laptop computer 
connected to the NIRS. These data are the changes in light attenuation (optical densities:
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OD) at four wavelengths due to absorption by the tissue chromophores. A software 
program called ONMAIN® (Hamamatsu Photonics K.K., Hamamatsu, Japan) was used 
to convert these data into changes in concentration changes o f Cyt Ox (pmol/L) using 
the previously defined algorithm in the NIRO 500. This was then transferred to excel® 
data sheets (M icrosoft Company, Seattle, USA) for analysis. The data at the relevant 
time points were collected as the mean o f 2 -minute data and calculated in regard to the 
baseline value at the start o f the experiment.
3.4 Ultrasonic transit time flowmetry
Portal vein blood flow (PVBF) was measured using ultrasonic transit time flowmetry.
3.4.1 Basic principles
Using wide-beam illumination, two transducers pass ultrasonic signals back and forth, 
alternately intersecting the flowing liquid in the upstream and downstream directions. 
The transit time o f such beam is a function o f the volume flow intersecting this beam, 
regardless vessel dimensions or cross-sectional area. The flowmeter derives an accurate 
measure o f the transit time it took the wave o f ultrasound to travel from one transducer 
to the other. The difference between the upstream and downstream -integrated transit 
times is a measure o f  volume flow rather than velocity (Takata and Robotham 1992). 
The ultrasonic transit time flowmetry has been demonstrated to provide an accurate 
method for hepatic inflow measurement (Ayuse et al. 1994; Doi et al. 1988; Jakab et al. 
1995).
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3.4.2 Ultrasonic transit time flowmeter
PVBF was measured continuously using a dual transonic transit time flowmeter 
(HT207, Transonic Systems Inc, NY, USA). The flowmeter perivascular probe was 
placed around the portal vein. The accuracy o f this technique is dependent on careful 
positioning and alignment o f the probe with respect to the vessel. The vessel should be 
positioned within the central area o f uniform ultrasonic intensity o f the probe window 
i.e. away from the probe window edges, which have lower ultrasonic beam intensity 
(Takata and Robotham 1992). Also it requires accurate selection o f the probe size which 
was determined by the outer diameter o f the blood vessel.
3.4.3 Data collection, analysis
Data from the continuous measurement by the ultrasonic flowmeter were collected via 
the NIRS program. After conversion o f the NIRS data to excel sheets, the ultrasonic 
flowmeter data at the relevant points were calculated as a 2 -min data.
3.5 Liver transaminases
Alanine aminotransferase (ALT), aspartate aminotransferase (AST) and creatinine 
kinase (CK) activity were measured in serum. Blood samples were centrifuged at 2,000 
g for 10 min at room temperature. Serum was separated from the samples and stored at 
-20°C  until assayed. Measurements were made using an automated clinical chemistry 
analyser (Hitachi® 747, Roche Diagnostics, Lewes, UK).
3.6 Histology
Small wedge biopsies were taken in baseline and at the end o f the procedure from the 
ischaemic liver lobes. The liver tissue was fixed in neutral buffered formalin (10%),
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embedded in paraffin and stained with haematoxylin and eosin (H&E). Sections were 
examined under microscope (digital light microscope CLF 60 optical system, Nikon UK 
Ltd, Surrey, UK). For assessment o f the degree o f injury a semi quantitative method 
was used in which a blinded liver pathologist estimated the number o f neutrophils 
(PMN) in sinusoids, the aggregation o f PMN, structural changes in Kupffer cells and 
the presence o f necrosis and apoptosis in 5 high power fields per slide.
For steatotic livers formalin fixed but not paraffin embedded tissue was stained for fat 
using the Swank & Davenport modification o f the Marchi method (Swank RL 1935). 
The grade o f steatosis was analysed in a semi-quantitative manner: mild (<30 %), 
moderate (30-60 %) and severe (>60 %) using a clinically applied grading system 
(A dam e/ al. 1991).
3.7 Proton Nuclear M agnetic Resonance (*H NMR) Spectroscopy
*H NM R spectra o f hepatic bile samples was obtained using spectrometer (Eclipse+ 
500; JEOL Ltd., Tokyo, Japan) operating at 11.7 Tesla (500 MHz for *H). All Spectra 
were recorded at 25°C. 600 pL o f bile was placed in a 5 mm tube with a 2 mm coaxial 
insert containing 100 pL o f 1 mg/ml o f sodium trimethylsilyl-[2 H4]propionate (TSP) 
dissolved in deuterium oxide (2H20 ,  Fluorochem Ltd., Old Glossop, Derbyshire, UK) 
and set at 0.0 parts per million (ppm). A basic single pulse sequence was used to acquire 
the one-dimensional spectra using a 45° pulse (8.25 ps) with acquisition duration of 
4.36 s and a relaxation delay o f 5 s. To reduce the large water resonance signal a gated 
secondary irradiation at the water frequency was applied. Published peak assignments 
(Ellul et al. 1992; Melendez et al. 2001; Sequeira et al. 1994; Sequeira et al. 1995) were 
used. In brief, these were bile acid peaks (0.7-2.5 ppm), C-18 bile acids proton peaks 
(0.70 ppm), cholesterol peaks (0.90 ppm), PC tail group -(C H 2)n ( 1 2 0  ppm), lactate
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methyl group (CH 3 ) (1.33 ppm), acetate (1.91 ppm), C-25 taurine methylene proton 
peak (3.10 ppm), PC head group -N +(C H 3 ) 3  (3.20 ppm), C-26 taurine methylene proton 
peak (3.50 ppm), C-25 glycine methylene proton peak (3.80 ppm), lactate (4.12 ppm). 
Integration o f the ]H NM R spectra areas was measured relative to the TSP area and 
obtained using M estRe-C software (version 2.3a, Departmento de Quimica Organica, 
Universidade de Santiago de Compostela).
3.8 Capillary electrophoresis
The concentration o f NO* metabolites, nitrite (NO 2*) and nitrate (NCV), were 
determined using capillary electrophoresis (Davies et al. 1999). Plasma samples were 
centrifuged at 13000 rpm through a Vectrospin Micro 30 kDa ultra-filtration device 
(Whatman International Limited, Kent, UK) for 30 min. A P/ACE System 5500 (CE 
machine) equipped with a P/ACE diode array detector (DAD), automatic injector, a 
fluid-cooled column cartridge and a System Gold data station (Beckman Instruments 
Limited, Buckinghamshire, UK) was used for analysis. Samples were passed through a 
50 pm x 47 cm (40 cm to detector) fused-silica capillary (Composite Metals Services, 
Worcestershire, UK) with an electrolyte consisting o f 150 mM sodium chloride / 5 mM 
Tris-HCl at pH 7.4 with 2 mM TTAB. Prior to addition, the TTAB was passed through 
a SAX anion exchange cartridge (Phenomenex Limited, Cheshire, UK) to replace the 
bromine ions with hydroxide ions. The electrolyte was passed through a 0.45 pm 
syringe filter (W hatman International Limited, Kent, UK) before use. The analysis was 
performed at 25°C. The solutions were injected into the capillary by hydrodynamic 
injection using a pressure injection o f 0.5 psi for 15 s. The components in the samples 
were separated using a voltage o f "10 kV. The DAD was set at 214 nm with a 
bandwidth o f 4 nm. The capillary was rinsed before each injection with 0.1 M NaOH
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and electrolyte for 1 and 2  min, respectively. The sample concentrations o f N 0 2' and 
N 0 3' were determined by comparison with standard solutions o f sodium nitrite (0, 2, 4, 
6 , 8  and 10 pM ) and sodium nitrate (0, 10, 20, 30, 40 and 50 pM ), respectively.
All chemicals were obtained from Sigma Chemicals Limited (Dorset, UK).
3.9 Electron Paramagnetic Resonance (EPR) Spectrometry
S-nitrosothiols (RSNOs) were measured in plasma by EPR spectrometry (Rocks et al. 
2005) . With this technique the RSNOs are degraded using an alkaline pH (pH 10.5) in 
the presence o f the spin trap complex N-methyl-D-glutamine dithiocarbamate (MGD)2- 
Fe2+.
Blood samples (1 mL) were added to EDTA-coated tubes containing 10 pL of N- 
ethylmalemide (NEM). The samples were centrifuged immediately at 3000 rpm for 10 
minutes. The supernatant was aliquoted into small centrifuge tubes and snap frozen in 
liquid nitrogen and kept at -70 °C for up to 4 weeks.
During analysis plasm a samples were placed in an evacuated glass vial, kept on ice and 
the concentration o f RSNOs present was measured the same day. First, a solution of 0.2 
M Caps buffer, adjusted to pH 10.5, was placed in a plain vacutainer (Becton-Dickinson 
UK Ltd., Oxford, UK) and deaerated for 15 min using nitrogen gas. A pH of 10.5 was 
used to in order to promote the decomposition o f RSNOs to NO', while avoiding the 
decomposition o f nitrite to NO that occurs under acidic conditions. The deaerated 
buffer was then used to prepare 20 mM ammonium ferrous sulfate solution in another
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vacutainer deaerated with nitrogen gas. A gas-tight syringe was used to add the 
ammonium ferrous sulfate solution (500 pi) to MGD powder to form the (MGD)2- Fe2+ 
complex (the final concentration o f MGD and Fe2+ were 50 and 10 mM, respectively.
2 “F(MGD)2- Fe solution (100 pi) was then removed using a gas-tight syringe and added 
to 100 pi o f the biological sample or standard. These last two steps were performed 
using air-tight, evacuated, glass vials with a rubber septum in the cap. The NO released
0 4-from the decomposed RSNOs reacts with (MGD)2- Fe to produce a paramagnetic 
complex, which is measured by EPR spectrometry. The optimum time to measure the 
(MGD)2- Fe -NO formed was determined by monitoring the decomposition of 
nanomolar concentrations o f S-nitrosoglutathione and S-nitrosoalbumin over time. 
Consequently, the reaction mixtures were tested by EPR spectrometry 3 min after the 
biological fluid or standard had been added to the spin trap.
A calibration curve was constructed by adding (MGD)2- Fe to different concentrations 
o f the standard, S-nitrosoglutathione. The final concentrations o f S-nitrosoglutathione 
were 1000, 800, 600, 300 and 0 nM. The peak area o f the (MGD)2- Fe2+-NO signal was 
plotted against the concentration o f S-nitrosoglutathione added to the reaction mixture. 
In order to investigate if  the yield o f NO from S-nitrosoalbumin is similar to that of S- 
nitrosoglutathione, a preliminary experiment was performed. Human serum albumin
-i
sample containing a proportion o f S-nitrosoalbumin was prepared by exposing a 
solution o f albumin to acidified nitrite. This sample was analysed for RSNO content by 
the Saville reaction (Feelish and Stamler 1996; Saville 1958) using a GSNO standard 
curve (Gladwin et al. 2002). The same sample was then also analysed for RSNO 
content using the EPR assay calibrated using a GSNO standard curve as described 
above. On comparing the results from the Saville reaction with the results from the EPR
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method, the value for RSNO content was in close agreement. This confirmed that the 
yield o f NO from S-nitrosoalbumin was similar to the yield from GSNO.
A known amount o f S-nitrosoalbumin was also spiked into the sample o f whole human 
blood (immediately after collection onto EDTA and addition o f NEM ) to give a final 
concentration o f  1 pM o f added S-nitrosothiol). The sample was centrifuged as 
described above, and the resulting plasma sample was analysed by EPR spectrometry, 
providing a recovery o f the added S-nitrosothiol o f 71 %. This result is in agreement 
with a similar, previously reported, experiment in which a synovial fluid sample was 
spiked wit 1 pM  (final concentration) o f the low molecular weight S-nitrosothiol, 
GSNO, from which 71 % was recovered (Rocks et al. 2005).
The samples were analysed using a JEOL JES RE IX  spectrometer (Jeol Ltd, Welwyn 
Garden City, UK) equipped with an ES-UCX2 cylindrical mode X-band cavity. 
Samples were analyzed at room temperature in a WG-LC-11 quartz flat cell (Wilmad 
Glass, Buena, NJ, USA). The instrument parameters differed for each set of 
experiments. The spectra were recorded and stored using an IBM-compatible computer 
with SpecESR software (version 1.0, 1998; JEOL limited, Hertfordshire, UK) and the 
mean peak area was determined. Water was taken through the same procedure to act as 
a control. The EPR spectrometer parameters were: microwave frequency 9.45 GHz, 
microwave power 20 mW, centre field 330 mT, sweep width ± 5 mT, sweep time 250 s, 
number o f data points 8192, time constant 1 s, modulation frequency 100 kHz, and 
modulation width 0.4 mT. The spectra were taken as an average over 3 scans.
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3.10 Dihydrorhodamine (DHR) oxidation
The oxidation o f DHR 123 to rhodamine (RH) is partially peroxynitrite-dependent and 
has been used as a marker o f peroxynitrite formation (Cuzzocrea et al. 2000a; Kooy et 
al. 1995). 7 h after reperfusion in the I/R group or the equivalent time in the sham 
group animals were injected with DHR 123 (2 pmol/kg in 0.8 mL normal saline 0.9 %, 
Sigma-Aldrich Company Ltd, Dorset, UK). Twenty minutes later plasma samples were 
collected for rhodamine fluorescence evaluation. For fluorescence measurements a 
fluorometer (Thermo Electron Corporation, Basingstoke, UK) was used at an excitation 
wavelength o f 485 nm and emission wavelength o f 538 nm. The concentration of RH 
formation was calculated using a standard curve obtained with authentic RH (1 to 40 
nM, Sigma-Aldrich Company Ltd, Dorset, UK) prepared in plasma obtained from 
untreated rabbits.
3.11 Liver tissue Nitrotyrosine levels measured by mass spectrometry
Protein-bound nitrotyrosine levels were measured in liver tissue from rabbits at baseline 
and seven hours postreperfusion using an isotope-dilution mass spectrometric method 
(Frost et al. 2000; Moore and Mani 2002). Tissue was homogenised in a mixture of ice- 
cold saline (2 mL) and chloroform / methanol (2:1) containing 10 ng 13C9 -nitrotyrosine 
and the protein precipitate (middle layer) was isolated by centrifugation at 2 0 0 0  x g for 
30 minutes at 4 °C. The supernatant was used for measuring free nitrotyrosine (in 
ventricles) and the protein precipitates were lyophilized under vacuum for assessment of 
protein -  bound nitrotyrosine. 1-1.5 mg o f lyophilized protein was hydrolyzed for 15 
hours at 120 °C in 1 mL 4 M sodium hydroxide following the addition o f 10 ng ,3 C9- 
nitrotyrosine and 10 pg o f 2 H4 -tyrosine as stable isotopic internal standards. These 
conditions prevent the artifactual nitration o f tyrosine that occurs during acidic
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hydrolysis conditions. Following two steps o f solid phase extraction, nitrotyrosine and 
tyrosine were quantitated by stable isotope dilution gas chromatography / negative ion 
chemical ionization mass spectrometry. Results o f protein bound nitrityrosine are 
expressed as a ratio o f nitrotyrosine to tyrosine (pg/pg).
3.12 Data collection and statistical analysis
Data from the pulse oximeter, blood pressure and portal flow monitor, LDF and NIRS 
were collected continuously on a laptop computer. The data were averaged for two 
minutes before the induction o f ischaemia (baseline), at the end o f ischaemia and at the 
end o f each hour o f the reperfusion period. Changes in hepatic tissue oxygenation at the 
end o f each period were calculated relative to baseline. Values are expressed as mean, 
standard deviation (s.d.). Student’s t test for paired samples was used for comparison 
within the group, at different time points. Student’s t-test for independent samples was 
used for comparisons between two groups and one-way ANOVA with Bonferroni 
adjustment for multiple comparisons, unless otherwise stated. P  < 0.050 was considered 
statistically significant.
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CHAPTER 4
ESTABLISHMENT AND REFINEMENT OF AN EXPERIMENTAL  
RABBIT MODEL FOR THE STUDY OF W ARM LIVER 
ISCHAEMIA / REPERFUSION INJURY
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4.1 Introduction
Liver I/R injury involves two phases, as mentioned previously, the early phase (within 
two hours o f reperfusion)(Jaeschke and Farhood 1991) and the late phase (after 4 h) 
(Colletti et al. 1990; Jaeschke et al. 1990). The early phase is associated with Kupffer 
cell-induced oxidative stress, while the late phase results mainly from the accumulation 
o f neutrophils and the production o f ROS and RNS. The degree o f injury is much more 
extensive during the late phase. I/R pathophysiology is very complex with the activation 
o f different metabolic pathways and the release of mediators which induce liver injury 
(Glantzounis et al. 2005a; Jaeschke 2003; Lentsch et al. 2000). Progress in the 
development o f effective therapeutic strategies for liver I/R injury requires further 
clarification o f the pathophysiology, and study of the mechanism and timing of any 
beneficial effects.
The rabbit lobar liver I/R model has been used before for assessment o f changes in 
hepatic oxygenation measured by near infrared spectroscopy (El Desoky et al. 2001). In 
that study anaesthesia was induced by 0.5 ml/Kg Hypnorm (fentanyl citrate and 
fluanisone) and maintained with Hypnorm 2.5 mg/Kg intramuscularly and the inhaled 
agent Halothane through face mask. Lobar ischaemia was applied in the median and left 
liver lobe for 1 h followed by 7 h o f reperfusion. Polyethylene catheters were inserted in 
the femoral artery for monitoring o f mean arterial blood pressure (MABP) and for blood 
sampling and into the femoral vein for fluid administration.
In the present study the anaesthetic protocol was modified to allow a longer period of 
study under stable anaesthesia. For maintenance o f anaesthesia isoflurane 0.5-3% was
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used though an anaesthetic circuit, along with 25-40 % o f oxygen mixed with nitrus 
oxide (N2 O). The reason for this is that isofiurane is metabolised mainly in the lungs 
rather in the liver and avoids cumulative effects o f hepatotoxicity. Also a tracheostomy 
was performed after the induction o f anaesthesia with the placement o f a paediatric size 
tube in the trachea. This offered better metabolic stability to the animals, by maintaining 
stable oxygen saturation and acid-base balance.
To assess both the early and the initial part o f the late phase o f liver I/R injury 
monitoring o f the reperfusion period was extended up to 7 hours. During this period the 
rabbits remained under general anaesthesia. For technical reasons an ear marginal vein 
was used for administration of intravenous fluids instead o f the femoral vein. The 
experiments were terminated by exsanguination.
The femoral arterial line was initially used for continuous monitoring o f the arterial 
blood pressure and blood sampling. Use o f a femoral arterial line is the standard method 
in experimental studies with rats (Martin et al. 1996; M unzenmaier and Greene 2006; 
Reinert et al. 2004; Torres-Reveron et al. 2006; Yobum et al. 1984) and rabbits 
(Madsen et al. 1979; M ossberg and Taegtmeyer 1991; Nahoul and Gilbert 1991). It has 
also been used for studies focusing on liver function (El Desoky et al. 1999;
■*»
Kotzampassi et al. 2003; Ueda et al. 1999) and liver I/R (El Desoky et al. 2001). 
However, the placement o f the femoral arterial line could reduce limb blood supply with 
resulting systemic effects.
Prolonged limb I/R injury can produce reactive oxygen species (ROS) and consumption 
o f endogenous antioxidants (Sun et al. 1999; Yassin et al. 2002) resulting in remote
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organ injury including the heart, lungs, liver, bowel and kidneys. An experimental study 
with rats, showed that 4 h o f bilateral limb ischaemia followed by 3 h reperfusion 
caused remote hepatic injury, induced mainly via activation o f Kupffer cells. This 
process was complement dependent (Brock et al. 2001). Experimental and clinical 
studies (Corson et al. 1992; Edrees et al. 2003; Harkin et al. 2001; Yassin et al. 1996) 
have also shown that limb I/R injury can alter intestinal structure and permeability 
associated with systemic endotoxaemia and cytokines activation.
Previous studies have demonstrated systemic effects o f complete limb I/R. Whether the 
reduction in limb perfusion encountered during femoral arterial line cannulation has a 
remote effect on organ function has not previously been reported; but it is clearly vital 
to experimental design o f studies on liver function or hepatic I/R. The aim o f the present 
study was to investigate the effect o f a femoral arterial line on liver function, in a rabbit 
model o f lobar liver I/R.
4.2 Materials and methods
4.2.1 Animal model
The study was conducted under a license granted by the Home Office in accordance 
with the Animals (Scientific Procedures) Act 1986. New Zealand white rabbits (3.4 ± 
0.8 kg, n=24) were used. Anaesthesia was induced by intramuscular injection of 0.5 
ml/kg Hypnorm (Fentanyl citrate and fluanisone, Janssen Animal Health Ltd., 
Buckinghamshire, UK). Following tracheostomy anaesthesia was maintained with 
Isoflurane (0.5-3%) through an anaesthetic circuit.
Body temperature was maintained at 37-38.5°C by a warming blanket (Homoeothermic 
blanket control unit; Harvard Apparatus, Southmatick, Massachusetts, USA). 
Haemoglobin saturation and heart rate were continuously recorded by a pulse oxymeter 
(Ohmeda Biox 3740 pulse oxymeter; Ohmeda, Louisville, Colorado, USA). For the 
placement o f the arterial line in the femoral artery a 2-3 cm skin incision was performed 
in the right groin. After dissecting the subcutaneous tissue, the femoral structures were 
identified and the femoral artery was separated from the femoral vein and the femoral 
nerve. The distal part o f the common femoral artery was ligated with 2/0 silk. A 
microvascular clip was applied in the external iliac artery. An arteriotomy was 
performed on the common femoral artery and a radiopaque catheter (20 GA) was 
inserted to the aorta and fixed with 2/0 silk. The femoral line was used for monitoring of 
the arterial blood pressure and collection o f blood samples. For the placement o f an ear 
arterial line, a 20G radiopaque catheter was placed in the right ear marginal artery and 
fixed with 3/0 Prolene. In both groups also an ear marginal vein was cannulated with 
radiopaque catheters (22 G) for the administration o f anaesthetics and fluids. After the 
placement o f the arterial and venous lines a laparotomy was performed through a roof 
top transverse incision. The ligamentous attachments from the liver to the diaphragm 
were divided and the liver was exposed. The bile duct was cannulated with a 
polyethylene catheter (PE-50, 0.58 mm inner diameter, Portex, Kent, UK) to measure 
bile flow.
Lobar ischaemia was induced by clamping the vascular pedicles o f the median and left 
lobes o f the liver, using a microvascular clip. This method produces a significant 
ischaemic insult without inducing mesenteric venous hypertension (Koo et al. 1992). 
After 60 min o f ischaemia the vascular clip was removed and reperfusion was allowed
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for 7 h. Normal saline 0.9% (15 ml/kg/h) was administered through the ear marginal 
vein to compensate for intraoperative fluid loss.
At the end o f the experiment the animals were killed by exsanguination.
4.2.2 Experimental groups and protocol
Animals were allocated to four experimental groups (n= 6  in each). Groups 1 and 2 
underwent sham laparotomy but no liver ischaemia. In group 1 (sham femoral), an 
arterial line was placed in the right femoral artery while in group 2  (sham ear) this was 
placed in the right ear artery. In groups 3 and 4, liver lobar ischaemia was induced for 
60 min followed by 7 h o f reperfusion. In group 3 (I/R femoral), the arterial line was 
placed in the right femoral artery while in group 4 (I/R ear) this was placed in the right 
ear artery.
Blood and liver tissue samples were taken at baseline and at the end o f 7 h reperfusion 
in the I/R groups or after the equivalent o f the ischaemia (1 h) and reperfusion period (7 
h) o f the I/R animals in the sham groups for subsequent biochemical and histological 
studies.
4.2.3 Biochemical measurements
Serum alanine aminotransferase (ALT) and creatine kinase (CK) activities were 
measured using an automated clinical chemistry analyzer (Hitachi 747, Roche 
Diagnostics Ltd., Sussex, UK). Plasma lactates were measured in fresh blood samples 
using an automatic blood gas analyzer.
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4.2.4 Bile flow
Bile was continuously collected from the common bile duct catheter and the volume 
was expressed as jxL/min/lOOg o f wet liver weight.
4.2.5 Histopathology
Liver biopsies were taken from the ischaemic lobes at the end o f the experiment. 
Formalin fixed paraffin embedded blocks o f liver were cut at 4 microns and stained 
with haematoxylin and eosin (H & E) and reviewed by a pathologist, blinded to 
treatment o f the animals. The tissue was semiquantitatively scored for the number of 
polymorphs in a high powered field using an Olympus BX50 microscope at x 400 
magnification. An average o f 5 fields was used. A score was devised; a score of 0-3 
was given to the number o f single PMNs in sinusoids (1: 1-5, 2: 5-20, 3: >20); a score 
0-3 for aggregated PMNs (1: 1-2 clusters, 2: 2-5, 3 > 5). A comment was also made if 
the aggregated PMNs were associated with hepatocyte necrosis. The presence or 
absence o f apoptosis, judged by shrunken, dark stained hepatocytes, was also made in a 
semiquantitative manner. Comment was made on presence or absence o f Kupffer cell 
hyperplasia and if  there were any other changes to hepatocytes, taking particular note of 
any zones affected. Immediately subcapsular areas and foci around large hepatic veins 
were not counted, as these would have shown a disproportionate amount of PMN 
infiltrate.
4.2.6 Statistical analysis
The results were expressed as mean ± Standard Deviation (SD). Comparisons within 
groups were made using the student’s t test for paired samples, while comparisons
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between groups were made using the student’s t test for independent samples. P values 
less than 0.05 were considered to be significant.
4.3 Results
4.3.1 Systemic haemodynamics
Animals tolerated the prolonged general anaesthesia (>9h) and remained 
haemodynamically stable. In the sham fern group systemic mean arterial blood pressure 
(MABP) declined during the late phase o f reperfusion compared to baseline, while in 
the sham ear group MABP remained relatively stable. However there were no 
statistically significant differences between the two groups (table 4.1). In the I/R groups 
MABP fell in the reperfusion period compared to baseline. This decline was more 
prominent for the I/R ear artery group (table 4.1).
Pulse rate (PR) slowed in the sham fern group, especially during the late phase of 
reperfusion compared to baseline. It remained stable in the sham ear group throughout 
the experiment. The pulse rate was not statistically different at any time point between 
the two groups (table 4.2). In the I/R fern group PR fell in the reperfusion period 
compared to baseline, while remained stable in the I/R ear group (table 4.2).
Oxygen saturation (Sa0 2 ) remained stable through the experiment.
4.3.2 Biochemical measurements
There was a significant increase in serum ALT activity (Fig. 4.1), plasma lactate levels 
(Fig. 4.2) and CK activity (Fig. 4.3) in the I/R femoral line group compared to the I/R 
ear line group, at 7 h post-reperfusion. In the sham groups, serum ALT activity, 
plasma lactate levels and CK activity were also significantly higher in the femoral line
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group compared to the ear line (Fig. 4.1-4.3). ALT was higher in the I/R groups 
compared to sham groups. Lactates and CK were very high in the sham femoral line 
group and actually higher compared to the ear line I/R group.
Table 4.1. Mean arterial blood pressure (MABP) in mm Hg, during the experiment. 
Blood pressure fell in the sham fern group during the experiment and remained 
relatively stable in the sham ear group. In the I/R groups there was also a drop during 
reperfusion from baseline and this drop was more prominent in the I/R ear line group. 
Results are expressed as mean ± SD. *p < 0.05, compared to baseline
G roups Base­
line
Ischaemia
or
equivalent
1st 2nd 3rd 4th 5th 6th 7th
Sham
feni
73 f 6 69 l  7 67+ 5 58 + 3 64+3 61+ 4 62+ 5* 61 + 2 * 65 + 7
Sham
e a r
67 + 8 66 + 8 60+ 6 59 + 7 60+6 59+ 7 60+ 5 63+ 4 63 + 8
I/R fern 69 ± 4 65 ± 5 58+ 4 59 ± 5 58+9 59+12 60+10 62+10 62+10
I /R e a r  64 ± 5 57 + 5 56+5 51 ± 7 49+9* 49+10* 49+11* 50+10* 50+12*
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Table 4.2. Pulse rate (beats / min) during the experiment. Pulse rate remained stable 
during the experiment in the ear artery groups, while declined significantly from base 
line during the experiment in sham fern and the I/R fern groups. Results are expressed 
as mean ± SD. *p<0.05, compared to baseline
G roups Baseline Ischaemia
or
equivalent
1st 2nd 3 rd 4th 5th 6th 7th
Sham
fem
226±28 219*21 210*24 212*25 211*25 203*31* 198*29* 193*32* 191*31*
Sham
e a r
223±27 224*23 221*20 219*20 223*15 224*18 224*20 221*26 223*26
I/R  fem 215*22 194*32 191*26 188*23 190*8 179*25* 175*14* 176*17* 171*18*
I/R e a r 232*28 218*30 224*33 220*31 221*33 215*26 219*22 221*29 221*29
SOO-i
4 0 0 -
30 0 -
5  J< 200-1
1 0 0 - * * i
X
S ham ( f e m ) 
S h a m  (ear )  
I/R ( f em )  
I/R (ear)
BL 7 hrs
T ime
Figure 4.1 Serum alanine aminotransferase (ALT) activity (U/L) in femoral and ear 
arterial line sham and ischaemia-reperfusion (I/R) groups. There was a 
significant increase in ALT activity in all groups, except in the sham ear group at 7 
hrs compared to baseline. The ALT levels were significant higher in the femoral line 
groups compared to the ear artery groups at 7 hrs post reperfusion.
BL: baseline, *p<0.05, (7 hrs vs BL), **p<0.05 (femoral vs ear at 7 hrs).
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Figure 4.2. Plasma lactate (mmol/L) in femoral and ear arterial line sham and ischaemia 
reperfusion (I/R) groups. There was a significant increase in plasma lactate in all 
groups, except for the sham ear group at 7 hrs post- reperfusion compared to baseline. 
The plasma lactate levels were significant higher in the femoral line groups compared 
to ear line groups at 7 hrs post-reperfusion. BL: baseline, *p<0.05, (7 hrs vs BL), 
**p<0.05 (femoral vs ear at 7 hrs).
4.3.3 Bile production
Bile production was significantly decreased in both I/R groups at 7 h post-reperfusion 
compared to baseline but the decrease was more prominent in the I/R femoral line group 
(Figure 4.4). Bile flow was also significantly decreased at the end o f  the experiment, 
compared to baseline, in the sham femoral line group, while it remained unchanged in 
the ear artery group (Figure 4.4).
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Figure 4.3. Creatine kinase (CK) activity (U/L) in the femoral and ear arterial line sham 
and ischaemia-reperfusion (I/R) groups. There was an increase in CK activity in all 
groups, except the sham ear group at 7 hrs post- reperfusion compared to baseline. The 
CK levels were significant higher in femoral line groups compared to the ear artery 
groups at 7 hrs post reperfusion. BL: baseline, *p<0.05, (7 hrs vs BL), **p<0.05 
(femoral vs ear at 7 hrs).
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Figure 4.4. Bile flow (pL/min/lOOg) in femoral and ear arterial line sham and 
ischaemia-reperfusion (I/R) groups. There was a significant decrase in bile flow in all 
groups, except the sham ear group at 7 hrs post- reperfusion compared to baseline. Bile 
flow was significantly reduced in the femoral line groups compared to ear artery groups 
at 7 hrs post -reperfusion. BL: baseline, *p<0.05, (7 hrs vs BL), **p<0.05 (fem vs ear 
at 7 hrs).
4.3.4 Histopathology
Representative rabbit liver histology at baseline is shown in picture 4.5.
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Figure 4.5 Representative photomicrograph o f liver histology at baseline (H&E x20). 
It shows a small portal tract (top left) with normal intact hepatocyte plates and a 
terminal hepatic venule (bottom right).
The histological score regarding the number o f single PMNs in sinusoids was 10 for the 
sham fem group, 9 for the sham ear group, 17 for the I/R fem group and 14 for the I/R 
ear group. The score regarding the aggregated PMNs was 8  for the sham fem group, 2 
for the sham ear group, 15 for the I/R fem group and 11 for the sham ear group.
Hepatocellular necrosis, apoptosis and Kupffer cell hyperplasia was more severe in the 
I/R femoral line group compared to the I/R ear line group (Figure 4.6). There was also 
histological evidence o f liver injury, at the end o f the experiment in the sham femoral 
line group (Figure 4.7), while the liver morphology was preserved in the sham ear artery 
group without evidence o f significant liver injury (Figure 4.7).
Sham-femoral Sham-ear
Figure 4.6 Representative photomicrographs o f liver histology at 7 h post- reperfusion 
in the femoral and ear arterial line sham groups. It shows neutrophil aggregation and 
hepatocellular necrosis (H&E x200) in the femoral line, while in the ear line shows 
well preserved hepatic structure without evidence o f hepatocellular necrosis (H&E
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l/R-femoral I/R-ear
Figure 4.7 Representative photomicrographs o f liver histology at 7 h post-reperfusion 
in femoral and ear arterial line ischaemia-reperfusion groups showing massive 
neutrophil aggregation and extensive necrosis (H&E x200) in the femoral line group. 
The ear arterial line group shows less neutrophil aggregation and necrosis.
109
4.4 Discussion
This study has investigated the influence o f femoral arterial line insertion to liver 
function in an experimental model o f lobar liver ischaemia-reperfusion injury. Femoral 
line insertion induces limb skeletal muscle ischaemia. Skeletal muscle is relatively 
resistant to ischaemia for up to 2 h with minimal risk o f ischaemic necrosis (Eckert and 
Schnackerz 1991). However with prolonged periods o f ischaemia total muscle necrosis 
can result. The duration o f ischaemia is considered to be the most important factor 
determining the outcome; after 6  h o f ischaemia the incidence o f death, limb loss or 
both increases (Kendrick et al. 1981).
Despite its clinical importance, relatively little is known about the systemic responses to 
acute ischaemic injury o f skeletal muscle tissue. Acute interruption o f arterial blood 
flow to the extremities may be associated with significant morbidity and mortality (Sun 
et al. 1999; Sun et al. 1998). Rhabdomyolysis, compartment syndrome and even 
circulatory shock can result from skeletal muscle ischaemia (Sirsjo et al. 1996; Sun et 
al. 1998). New Zealand white rabbits have previously been shown to tolerate 8  h of 
right hind limb ischaemia (Sun et al. 1998). Beyond this period there is very high 
mortality with major cellular destruction mainly due to systemic inflammatory response 
leading to multi-organ failure. There is experimental evidence suggesting that hepatic 
injury following a remote inflammatory insult occurs in a biphasic manner much like 
that o f local liver injury (Brock et al. 2001; Jaeschke and Farhood 1991; Lichtman and 
Lemasters 1999).
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The present study raises concerns for the interpretation o f the results o f experimental 
studies which have used an arterial femoral line, since it has shown that femoral artery 
cannulation produces remote systemic effects including liver injury. As shown above 
the femoral line groups (sham and liver I/R) had a significant increase in ALT activity 
compared to the respective ear artery groups. ALT principally resides within the 
cytoplasm o f hepatocytes and its measurement in the serum may occur as a result o f cell 
necrosis and /or an increase in membrane permeability (Rej 1989). Differences in the 
levels o f ALT suggest that a large fraction o f hepatocytes experienced some degree of 
injury. Our finding that ALT activity was significantly increased compared to baseline 
in the femoral artery sham group is a clear indication that limb ischaemia causes remote 
hepatic injury.
CK has three isoenzymes: CK-MM located in skeletal muscles, CK-MB found 
predominantly in cardiac tissue and CK-BB found in brain (Sun et al. 1998). CK 
elevations are indicators o f tissue ischaemia or injury. In the present study CK was 
significantly higher in the femoral line groups compared to the ear line groups. This 
would suggest that the CK originated mainly from the ischaemic limb.
Lactate is the final product o f anaerobic glucose metabolism. Tissue ischaemia or 
hypoxia can lead to increased production o f lactates. In the present study the increase in 
lactates was mainly due to muscle hypoxia, as demonstrated by the high lactate levels in 
the femoral sham group. Lactate levels were also increased by liver I/R in the ear line 
group, but less compared to the femoral arterial line group. The increase in lactates was 
exacerbated by impaired liver function. The increased levels in I/R femoral group over
I l l
sham femoral would suggest that this group has increased production o f lactates and 
reduced clearance.
Bile excretion is regarded as a good marker o f hepatocellular function and bile flow is 
decreased with liver injury (El Desoky et al. 2001). In the present study bile flow 
remained unchanged over the experimental period in the ear artery sham group while 
decreased significantly from baseline to the end o f the experiment in the sham femoral 
line group.
The present study has not investigated the mechanisms by which limb ischaemia can 
cause remote liver injury. Oxidative stress, release o f cytokines, activated neutrophils 
and endotoxaemia are the pathogenetic factors associated with remote organ injury in 
limb I/R injury (Kyriakides et al. 2000). An experimental study o f rabbit hind limb 
ischaemia for 12 h followed by 4 h o f reperfusion, showed that ischaemic injury 
significantly increased luminal amplified tert-butylhydroperoxide-initiated 
chemiluminescence, a marker o f free radical production. Reperfusion of the ischaemic 
tissue tended to bring the values back towards baseline levels (Sun et al. 1999). The 
oxidative stress was most pronounced in the heart tissue, followed by the spleen, 
skeletal muscle, lung, liver and kidney. The authors suggested that the main cause of 
mortality was cardiac tissue injury.
Several studies have suggested that cytokines including Inteleukin - 6  (IL-6 ) are released 
directly from the endothelium o f injured tissue within hours o f injury or surgery 
(Roumen et al. 1993). These cytokines circulate on reperfusion and can mediate remote 
organ injury. An experimental study where rats underwent 3 h bilateral hind limb
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ischaemia followed by 1 h o f reperfusion, produced a systemic inflammatory response 
as demonstrated by the increase in plasma tumour necrosis factor-alpha (TNF-a) and 
IL-6 concentrations with liver, kidney and lung dysfunction (Yassin et al. 2002). 
Uncontrolled production o f cytokines can induce a systemic inflammatory response that 
could inflict fatal damage and contribute to the development o f multiorgan dysfunction 
syndrome (MODS) (Haupt et al. 1997; Schlag and Redl 1996).
Experimental studies o f hindlimb I/R found that polymorphonuclear leukocytes (PMN) 
play a central role in organ damage (Klausner et al. 1988; Kyriakides et al. 2000). After 
ischaemia, local tissue reperfusion generates a number o f inflammatory mediators that 
activate circulating PMNs and remote endothelium. Remote organ stimulation by 
circulating mediators leads to generation o f chemoattractants, which are responsible for 
PMN recruitment and activation (Klausner et al. 1989; W elboum et al. 1991). In fact 
PMN activation before the ischaemic insult moderates both local and remote organ 
injury (Klausner et al. 1988). An experimental study where mice underwent 2-h 
bilateral tourniquet hind-limb ischaemia followed by 3 h o f reperfusion showed that 
remote liver injury is mediated by activated neutrophils and is complement dependent 
(Kyriakides et al. 2000). In our study by using a semiquantative histological system we 
found that in the femoral line groups, there were more PMNs in the sinusoids and also 
more aggregates PMNs compared to the respective ear line groups. This was correlated 
with more extensive necrosis and more significant Kupffer cell hyperplasia.
Although previous studies have shown that remote injury after limb ischaemia occurs 
mainly during limb reperfusion, the present study has shown that cannulation o f the 
femoral artery can cause liver injury without reperfusion. Collateral circulation could
occur through the iliolumbar artery, deep femoral artery, medial and lateral circumflex 
femoral arteries o f the ischaemic limb with internal iliac and deep femoral arteries of 
the nonischemic leg thus allowing a reperfusion phenomenon (Sun et al. 1999). 
Cannulation o f the femoral artery may be creating a condition o f low flow I/R injury. 
The mechanism proposed in the present study is that low flow I/R can cause remote 
liver injury through the release o f mediators from the ischaemic limb.
4.5 Conclusions
Limb ischaemia resulting from femoral artery cannulation can produce remote liver 
injury. The use o f the ear artery instead avoids remote hepatic injury. Experimental 
studies aiming at studying liver function should avoid femoral cannulation.
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4.7 Chapter summary
In this work an experimental rabbit lobar liver ischaemia-reperfusion model was 
evaluated. This model aimed to monitor both early and initial part o f late phase of 
reperfusion (up to 7 hrs). The effect o f femoral arterial line placement on liver function 
was studied. Femoral arterial lines are commonly used for continuous monitoring of 
arterial blood pressure in experimental studies. However, placement o f the catheter in 
the femoral artery could produce acute limb ischaemia with associated systemic effects. 
4 groups o f animals (n=6 each) were studied: Groups 1 and 2 (Sham) underwent 
laparotomy but no liver ischaemia. In groups 3 and 4 (I/R) liver lobar ischaemia was 
induced for 60 min followed by 7 h o f reperfusion. In groups 1 and 3 the arterial line 
was placed in the femoral artery whereas in groups 2 and 4 in the ear artery. Liver 
function was assessed by serum alanine aminotransferase (ALT) activity, bile flow, 
plasma lactate levels and histology. The results were expressed as mean ± standard 
deviation (SD).
All animals tolerated the prolonged anaesthesia well. Blood pressure declined during 
the experiment mainly in the I/R groups. PR also slowed during the experiment, mainly 
in the I/R groups. Oxygen saturation remained stable during the experiment. ALT and 
lactate levels were significantly higher in the I/R femoral line group compared to the I/R 
ear line group, at 7 h post-reperfusion and bile production was significantly lower 
(75±9.6 vs 112±10 pL/min/lOOg liver weight). Histopathology showed more extensive 
hepatocellular necrosis and neutrophil accumulation in the I/R femoral line group 
compared to I/R ear line group. The sham femoral group showed liver injury which 
was more marked than the ear line group (all p < 0.05). In conclusion, femoral artery 
cannulation induces remote liver injury most probably through the systemic effects of 
low blood flow limb I/R injury. The use o f femoral arterial lines should be avoided in 
studies concerning liver function.
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CHAPTER 5
CHANGES IN BILE COMPOSITION FOLLOWING HEPATIC 
WARM ISCHAEMIA / REPERFUSION: AN EXPERIMENTAL 
EVALUATION USING PROTON MAGNETIC RESONANCE
SPECTROSCOPY
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5.1 Introduction
In the previous chapter a rabbit lobar liver I/R model was evaluated and refined. In this 
chapter changes in bile composition during liver I/R, will be studied using proton 
nuclear magnetic resonance (*H NMR) spectroscopy. Bile formation is an active 
secretory process involving bile salt dependent and independent mechanisms (Bowers et 
al. 1987). Bile excretion is used as an indicator o f liver function and recovery following 
ischaemia in experimental studies (Bowers et al. 1987; Glanemann et al. 2003; 
Jamieson et al. 1988; Sumimoto et al. 1988; Terajima et al. 2000) and clinical liver 
transplantation (Boyer 2002). However, little is known about changes in bile 
composition during liver ischaemia and following reperfusion.
Bile formation is an osmotic filtration-driven process that depends on the proper 
function o f transport systems in both the basolateral and apical or canalicular 
membranes o f hepatocytes (Boyer 1996; Trauner and Boyer 2003). Bile secretion is 
driven by active excretion o f organic solutes into the bile canaliculus, followed by 
passive inflow o f water, electrolytes, and non-electrolytes from hepatocytes and across 
semi-permeable tight junctions (Trauner and Boyer 2003).
Liver ischaemia reduces energy dependant transport processes and is therefore 
associated with reduced bile flow (Smith and Blandford 1995). Bile flow recommences 
on reperfusion, and has thus been considered to be a marker o f liver function and used 
to assess clinical liver transplantation studies (Sequeira et al. 1995; Small et al. 1969; 
Stark et al. 1985). However the changes in bile composition during ischaemia and 
reperfusion have not been widely investigated.
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In recent years, high resolution !H NMR spectroscopy has been established as a 
powerful technique to explore the biochemical composition o f biological fluids such as 
plasma, bile, seminal and synovial fluids, in various pathological conditions (Ishikawa 
et al. 1999). This technique is rapid, non-invasive and non-destructive and can detect 
metabolites present at the millimolar concentration. In bile, it has been used to 
investigate biliary lipids (Vejchapipat et a l  2002) and conjugated bile acids (Scarpa et 
al. 2001). In the liver, NM R has also been used to assess glutamine metabolism 
(Hayakawa et al. 1997), energy status after warm ischaemia (Powell J 1990), and to 
study effects o f I/R on liver cell membranes (Melendez et al. 2001; Paczkowska et al. 
2003). A preliminary study o f 1H NMR analysis o f bile after liver transplantation has 
been reported by Powell et al in 1990, suggesting that this technique might help to 
distinguish ischaemia from rejection post-transplant by detecting large resonance peaks 
for the ischaemic metabolites lactate and acetate (Powell J 1990). More recently, there 
has been growing interest in attempting to predict graft function by analyzing bile 
production immediately after transplantation (Vilca et al. 2004).
Melendez et al in 2001 published a small pilot study consisting o f only four liver 
transplants in which they analyzed donor organ bile before and after transplant. One 
recipient had primary graft non-function, another had early graft dysfunction and two 
had good early graft function. NMR analysis o f bile demonstrated that good graft 
function was associated with rapid clearance o f sugar peaks derived from University of 
Wisconsin solution, lower lactate and an increase in PC head group and bile acid levels 
(Melendez et al. 2001).
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With advances in M R imaging technology, spectroscopy is an increasingly available 
option. In vivo spectroscopic assay o f gall bladder has recently been reported (Prescot et 
al. 2003). The obvious implication is for the use o f in vivo bile spectroscopy to assess 
liver function in a non-invasive manner. However, controlled experiments to determine 
the effect o f first warm and then cold I/R injury on bile constituents are needed.
The aim o f this pilot study was to examine bile composition changes during liver 
ischaemia and reperfusion in an established model o f warm lobar liver I/R injury 
(Glantzounis et al. 2004) to determine any compositional changes during I/R. In the 
present study the femoral arterial line was used for arterial blood pressure measurement 
and blood withdrawal, since this study was performed in the first stages o f this thesis 
and the detrimental effect o f femoral artery cannulation to remote organs was not clear. 
However this is unlikely to affect the bile spectroscopy changes with time.
5.2 Materials and methods
5.2.1 Model of lobar ischaemia/reperfusion
The study was conducted under a license granted by the Home Office in accordance 
with the Animals (Scientific Procedures) Act 1986. New Zealand white rabbits (3.8 ± 
0.5 kg) were used in a model o f lobar ischaemia (Glantzounis et al. 2004). Anaesthesia 
and surgical procedure are described in section 3.1. Briefly, anaesthesia was induced by 
an intramuscular injection o f 0.5 ml/kg fentanyl citrate and fluanisone (Hypnorm). 
Following tracheostomy anaesthesia was maintained with isoflurane (0.5-3%) through
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an anesthetic circuit. Haemoglobin saturation and heart rate were continuously recorded 
by a pulse oxymeter. One catheter (20 G) was inserted into the right femoral artery for 
arterial blood pressure monitoring and collection o f blood samples. The ear marginal 
vein was cannulated with another catheter (22 G) for the administration o f anaesthetics 
and fluids.
Laparotomy was performed through a midline incision. The ligamentous attachments 
from the liver to the diaphragm were divided and the liver was exposed. The bile duct 
was cannulated with a polyethylene catheter for measurement o f bile flow and 
collection o f samples for 'H  NM R spectroscopy.
5.2.2 Experimental groups and protocol
Two groups o f animals were used; the I/R group (n=6) had lobar liver ischaemia 
induced by clamping the vascular pedicles o f the median and left lobes of the liver, 
using an atraumatic microvascular clip. After 60 min of ischaemia the vascular clip was 
removed and reperfusion was allowed for 7 h. During the I/R period, the abdomen was 
covered with a plastic wrap to prevent fluid evaporation. The sham control group (n=6) 
underwent laparotomy for 9 hours, without hepatic inflow occlusion. In both groups 10 
ml/kg/h o f 0.9 % NaCl was administered iv to compensate for intraoperative fluid loss.
5.2.3 Blood sampling for liver function
Arterial blood samples (1 ml each) were taken before the induction o f liver ischaemia 
(baseline), at the end o f ischaemia (60 min) and 2, 5 and 7 h after reperfusion for 
measurement o f alanine aminotransferase (ALT) and aspartate aminotransferase (AST)
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activity. An equal volume o f normal saline was used to replace the volume of the blood 
taken. Serum was separated from the samples and stored at -20°C until assayed. The 
measurements were done using an automated clinical chemistry analyzer (Hitachi 747, 
Roche Diagnostics Ltd., Sussex, UK).
5.2.4 Liver Histopathology
Small wedge biopsies were taken at the end o f the procedure from the ischaemic lobes. 
Formalin-fixed liver tissue samples were embedded in paraffin and stained with 
haematoxylin and eosin for subsequent microscopy (digital light microscope CLF60 
optical system, Nikon UK Ltd, Surrey, UK). For assessment o f the degree o f injury a 
semi quantitative method was used in which a blinded liver pathologist estimated the 
number o f neutrophils (PMN) in sinusoids, the aggregation o f PMN, the hypertrophy of 
Kupffer cells and the presence o f necrosis and apoptosis in 5 high power fields per slide
5.2.5 Measurement of cytochrome oxidase activity
The effect o f I/R on intracellular liver tissue oxygenation was measured by near infrared 
spectroscopy (NIRS) as described in section 3.3. The optical-fibre bundles (probes) 
were positioned on the left lobe o f the liver, with a 10 mm separation. A flexible probe 
holder was used to ensure that probes have a satisfactory contact with the liver surface 
and a fixed inter-probe spacing. A NIRS algorithm was developed to measure 
continuously changes in the redox state o f Cua centre o f Cyt Ox in pMol/L. The pre- 
ischemic baseline was taken as baseline against which changes recorded.
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5.2.6 M easurement of bile flow and bile composition with NMR spectroscopy
The common bile duct was cannulated with a polyethylene catheter (PE-50, Portex, 
Kent, UK) for continuous collection o f bile. Bile samples were collected continuously 
and aliquoted in separate containers at the end o f baseline (before the I/R procedure), 
following 60 min ischaemia and hourly during reperfusion in the I/R group or the 
equivalent time in the sham group. The total bile volume collected was expressed as 
pL/min/lOOg o f liver wet weight and then each aliquot was analyzed by lH NMR 
spectroscopy. Spectra o f hepatic bile samples were obtained using a !H NMR 
spectrometer (Eclipse+ 500; JEOL Ltd., Tokyo, Japan) operating at 11.7 T (500 MHz 
for 'H). All Spectra were recorded at 25°C. 600 pL o f bile was placed in a 5 mm tube 
with a 2 mm coaxial insert containing a reference standard o f 100 pL o f 1 mg/ml of 
sodium trimethylsilyl-[ H^propionate (TSP) dissolved in deuterium oxide ( H2O, 
Fluorochem Ltd., Old Glossop, Derbyshire, UK) and set at 0.0 parts per million (ppm). 
A basic single pulse sequence was used to acquire the one-dimensional spectra using a 
45° pulse (8.25 ps) with an acquisition duration o f 4.36 s and a relaxation delay o f 5s. 
To reduce the large water resonance signal a gated secondary irradiation at the water 
frequency was applied. Published peak assignments (Melendez et al. 2001) were used. 
In brief, these were lactate methyl group peaks (1.33 ppm), acetate peaks (1.91 ppm), 
PC head group -N +(C H 3 )3  (3.20 ppm) and C-25 glycine methylene proton peak (3.80 
ppm), as shown in figure 5.1. Integration o f the !H NMR spectra areas was measured 
relative to the reference standard TSP area at baseline and obtained using MestRe-C 
software (version 2.3a, Departmento de Qui'mica Organica, Universidade de Santiago de 
Compostela).
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5.2.7 Data collection and statistical analysis
Values are expressed as mean ± standard deviation. Spectroscopy values are shown as a 
percentage change o f baseline values. For statistical analysis Student’s paired and 
unpaired t-test was used for comparisons within and between groups. Simple and 
polynomial regression analysis was used for correlations. P<0.05 considered 
significant.
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Figure 5.1 Proton nuclear magnetic resonance ( !NMR) spectrum of baseline bile. 
L=lactate, G=glycine, PC=phosphatidylcholine, TSP=sodium trimethylsilyl 
[2H4 ]propionate standard, Ac=acetate, H20=Water
5.3 Results
5.3.1 Liver biochemistry
In the sham-operated controls, ALT rose significantly at 5 and 7 h post-reperfusion 
compared to baseline (p < 0.05). A similar effect was seen in AST levels. In the I/R 
group there was a marked significant increase in ALT and AST at 2, 5 and 7 h 
reperfusion as shown in figures 5.2 and 5.3, respectively.
5.3.2 Liver Histopathology
Examination o f liver histology revealed polymorphonuclear leukocyte (PMN) 
accumulation in sinusoids, PMN aggregation, Kupffer cell hypertrophy, necrosis and 
apoptosis in the I/R group compared to the sham control group as shown in figure 5.4.
5.3.3 Bile Flow
There was a gradual decrease in bile flow in the sham group, over the period of the 
experiment compared to baseline, and this difference reached significance at 7 hrs post­
reperfusion (P=0.045). Bile flow in the I/R group was similar to sham controls at 
baseline but reduced significantly to 26.6% o f baseline during ischaemia (60±19 
pL/min/100g vs. 202±32 pL/min/100g; P=0.0022). Bile flow increased on reperfusion 
to but remained significantly less than sham as shown in figure 5.5. Mean total bile flow 
for the three reperfusion time points together was 45±9% o f baseline values.
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5.3.4 Changes in cytochrome oxidase redox state
During ischaemia there was a significant decrease in the redox state o f Cyt Ox Cua 
which was maximal at 15-20 minutes after induction o f ischaemia (Table 5.1). After 
reperfusion, in the 1/R group, initially Cyt Ox CuA redox state returned towards baseline 
values during the first two hrs o f reperfusion. However, subsequently Cyt Ox CuA redox 
state decreased again and reached levels lower than the ischaemic levels by the fifth 
hour o f reperfusion. There was also a decrease in Cyt Ox CuA redox state in the sham 
group during the experiment compared to baseline.
Table 5.1 C h an ges in the redox state o f  CuA centre o f  cy toch rom e o x id a se  (in  p M ol /  L) in the  
sham  and isch aem ia -rep erfu sion  (I/R ) groups during the exp erim en t, com pared  to b aseline. 
R esu lts are p resented  as m ean (S D ). * p <  0 .0 5  vs. b aselin e and sham  group.
Groups Baseline Ischaemia 2nd hour 5th hour 7,h hour
Sham 0.00 -7.5 ± 4.6 -1.3 ± 1.9 -3.7 ± 1.4 -6.5 ± 1.5
I/R 0.00 -23.1 ± 3.5' -11.1 ±3.8' -22.3 ±11.6* -24 ± 7.2*
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Figure 5.2 Changes in serum alanine aminotransferase (ALT) activity during 
ischaemia-reperfusion.
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Figure 5.3 Changes in serum aspartate aminotransferase (AST) activity during 
ischaemia-reperfusion.
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Figure 5.4 Light microscopy o f  liver changes during ischaemia-reperfusion (I/R). Light 
microscopy (xlOO) stained with hematoxylin and eosin showing extensive 
polymorphonuclear leukocyte (PMN) accumulation in sinusoids, PMN aggregation and 
necrosis in the I/R group (b) compared to the sham group (a).
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Figure 5.5 Bile flow following warm liver ischaemia-reperfusion
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5.3.5 ‘H NMR spectroscopy o f bile
A baseline spectrum o f  bile is shown in figure 5.1. There was no difference in biliary 
lactate concentration between the sham and I/R groups at baseline. Biliary lactate levels 
were significantly elevated in the I/R group at 5 h post-reperfusion to 165.44±22.97% o f 
initial baseline values (P=0.0036 vs. sham controls), followed by a decline at 7 h to 
89.13±29.91% o f  baseline values as shown in figure 5.6.
Analysis and integration o f  peaks corresponding to phosphatidylcholine (PC) head 
group (figure 5.7) revealed that ischaemia produced a two-fold increase 
(213.04±64.06% o f baseline vs. 82.13±31.91% o f  baseline in sham controls, P=0.0105). 
Mean values for PC over all time points tended to be higher in the I/R group compared 
to the sham group (P<0.0001 as assessed by AN OVA).
Acetate levels were reduced compared to baseline throughout the period of the 
experiment in both the I/R and sham groups (figure 5.8 and 5.9). The reduction was 
significantly greater in the I/R group by 5 h post-reperfusion (50.75 ± 13.24 % vs. 70.35 
± 6.86%, P=0.0391) and 7 h post-reperfusion (37.47 ± 7.49 % vs. 69.36 ± 13.29 %, 
P=0.0058) (I/R vs. sham).
Correlation o f !H N M R bile spectroscopy data with other parameters revealed that 
acetate decreased with increases in ALT (R=0.762, PO.OOOl) (figure 5.10). Acetate 
increased with increases in bile flow (R=0.458, P=0.0109) and the redox state of Cyt Ox 
(R=0.650, P=0.0001) as shown in figure 5.11. Phosphatidylcholine increased with 
increases in ALT (R=0.428, P=0.0295) and decreased with increases in bile flow 
(R=0.699, PO.OOOl) and redox state o f Cyt Ox (R=0.644, PO.OOOl). Lactate increased 
with increases in AST (R=0.445, P=0.0200) and tended to decrease with increase in the 
redox state o f Cyt Ox (R=0.319, P=0.0857), however these results did not reach 
statistical significance.
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Figure 5.6 Bile lactate levels following warm liver I/R. Lactate levels were calculated 
by integration o f  peaks at 1.3 ppm and expressed as a percentage o f baseline values 
(*p < 0.05, I/R vs. sham).
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Figure 5.7 Bile phosphatidylcholine (PC) levels following warm liver ischaemia- 
reperliision. PC levels were calculated by Integration of peaks at 3.2 ppm and expressed as a 
percentage of baseline values. (*p < 0.05, I/R vs. sham).
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Figure 5.8 Bile acetate levels following warm liver ischaemia-reperfiision.Acetate 
levels were calculated by integration o f  acetate peaks at 1.91 ppm and expressed as a 
percentage o f  baseline values. (*p < 0.05, I/R vs. sham).
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Figure 5.9 !H NMR bile spectra o f  acetate peaks (2.0-1.84 ppm) scaled to TSP o f  I/R 
group at (a) baseline and (b) after 7 hours o f reperfusion showing significant reduction.
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Figure 5.10. Correlation o f ALT with billiary acetate (p < 0.05).
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Figure 5.11. Correlation between changes in cytochrome oxidase redox state and 
biliary acetate (p < 0.05).
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5.4 Discussion
This is the first time that NMR analysis o f bile has been applied to a controlled 
experimental model o f warm liver I/R. Liver warm I/R injury can be divided into an 
early phase which is associated with Kupffer cell activation and a cytokine surge 
(Jaeschke et al. 1988; Jaeschke 1998) and a late phase (> 4 h) which is mainly due to 
the accumulation o f neutrophils and is associated with more extensive injury (Jaeschke 
et al. 1990; Lentsch et a l  2000).
In the present study, a rabbit lobar I/R model was used with reperfusion period o f seven 
hours (Glantzounis et al. 2004). This model permitted the analysis o f bile constituents in 
both the early phase and the beginning o f the late phase o f I/R injury. The lobar I/R 
model rather than total hepatic ischaemia was used as this avoids the production o f 
acute portal hypertension and intestinal ischaemia. Moreover, lobar clamping avoids the 
cessation o f biliary drainage, a characteristic o f the total hepatic ischaemia model 
(Jaeschke et al. 1988), permitting the effects o f I/R on biliary composition to be 
evaluated. As common bile duct cannulation results in the collection o f bile from both 
the ischaemic and non-ischaemic lobes we compared the findings from the I/R group 
with a sham (non-ischaemic) group to ensure that these changes in bile composition 
were the result o f the I/R procedure. Although previous studies have shown no 
difference in bile salt secretion or any other measured parameters, besides a decrease in 
bile flow, between ischaemic and non-ischaemic lobes in a similar lobar ischaemia rat 
model (Accatino et al. 2003). Tracheostomy and ventilation stabilized the model 
haemodynamically and permitted bile constituents to be analyzed into the late phase of 
I/R. An inhaled anaesthetic agent isoflurane, which is mainly metabolized in the lungs
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rather than in the liver, was also used for maintenance o f anaesthesia, in order to avoid 
cumulative effects or hepatotoxicity.
The hepatocyte is a polarized epithelial cell with sinusoidal and canalicular plasma 
membrane domains. Hepatic uptake o f biliary constituents is initiated at the sinusoidal 
membrane, which is in direct contact with portal blood plasma via the fenestrae of the 
sinusoidal endothelial cells and the space o f Disse (Nathanson and Boyer 1991). For 
cellular uptake o f taurine or glycine conjugated bile acids, an active transport 
mechanism is required (Trauner and Boyer 2003; W olkoff and Cohen 2003) as hepatic 
uptake o f bile salts occurs against a 5-10 fold concentration gradient between the portal 
blood plasma and the hepatocyte cytosol (Bowers et a l  1987; Glanemann et al. 2003). 
Canalicular excretion o f biliary constituents represents the rate-limiting step o f bile 
secretion since biliary constituents are excreted against high concentration gradients into 
bile. ATP-dependent transport systems in the liver transport biliary constituents against 
steep concentration gradients across the canalicular membrane that are often in the 
range o f 100- to 1,000-fold and are driven by ATP hydrolysis (Fisher et a l  1999; 
Sumimoto e /a /. 1988).
Bile flow decreased and ALT activity increased mildly over the duration o f the 
experiment in the sham-operated group suggesting minimal operative and anaesthetic 
trauma to liver function over this lengthy surgical procedure combined with remote 
liver injury from limb ischaemia, caused by femoral artery cannulation as previously 
discussed (Chapter 4). However, the 6-10 fold rise in ALT following reperfusion in the 
I/R group suggests significant I/R injury.
Cytochrome oxidase is the terminal complex o f the mitochondrial respiratory chain. It 
takes electrons from cytochrome c and catalyses the reduction o f oxygen to water with 
the concomitant synthesis o f ATP through the oxidative phosphorylation process (El 
Desoky et al. 2001; Hafez et al. 2004). In hepatocytes, approximately 90% of the 
oxygen is consumed by mitochondrial cytochrome oxidase. Absorption o f the NIR light 
by Cyt Ox occurs primarily at the Cua centre within Cyt Ox. There is a decrease in 
signal intensity on reduction o f this centre. The redox state o f Cyt Ox Cua is dependent 
on cellular oxygen availability. In the presence o f oxygen, electron transfer occurs and 
the enzyme becomes oxidised, whereas lack o f oxygen, results in a decreased flow of 
electrons and Cyt Ox becomes reduced. The increase in the reduction state of Cyt Ox 
reflects severe cellular hypoxia. NIRS has been used to measure liver tissue 
oxygenation changes following warm liver I/R injury (El Desoky et al. 2000). There 
was a significant decrease in the redox state o f Cyt Ox Cua following ischaemia that 
was still persistent at 5 h and 7 h following reperfusion in the I/R group.
The drop in bile flow during ischaemia corresponds to the exclusion o f liver mass in the 
I/R group during this phase. A post-reperfusion decrease in bile flow has been reported 
previously (Fisher et al. 1999; Sumimoto et al. 1988) and bile excretion has been used 
as an indicator o f liver function and recovery following ischaemia in experimental 
studies (Sumimoto et al. 1988) and clinical liver transplantation (Fisher et al. 1999). 
NMR spectroscopy o f bile revealed changes in the concentration o f some bile 
constituents. Bile lactate were elevated towards the beginning o f the late phase o f I/R 
where there is significant neutrophil activation. It has been observed that the injury 
produced during the beginning o f the late phase is a more extensive hepatocellular 
injury in comparison to the early phase (Glantzounis et al. 2004; Lentsch et al. 2000).
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Neutrophil sequestration, sinusoidal narrowing and vasoconstriction combine to form a 
‘no-reflow paradox’ whereby hepatocytes are subjected to a further perfusion deficit 
and persistent ischaemia (Menger et a l  1992; Peralta et a l  2000). This may explain the 
observed peak in lactate at this late time-point. Lactate levels have been shown to 
become elevated in bile even when they are not elevated in serum (Nishijima et a l 
1997). ATP degradation after ischaemia leads to the activation o f glycolysis, resulting in 
the net formation o f lactate. Serum lactate concentration has been shown to increase 
progressively following liver ischaemia, primarily from glycolytic/gluconeogenic 
pathway. This was verified by measuring glucose-6-phosphate and fructose-6-phosphate 
which were shown to increase with I/R injury (Peralta et a l  2000).
Phosphatidylcholine was raised following ischaemia and reperfusion at 2 h and 5 h. The 
main source o f phosphatidylcholine in cells is in the plasma membrane, which suggests 
that the increase during ischaemia and again at 5 h post-reperfusion may be associated 
with an increase in cellular breakdown and membrane lipid peroxidation. Increased 
biliary phosphatidylcholine has also been observed in other experimental studies 
(Suzuki et a l  2000) and in association with poor graft function (Melendez et a l 2001).
Acetate was observed to drop continuously from baseline throughout the experiment in 
the I/R group. Hepatocytes are one o f the few cells that can utilize fatty acids in the 
production o f energy through the p-oxidation helix (Ambrose and Easty 1977). This 
reaction requires ATP at its initiation. Post-reperfusion ATP is consumed to clear excess 
lactate and pyruvate and may not be readily available for fatty acid oxidation. The ATP 
reduction as a result o f I/R may result in decreased p-oxidation and acetate production is
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reduced. Biliary acetate decreased with increases in ALT and AST, established markers 
o f hepatocyte damage, and increased with increases in bile flow and redox state o f Cyt 
Ox Cua, accepted indicators o f liver function and viability.
In conclusion, bile spectroscopy has demonstrated significant changes in bile 
composition during I/R. These changes are evident despite a constant, albeit reduced, 
post-reperfusion rate o f bile flow. Having identified significant changes in lactate, PC 
and acetate with I/R, further studies are required to evaluate and quantify these changes.
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5.5 Chapter summary
Ischaemia-reperfusion (I/R) injury in liver resection and transplantation is associated 
with poor liver function and reduced bile excretion. Compositional changes in bile 
following liver I/R are o f growing interest. A rabbit model was used and two groups of 
animals were studied. In the I/R group, lobar liver ischaemia was induced in New 
Zealand white rabbits (n=6) by inflow occlusion to the median and left liver lobes, 
under general anesthesia, for 60 min, followed by 7 h reperfusion. The sham group 
(n=6) underwent laparotomy for 9 hours but no liver ischaemia. In both groups the bile 
duct was cannulated and bile was collected continuously and blood was collected for 
analysis o f transaminases. Bile composition was determined by proton nuclear magnetic 
resonance ( !H NMR) spectroscopy. Liver oxygenation was determined throughout the 
experiment using near infrared spectroscopy. During ischaemia bile excretion decreased 
(60 ± 19 pL/min/lOOg vs. 202 ± 32 pL/min/lOOg; P=0.0022) and biliary 
phosphatidylcholine increased (213.04 ± 64.06% o f baseline vs. 82.13 ± 31.91% of 
baseline, P=0.0105) in the I/R group. With reperfusion in the I/R group, bile flow 
returned to 45 ± 9% o f baseline, ALT and AST were raised at 7 h (P=0.0001 and 
P=0.0376 respectively), biliary lactate was elevated at 5 h post-reperfusion to 165.44 ± 
22.97% o f baseline (P=0.0036). Acetate levels were significantly decreased at 7 h post­
reperfusion (37.47 ± 7.49% vs. 69.36 ± 13.29%, P=0.0058). In conclusion, *H NMR 
spectroscopy has demonstrated significant changes in bile composition associated with 
I/R injury and could be applied as marker to assess the effectiveness o f therapeutic 
strategies and also for early diagnosis o f liver dysfunction (e.g. post liver 
transplantation).
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CHAPTER 6
THE EFFECT OF CONTINUOUS N-ACETYLCYSTEINE 
INFUSION ON LIVER FUNCTION DURING WARM ISCHAEMIA- 
REPERFUSION IN NORMAL LIVER
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6.1 Introduction
In the previous chapter significant changes were found in bile volume and composition 
during hepatic I/R. This chapter studies the effect o f the antioxidant N-acetysteine, in 
rabbits with normal liver, undergoing liver I/R. As mentioned before, liver I/R injury 
occurs during major liver surgery and transplantation or following haemorrhagic shock and 
subsequent fluid resuscitation (Huguet et a l  1994; Henderson 1999; Vedder et a l 1989). 
Extracorporeal circulation used in cardiac or vascular surgery is also associated with low- 
flow I/R o f the liver (Pannen 2002). When the degree o f injury is severe it may result in 
both liver failure (Huguet et a l  1994) and remote organ failure in the lungs, heart and the 
systemic circulation (Matuschak 1994; Lichtman and Lemasters 1999). The 
pathophysiology o f liver I/R involves the activation o f many metabolic pathways and the 
release of mediators that induce liver injury (Lentsch et a l  2000). There is growing 
evidence that there are two distinct phases of liver injury after warm ischaemia and 
reperfusion (Colletti et a l  1990; Jaeschke et a l  1990; Jaeschke and Farhood 1991; Lentsch 
et a l  2000). The initial phase (within two hours o f starting reperfusion) is characterized by 
Kupffer cell-induced oxidative stress (Jaeschke and Farhood 1991). The late phase (after 
four hours) mainly results from the accumulation o f neutrophils and is associated with more 
extensive injury (Jaeschke et a l 1990). Main contributors to the liver damage are ROS and 
RNS, which are released in both phases o f reperfusion and produce significant oxidative 
stress (Jaeschke 2000). Mammals have a complex antioxidant system to protect themselves 
from such stress. One o f the most important components o f the intracellular antioxidant 
system is glutathione, a powerful active radical scavenger that is depleted during severe 
liver I/R injury (Liu et a l  1994).
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A-acetylcysteine (NAC) is a thiol-containing compound used in the management of 
fulminant liver failure after paracetamol overdose (Prescott et al. 1979; Chyka et al. 2000). 
One mechanism by which NAC acts, is by entering cells and undergoing hydrolysis to 
cysteine, a glutathione precursor capable of rapidly replenishing depleted intracellular 
reduced glutathione concentrations (Halliwell B and Gutteridge JMC 1999). NAC also 
scavenges several ROS and RNS directly (Cotgreave 1997). Experimental studies in which 
NAC has been used to reduce warm liver I/R injury have produced conflicting results 
(Chavez-Cartaya et al. 1999; Koeppel et al. 1996) and the use o f antioxidants for liver I/R 
still requires study o f the mechanism and timing of any beneficial effects.
The present study evaluated the effect of NAC administration on liver function in both the 
early phase and initial part o f the late phase of warm liver I/R injury. A rabbit lobar I/R 
model was used in which several markers of liver function were monitored continuously or 
at intervals for seven hours after the ischaemic injury. For continuous monitoring of arterial 
blood pressure and blood withdrawal the right femoral artery was cannulated. This was 
done because the effects o f limb ischaemia to remote organs was not apparent at the time 
this study was performed.
6.2 Materials and methods
6.2.1 Animal model-measurements
The study was conducted under a license granted by the Home Office in accordance with 
the Animals (Scientific Procedures) Act 1986. New Zealand white rabbits with mean (s.d.) 
body weight (BW) 3.8 (0.5) kg; n = 18) were used. The mean (s.d) liver weight (LW) was 
90 (15) and the mean (s.d) LW/BW ratio (%) was 2.5 (0.26). Anaesthesia and surgical
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procedure are described in section 3.1. Briefly anaesthesia was induced by intramuscular 
injection o f 0.5 ml/kg Hypnorm and maintained with 0.5-3 % isoflurane through an 
anaesthetic circuit following tracheostomy. A radio-opaque catheter 20 gauge (GA) was 
inserted into the right femoral artery for monitoring o f arterial blood pressure and collection 
of blood samples. Ear marginal veins were cannulated with radio-opaque catheters (22 G A) 
for the administration o f anaesthetics, fluids and medication.
Laparotomy was performed through a midline incision. Lobar ischaemia was induced by 
clamping the vascular pedicles o f the median and left lobes o f the liver, using an atraumatic 
microvascular clip. After 60 min of ischaemia, the vascular clip was removed and 
reperfusion was allowed for 7 h. At the end of the experiment the animals were killed by 
exsanguination.
Three groups o f animals were used. In the NAC group 150 mg/kg NAC (Parvolex®; 
Medeva Pharma, Ashton-under-Lyne, Lancashire, UK) in 20 ml 5 % dextrose was infused 
intravenously through the ear vein over the 15 min before reperfusion and maintained at 10 
mg per kg per h in 5 % dextrose (10 ml/hour) during the 7 h reperfusion period. In the I/R 
group 20 ml five per cent dextrose was infused intravenously 15 min before reperfusion and 
continued at a dose o f 10 ml/h during the reperfusion period. Animals in the sham operation 
group underwent laparotomy but no liver ischaemia. In all groups 0.9 % sodium chloride 
was administered intravenously at 10 ml per kg per h to compensate for intraoperative fluid 
loss.
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Laparotomy and baseline measurements were completed over one hour. In the sham group 
monitoring continued for the equivalent o f the ischaemia and reperfusion periods in treated 
animals (total monitoring period 9 h).
Portal flow was monitored continuously using a perivascular transonic flow probe 3 mm in 
diameter (see section 3.4).
Arterial blood samples (1 ml each) were taken before the induction of liver ischaemia 
(baseline), at the end o f ischaemia (60 min) and two, five and seven hours after reperfusion 
for measurement o f alanine aminotransferase (ALT) activity. Serum was separated from the 
samples and stored at -20°C until assayed. Measurements were made using an automated 
clinical chemistry analyser (Hitachi® 747, Roche Diagnostics, Lewes, UK).
Hepatic microcirculation was measured by a surface laser Doppler flowmeter (LDF), 
following the procedure described in section 3.2.
Intracellular hepatic tissue oxygenation was measured by near-infrared spectroscopy 
(NIRS). Basic principles o f NIRS are described in section 3.3. For continuous monitoring 
of hepatic tissue cytochrome oxidase redox state, NIRS probes were positioned flat on the 
surface o f the left lobe of the liver 10 mm apart. A flexible probe holder was used to ensure 
satisfactory contact with the liver surface with fixed interprobe spacing. NIRS 
measurements during ischaemia and reperfusion were expressed relative to baseline values 
before vascular occlusion.
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A bolus o f 0.5 mg/kg ICG (Cardiogreen®, 90 per cent dye content; Sigma Chemical 
Company, Poole, UK) was given after seven hours o f reperfusion. ICG was dissolved in 
sterile water (50 mg per 10 ml) and administered via the marginal ear vein over 20 sec. 
Continuous measurement o f hepatic ICG by NIRS produced a concentration-time curve. 
This curve was analysed to produce two exponential rate constants: a, which represented 
hepatic ICG uptake from the plasma to the hepatocytes and p, which represented hepatic 
ICG excretion from the liver by cytoplasmic transport and biliary excretion (Shinohara et 
a l 1996).
6.2.2 Data collection and statistical analysis
Data from the pulse oximeter, blood pressure and portal flow monitor, LDF and NIRS were 
collected continuously on a laptop computer. The data were averaged for two minutes 
before the induction o f ischaemia (baseline), at the end o f ischaemia and at the end of each 
hour o f a seven hour reperfusion period. Changes in hepatic tissue oxygenation at the end 
of each period were calculated relative to baseline. Values are expressed as mean (s.d.). 
Student’s t test for paired samples and one-way ANOVA with Bonferroni adjustment for 
multiple comparisons were used for statistical analysis. P  < 0.050 was considered 
significant.
6.3 Results
6.3.1 Systemic haemodynamic variables
In all three groups systemic mean arterial blood pressure fell in the reperfusion period 
compared with baseline. These changes were not significantly different between groups 
(Figure 6. 1). In all groups the pulse rate slowed during the course o f the experiment in
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comparison with baseline measurements. The pulse rate stayed closer to baseline in the 
NAC group than the l/R group; this difference was significant in the fifth (P -  0.026), sixth 
(P = 0.025) and seventh (P = 0.016) h of reperfusion (Figure 6.2).
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Figure 6.1 Mean arterial blood pressure (MABP) during ischaemia and reperfusion. Values 
are mean (s.d.). NAC, A-acetylcysteine; l/R, ischaemia-reperfusion. There were no 
significant differences between groups
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Figure 6.2 Pulse rate during ischaemia and reperfusion. Values are mean (s.d.). NAC, 
yV-acetylcystcine; I/R, ischaemia-reperfusion. *P < 0.050 versus I/R group (one-way 
ANOVA with Bonferroni adjustment for multiple comparisons)
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6.3.2 Hepatic haemodynamic parameters
There were no differences in portal blood flow values between the groups at baseline. 
During the period o f ischaemia the portal flow was reduced in both the NAC (P = 0.003) 
and I/R (P = 0.001) groups, compared with baseline values. The reduction started one 
minute after the induction o f ischaemia and was maximal by ten minutes. During the rest of 
the experiment, the portal flow fluctuated in all three groups. In the sham group there was 
an increase in portal flow rate. Portal flow was significantly greater in the sham group in 
comparison to that in the NAC and I/R groups during the first (P = 0.037), sixth (P = 0.025) 
and seventh (P = 0.033) hours of reperfusion (Fig. 6.3).
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Figure 6.3 Portal flow during ischaemia and reperfusion. Values are mean (s.d.). NAC, 
V-acetylcysteine; I/R, ischaemia-reperfusion. *P < 0.050 versus baseline (Student's t test 
for paired samples); "\P < 0.050 versus NAC and I/R groups (one-way ANOVA with 
Bonferroni adjustment for multiple comparisons)
147
6.3.3 Liver function tests
Mean serum ALT activity at baseline was within the normal range, with no significant 
differences between the three groups (Fig. 4). After reperfusion, the mean ALT activity in 
the NAC and l/R groups was significantly higher than that in the sham-operated group. The 
serum ALT activity was less severe in the NAC group than I/R group in the fifth (P = 
0.007) and seventh (P = 0.021) hours of reperfusion (Fig. 4). By the end o f the experiment 
ALT activity had increased twofold in the sham-operated group compared with baseline 
values (Fig. 6.4).
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Fig. 6.4 Serum alanine aminotransferase (ALT) activity during ischaemia and reperfusion. 
Values are mean (s.d.). NAC, /V-acetylcysteine; I/R, ischaemia-reperfusion. *P < 0.050 
versus NAC group (one-way ANOVA with Bonferroni adjustment for multiple 
comparisons)
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6.3.4 Hepatic microcirculation
There was no significant difference in the hepatic microcirculation over the nine hour sham 
operation. Following I/R, flow in the microcirculation was reduced in the NAC and I/R 
groups. NAC treatment was associated with an increased flow in the hepatic 
microcirculation after the third hour o f reperfusion compared with that in the I/R group, but 
this was not statistically significant until the fifth hour (P = 0.036) (Fig. 6.5).
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Fig. 6.5 Hepatic microcirculation during ischaemia and reperfusion. Values are mean (s.d.). 
NAC, TV-acetylcysteine; I/R, ischaemia-reperfusion. *P < 0.050 versus NAC group (one 
way ANOVA with Bonferroni adjustment for multiple comparisons). There were no 
significant differences in the hepatic microcirculation during the experiment in the sham- 
operated group (Student's t test for paired samples)
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6.3.5 Hepatic tissue oxygenation
During ischaemia there was a significant decrease in cytochrome oxidase redox state, 
which was maximal at five to ten minutes after induction of ischaemia (Fig. 6.6). After 
reperfiision, cytochrome oxidase redox state returned towards baseline values during the 
first hour in the I/R group, but subsequently decreased. In the NAC group, redox state of 
Cyt Ox also fell with ischaemia but was significantly better compared to the I/R group in 
the second (P = 0.023), sixth (P = 0.005) and seventh (P = 0.004) hours after repcrfusion 
(Fig .6.6). Levels in the NAC group were similar to those in the sham group in the sixth and 
seventh hours (Fig. 6.6).
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Fig. 6.6 Changes in cytochrome oxidase redox state relative to baseline during ischaemia 
and reperfusion. Values are mean (s.d.). NAC, V-acetylcysteine; I/R, ischaemia- 
reperfusion. *P < 0.050 versus NAC group (one-way ANOVA with Bonferroni adjustment 
for multiple comparisons)
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6.3.6 Indocyanine green (ICG) clearance
ICG uptake (a) and excretion (p) rates in NAC and I/R groups were reduced by I/R, in 
comparison to values in the sham group (Table 6.1). NAC produced a significant 
improvement in both ICG uptake and excretion at seven hours after ischaemic injury 
compared with rates in the I/R group (Table 6.1).
Table 6.1. Hepatic indocyanine green (ICG) uptake and excretion rates.
GROUPS a  (min !) p (min *)
NAC 2.245 ± 0.32* 0.024 ± 0.0071
I/R 0.848 ± 0.394* 0.005 ± 0.001 +
Sham 2.565 ± 0.488 0.064 ±0.019
Values are mean ± (SD.) o f six animals in each group, a: Hepatic ICG uptake rate; p: 
hepatic ICG excretion rate; I/R: ischaemia / rcperfusion, *p= 0.001, NAC vs I/R group, 
+p=0.032, NAC vs I/R group. One way analysis o f variance (ANOVA) with Bonferroni 
adjustment for multiple comparisons were used.
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6.4 Discussion
The late phase o f warm liver I/R injury is considered to start at four hours after reperfusion 
and is mainly due to release of ROS and proteases from activated neutrophils. This 
produces more extensive hepatocellular injury than the early phase (Jaeschke et al. 1990; 
Harbrecht et al. 1993).
The present study investigated continuous infusion o f NAC in a liver I/R model, which 
allowed hepatic function and haemodynamics to be evaluated in both the early and initial 
late phase o f liver I/R injury. Liver microcirculation and intracellular oxygenation were 
continuously recorded during a reperfusion period o f 7 h. An inhaled agent (isoflurane), 
which is mainly metabolized in the lungs rather the liver, was used for maintenance of 
anaesthesia, to avoid cumulative effects or hepatotoxicity. The sham group allowed the 
effects o f prolonged anaesthesia and surgical trauma alone to be evaluated. The duration of 
general anaesthesia was similar to that for major human liver surgery (liver resection and 
transplantation).
In the sham-operated control group, arterial blood pressure dropped, ALT activity was 
significantly increased and hepatic intracellular oxygenation was significantly decreased 
during the period o f anaesthesia compared to baseline. This was the effect of remote liver 
injury due to limb ischaemia caused from the canulation o f femoral line. Also the 
anaesthetic agent and operative. trauma could affect liver function during the lengthy 
surgical procedure.
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Analysis o f the changes in microcirculation and intracellular oxygenation during the seven 
hour reperfusion period suggests that the initial part o f the late phase starts from the third 
hour after reperfusion and reaches a peak at the sixth hour. A previous study (Jaeschke et 
a l 1990) suggested that the late phase starts 6 h after reperfusion, based on the 
measurement o f hepatocellular necrosis and neutrophil infiltration. Histological changes 
indicative o f liver injury are likely, however, to be detected later than changes in the 
hepatic microcirculation or tissue oxygenation.
Portal flow values were calculated with respect to bodyweight to eliminate variations 
related to animal size. There was a significant decrease in portal flow during ischaemia in 
the I/R and NAC groups. This decrease may result in a reduced metabolic need o f the liver. 
Similar findings have been reported in previous studies (El Desoky et a l 1999). During 
reperfusion there was fluctuation in portal flow in all three groups. In the sham group, the 
trend in portal flow was for a gradual increase during reperfusion, which might have been 
an effect o f isoflurane which increases hepatic blood flow and oxygen supply despite 
lowering systemic arterial pressure (Bernard et a l  1991; Gatecel et I  2003).
During inflow occlusion in the I/R group, the hepatic microcirculation dropped acutely 
almost to zero. There was a short-term recovery during the first two hours of reperfusion, 
followed by a further decrease. Mechanisms that might contribute to this impairment of 
sinusoidal perfusion include sinusoidal endothelial cell swelling with luminal narrowing 
(Vollmar et a l 1994) and sinusoidal vasoconstriction mediated by an altered endothelin- 
nitric oxide balance (Pannen et a l  1998; Pannen 2002; Scommotau et a l  1999). The 
increased expression o f adhesion molecules, with subsequent leucocyte and endothelial cell
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interaction, may also play a crucial role in these changes in the microcirculation, especially 
during the late phase o f reperfusion injury (Vollmar et al. 1995). It has been reported that 
the changes in microcirculation during the immediate reperfusion period in liver 
transplantation correspond directly with the maximum postoperative enzyme release from 
the liver (Klar et al. 1997) and are o f value in assessing and predicting the degree of liver 
injury (Pannen 2002).
Cytochrome oxidase is the terminal electron carrier of the mitochondrial respiratory chain 
that catalyses the reduction of oxygen to water with the concomitant synthesis of adenosine 
triphosphate through the oxidative phosphorylation process (Capaldi 1990). In hepatocytes, 
approximately 90 per cent of the oxygen is consumed by mitochondrial cytochrome 
oxidase(Capaldi 1990). Changes in cytochrome oxidase redox state are indicative of the 
level o f intracellular oxygenation and mitochondrial activity (Seifalian et al. 2001b; Koti et 
al. 2002). The degree o f impairment o f the hepatic mitochondrial redox state determines the 
survival rate o f patients after haemorrhagic shock and resuscitation (Nakatani et al. 1995). 
In the present study, during ischaemia there was a significant fall in cytochrome oxidase 
redox state in the I/R group, reflecting severe cellular hypoxia. Levels returned towards 
baseline during the first hour of reperfusion but subsequently decreased and by 7 h had 
reached levels similar to those observed during ischaemia. This further decline in 
cytochrome oxidase indicates persistent tissue and cellular hypoxia, that correlates well 
with the changes in hepatic microcirculation during the late phase o f reperfusion injury.
ICG uptake is related to liver blood flow and excretion is related to hepatocellular injury 
(El Desoky et al. 1999). Direct measurement of ICG by NIRS may avoid the inaccuracies
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inherent in assessing liver function from peripheral blood clearance o f ICG (Ott et a l 
1994). In the present study I/R produced a significant reduction in both the uptake and 
excretion o f ICG compared with levels in the sham-operated group.
The effect of NAC on liver I/R injury was evaluated using a dose o f NAC similar to that 
used for patients with fulminant hepatic failure due to paracetamol overdose (Harrison et al. 
1991). The administration o f NAC maintained the pulse rate close to baseline levels, 
reduced liver injury (as indicated by ALT serum activity) and improved flow in the 
microcirculation and intracellular tissue oxygenation. All these effects were obvious by the 
fifth hour o f reperfusion. NAC also improved ICG clearance at seven hours after 
reperfusion. In another experimental study, in which a rat lobar liver I/R model was used, 
no benefit was shown with NAC administration in warm I/R injury (Chavez-Cartaya et a l 
1999), although a shorter ischaemic period was used (45 minutes) and the NAC (300 
mg/kg) was administered intramuscularly before ischaemia, which may have resulted in a 
less reliable systemic distribution or a shorter-term effect. The effect o f NAC on the hepatic 
microcirculation in the late phase of reperfusion has not been reported previously. Previous 
experiments were limited to the first 1 to 2 h after reperfusion and the results were 
conflicting (Chavez-Cartaya et a l  1999; Koeppel et a l  1996).
The effect o f NAC on cytochrome oxidase level in the altered parenchymal 
microcirculation with I/R was examined, with clear evidence o f effects on the delivery and 
metabolism of oxygen in the hepatic parenchyma. This study did not assess the delayed 
effect o f NAC (at 24 or 48 h), as the model used was not appropriate for these longer 
periods.
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The mechanism underlying the protective effect o f NAC in the late phase o f warm I/R 
injury was not established in this study. However, NAC is a precursor of glutathione 
regeneration (Halliwell B and Gutteridge JMC 1999), is a direct scavenger of free radicals 
(Cotgreave 1997), inhibits inducible nitric oxide synthase expression (Hur et al. 1999) and 
inhibits the expression of intercellular adhesion molecule one and vascular cell adhesion 
molecule one (Weigand et al. 2001).
Further studies are required to assess the effect o f NAC at later time points and to elucidate 
the underlying mechanisms of action. Use of other thiols such as bucillamine (Amersi et al.
2002) or a combination o f NAC with other antioxidants such as melatonin (Sener et al.
2003) may further reduce liver I/R injury. A large randomized clinical trial will be required 
to demonstrate a clear benefit o f NAC administration in human liver warm I/R.
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6.5 Chapter summary
/V-acetylcysteine (NAC) may modulate the initial phase (less than two hours) of warm liver 
ischaemia-reperfusion injury (I/R) but its effect on the late phase remains unclear. The 
present study investigated the role of NAC during the early and late phases in a rabbit lobar 
I/R model.
Liver ischaemia was induced by inflow occlusion to the median and left liver lobes for 60 
minutes, followed by 7 h o f reperfusion. In the NAC group (n = 6), NAC was administered 
intravenously at 150 mg per kg over the 15 min before reperfusion and maintained at 10 
mg per kg per hour during reperfusion. In the I/R group (n = 6), 20 ml five per cent 
dextrose was infused over the 15 min before reperfusion and continued at a rate of 10 ml/h. 
Animals in a sham operation group {n = 6) underwent laparotomy but no liver ischaemia. 
All animals were killed at the end o f the experiment.
Intracellular tissue oxygenation was improved after the second hour of reperfusion in 
animals treated with NAC compared with that in the I/R group (P = 0.023). Hepatic 
microcirculation improved after the fifth hour of reperfusion (P = 0.036) and liver injury 
was reduced after the fifth hour, as indicated by alanine aminotransferase activity (P = 
0.007) and indocyanine green clearance (uptake, P = 0.001; excretion, P  = 0.032).
In conclusion the main protective effect of NAC becomes apparent five hours after hepatic 
ischaemic injury.
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CHAPTER 7
THE EFFECT OF N-ACETYLCYSTEINE ADMINISTRATION ON 
LIVER FUNCTION IN HEPATIC ISCHAEMIA-REPERFUSION IN
STEATOTIC LIVER
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7.1 Introduction
Having demonstrated a significant reduction in liver I/R with a continuous infusion o f NAC 
in normal liver (chapter 6), a controlled study of the administration of NAC in steatotic 
liver I/R was planned. Hepatic steatosis occurs with obesity, alcohol abuse and metabolic 
disorders (Neuschwander-Tetri and Caldwell 2003), and an incidence up to 11% has been 
reported in autopsy studies on accidental deaths (Underwood Ground 1984). It is now well 
recognised that steatotic livers are more susceptible to I/R injury than normal livers 
(Selzner and Clavien 2001). The mechanisms involved are still poorly understood but, as 
fat accumulates within the hepatocytes, cell volume increases resulting in a decreased 
sinusoidal space (Hakamada et al. 1997) and impaired microcirculatory blood flow (Selzner 
and Clavien 2001). Sinusoidal blood flow can be reduced by 50% in fatty livers (Ijaz et a l 
2003; Seifalian et al. 1999). Steatosis represents a risk factor in liver surgery, with a 
mortality rate up to 14% in patients undergoing major hepatic resections (Behrns et al. 
1998). Similarly, the use o f steatotic grafts for transplantation is associated with a much 
higher risk o f primary graft non-function or dysfunction (Busuttil and Tanaka 2003).
As a period o f ischaemia is often necessary in liver surgery, and is inevitable in organ 
retrieval and transplantation, pharmacological modulation could potentially protect steatotic 
livers, minimizing the detrimental effects of I/R injury.
N-acetylcysteine (NAC) is a thiol-containing compound that interacts and detoxifies free 
radicals by non-enzymatic reactions, and is deacetylated to form cysteine, which supports 
biosynthesis o f glutathione, one o f the most important components o f the intracellular 
antioxidant system (Cotgreave 1997). Nakano et al. demonstrated that perfusion with NAC
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prior to organ retrieval reduced the extent o f I/R injury after 24 h o f cold storage in an 
isolated perfused rat steatotic liver (Nakano et al. 1997). Bucillamine, another thiol 
antioxidant, has recently been shown to prevent reperfusion injury in rat models of liver 
transplantation with both normal and fatty livers (Amersi et al. 2002).
In chapter 6 it was shown that continuous infusion o f NAC during reperfusion, in rabbits 
with normal liver undergoing 1 h o f lobar ischaemia, reduces significantly liver injury 
(Glantzounis et al. 2004).
The aim o f the present study was to determine whether administration o f NAC to rabbits
with fatty livers reduced liver I/R injury.
7.2 Material and methods
7.2.1 Animal model
Details o f exprerimental procedure are described in section 3.1. 12 New Zealand white 
rabbits with a mean body weight of 3.8 ± 0.5 kg were used. Steatosis was induced by
feeding the animals with a high cholesterol (2%) diet for 8 weeks.
One radiopaque catheter (20 GA) was inserted into the ear artery to collect blood samples 
and connected to a pressure transducer to monitor mean arterial blood pressure (MABP) 
and heart rate. Ear marginal veins were cannulated in both ears with radiopaque catheters 
(22 GA) for the administration of fluids and drugs. Normal saline 0.9 % was infused at a 
rate of 15 ml/kg/h to replace the intraoperative fluid losses.
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Laparotomy was performed through a bilateral subcostal (roof-top) incision. The ligaments 
from the diaphragm to the liver were divided and the liver was fully exposed. The bile duct 
was cannulated with a polyethylene catheter (PE-50, 0.58 mm inner diameter, Portex, Kent, 
UK). Bile flow was measured and calculated as pL/min/lOOg o f liver wet weight. 
Following dissection o f the portal vein, a perivascular Doppler probe (HT207; Transonic 
Medical System Inc, Ithaca, NY) was positioned around it to monitor the portal blood flow. 
Lobar ischaemia was induced by clamping the vascular pedicles o f the median and left 
lobes o f the liver, using an atraumatic microvascular clip. The microvascular clip was 
removed after 60 min o f ischaemia and reperfusion was allowed for 6 h.
7.2.2 Experim ental groups and protocol
Two groups o f steatotic animals (n=6 each) were used.
In group A (NAC) 150 mg/kg o f N-acetylcysteine (Parvolex, Medeva Pharma Limited, 
Lancashire, UK) in 20 ml of 5% Dextrose was infused intravenously through the ear vein 
over the 15 minutes immediately before reperfusion and maintained at 10 mg/kg/h in 5% 
Dextrose during the 6 hours reperfusion period.
In group B (I/R) 20 ml o f 5% Dextrose was infused intravenously 15 min before 
reperfusion and continued at a rate o f 10 ml/kg/h during the reperfusion period.
In both groups, after laparotomy and a 10 minutes period o f stabilization, systemic and 
hepatic haemodynamics, oxygen saturation, body temperature and bile flow were 
continuously recorded. Arterial blood samples were taken before the induction of liver 
ischaemia (baseline) and at 2, 5 and 6 h after reperfusion for measurement of alanine 
aminotransferase (ALT) activity. An equal volume o f normal saline was used to replace the
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volume o f the blood taken. Serum was separated from the samples and stored at -20°C until 
assayed. The measurements were done using an automated clinical chemistry analyser 
(Hitachi 747, Roche Diagnostics Ltd, Sussex, UK). A biopsy was taken from the left liver 
lobe at baseline and 6 h after reperfusion. Formalin-fixed liver tissue samples were 
embedded in paraffin and stained with haematoxylin and eosin for subsequent microscopy 
(digital light microscope CLF60 optical system, Nikon UK Ltd, Surrey, UK). Formalin 
fixed and not paraffin embedded tissue was stained for fat using the Swank & Davenport 
modification o f the Marchi method (Swank RL 1935).
7.2.3 Measurement of blood flow in the hepatic microcirculation
To determine the effect o f NAC in the hepatic microcirculation a Laser Doppler Flowmeter 
was used as described in section 3.2.
7.2.4 Bile flow and composition
To determine the effect o f NAC therapy on bile production and excretion, bile flow was 
measured and bile composition analysed with proton nuclear magnetic resonance 
spectroscopy (!HNMR) using a quantitative method. Bile samples were taken at baseline 
and each hour thereafter and stored at -80°C. Bile volume was expressed as pL/min/lOOg 
of liver weight.
’HNMR analysis was performed on an 11.7 Tesla (500 MHz for protons) spectrometer 
(Varian Unity +; Varian, Palo Alto, CA, USA) at 25°C. Bile was thawed at room 
temperature and placed in 5mm NMR tube. For a field / frequency lock a coaxial capillary
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insert was used (Wilmad, Buena, NJ, USA). This capillary insert was filled with a 
deuterium oxide solution of sodium [ d4] - trimethysilylpropionate (TSP) that acted both as 
a chemical shift reference and quantification standard. This capillary was calibrated by 
using a series o f known concentration solutions of deoxycholate and a calibration curve 
was obtained. This was then used for quantification of bile components (lactate, acetate, 
pyruvate and phosphatidylcholine) which enabled an accurate comparison of bile levels 
between the groups. One dimensional NMR spectra were obtained at 500 MHz with a 
sweep width o f 6 kHz. Presaturation of bile was carried out to attenuate the intensity of 
water signal. The spectra were analysed using software from MestRe-C version 3.1.1 
(Universidade de Santiage de Compostela, Spain). All spectra were integrated using a fixed 
range for each peak and published peak assignments (Melendez et a l  2001) shown in table 
1.
7.2.S Dihydrorhodamine 123 (DHR 123) oxidation
To determine the effect o f NAC on the production of ROS and RNS such as peroxynitrite, 
the in vivo oxidation o f dihydrorhodamine (DHR) 123 to rhodamine (RH) was studied (see 
also section 3.10). DHR 123 is a chemical compound and its oxidation to RH is partially 
peroxynitrite-dependent (Szabo, Salzman, and Ischiropoulos 1995). RH is a fluorescent 
substance that gives a characteristic colour to plasma, easily detected by fluorescence. 6 h 
after reperfusion animals were administered DHR 123 intravenously (2pmol/kg in 0.8 ml 
N. saline 0.9 %). Twenty minutes later plasma samples were collected for rhodamine 
fluorescence evaluation. For fluorescence measurements a fluorometer was used at an 
excitation wavelength o f 485 nm and emission wavelength o f 538 nm. The concentration of
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RH formation was calculated using a standard curve obtained with authentic RH (1 to 40 
nM) prepared in plasma obtained from untreated rabbits.
7.2.6 Data collection and statistical analysis
Data from the pulse oximeter, blood pressure monitor, transonic flowmeter and LDF were 
continuously recorded on a laptop computer. The data were averaged for 2 min before the 
induction o f ischaemia (baseline), at the end o f ischaemia, and each hour of a 6 h 
reperfusion period. The results are presented as mean (standard deviation). Student’s t test 
for paired samples was used to detect differences in values within the same group. The 
differences in values between the two groups were calculated using the Student’s t-test for 
unpaired samples. P < 0.05 was considered statistically significant. All statistical analysis 
was done using SPSS for Windows version 11.0 (SPSS Inc).
7.3 Results
7.3.1 Macroscopic appearance, histopathology
All animals fed with a high-cholesterol (2%) diet for 8 weeks developed moderate hepatic 
steatosis.The animals tolerated the high cholesterol diet with no mortality. At laparotomy 
the animals showed fatty deposition in the skin, liver and spleen. The liver was enlarged, 
yellowish in colour, with rounded edge and firm consistency (Figure 7.1). The mean liver 
weight was 130 ± 11 gr, while the LW / BW ratio (%) was 3.6 ± 0.33. Histology revealed 
centrilobular steatosis with macrovesicular fat accumulation (Figures 7.2 and 7.3). Mild to 
moderate polymorphonuclear infiltration was evident in the liver tissue at the end of 
reperfusion.
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Figure 7.1 Macroscopical appearance of steatotic rabbit liver (after 8 weeks of high 
cholesterol d ie t). The liver is enlarged, yellowish in colour with rounded edges.
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Figure 7.2 Histological features o f steatosis with high cholesterol diet for 8 weeks. 
Macro vesicular fat accumulation in hepatocytes and Kupffer cells mainly in the pericentral 
area can be seen.
166
Figure 7.3 Section o f liver stained with a special stain (Marchi method) showing a 
moderate amount of centrilobular fat (stained black). The arrows indicate two portal tracts 
(magnification lOOx).
7.3.2 Systemic haemodynamics
In both groups MABP and heart rate fell in the reperfusion period compared to baseline. 
There was no significant difference in MABP, heart rate and oxygen saturation values 
between the two groups through out the experiment.
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7.3.3 Hepatic haemodynamics
Portal flow values are demonstrated in figure 7.4. There was no significant difference in 
baseline values between the two groups. Portal flow was higher in NAC group after the 
third hour of reperfusion and this difference reached significance at the 6th h: 67.2 ± 7.2 vs. 
52.4 ± 9.7 ml/min, (NAC vs. I/R, p=0.025).
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Figure 7.4. Portal flow in NAC and ischaemia-reperfusion (I/R) groups (mean, SD). Portal 
flow was significantly higher in the NAC group compared to the I/R group at the 6th h post­
reperfusion (*p<0.05).
7.3.4. Hepatic Microcirculation (HM)
During ischaemia LDF values were significantly reduced in both groups and became almost 
nil (Figure 7.5). Following reperfusion in the I/R group, flow in the hepatic
t hmicrocirculation was significantly reduced from baseline by 5 h: 8 6  ± 9 vs. 60 ± 9 flux 
units, (BL vs. 5th h, p=0.03) and 6 th hour post-reperfusion: 8 6  ± 9 vs. 64 ± 10 flux units 
(BL vs. 6 th h, p=0.04). In the NAC group LDF values were similar between baseline and 
reperfusion (Figure 7.5).
Flow in hepatic microcirculation was better in the NAC group in comparison to I/R group 
after the 3rd h o f reperfusion and this difference became significant at the 5th h: 87 ± 21 vs. 
60 ± 9 flux units, (NAC vs. I/R, p=0.03) and at 6 th h: 89 ± 16 vs. 64 ± 10 flux units (NAC 
vs. I/R, p=0.02).
7.3.5 Liver function tests
No significant difference between baseline ALT values in the two groups was recorded 
(Figure 7.6). ALT values were significantly greater in the I/R group at 5th h: 154 ± 62 vs. 
229 ± 49 U/L, (NAC vs. I/R, p=0.04) and 6 th h o f reperfusion: 168 ± 74 vs. 270 ± 54 U/L, 
(NAC vs. I/R, p=0.02) (Figure 7.6).
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Figure 7.5. Hepatic m icrocirculation (HM) in NA C  and I/R groups (m ean, SD ). HM was sign ifi­
cantly better in N A C  group com pared to the I/R group at 5 ,h and 6 ,h h post-reperfusion (p< 0.05)
BL 2 5 7
Figure 7.6. Serum alanine am inotransferase (AL T) activity (m ean, SD ). ALT activity was sign ifi­
cantly low er in N A C  group com pared to the I/R group at 5 th and 6 th h post-reperfusion (*p< 0.05).
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7.3.6 Bile flow and Proton nuclear magnetic resonance (!HNMR) spectroscopy
Baseline bile flow was similar in the two groups (Figure 7.7). Bile flow was higher in the 
NAC treated animals during the reperfusion period. This difference almost reached 
significance at the 5th hour: 115 ± 29 vs. 89 ± 10 pL/min/100 g o f liver weight, (NAC vs. 
I/R, p=0.06) and became significant at the 6 th h of reperfusion: 116 ± 25 vs. 83 ± 19 
p.L/min/100 g o f liver weight (NAC vs. I/R, p=0.035) (Figure 7.7).
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Figure 7.7. Bile flow (mean, SD). Bile flow was significantly higher in the NAC group 
compared to the I/R group at 6 th h post-reperfusion (*p<0.05)
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Baseline control bile spectra are shown in figure 7.8. The results of the integration of the 
area under curve for the assigned peaks are shown in table 7.1. Bile lactate levels were 
lower, across all time points, in the I/R group compared to NAC group (Table 7.2). Bile 
acetate levels rose in the NAC group to almost two fold the baseline level at 6  h post­
reperfusion while in the control group they dropped to almost half their baseline levels. 
Acetate levels were significantly higher in the NAC group compared to the I/R at 5 h and 6  
h post reperfusion (p=0.021) as shown in table 7.2.
Pyruvate levels were significantly higher in the NAC group compared to controls at 2 and 5 
h post reperfusion (p=0.009 and p=0.021 respectively, Figure 7.9 and table 7.2).
During ischaemia there was a two fold rise in phosphatidylcholine (PC) levels in the I/R 
group compared to only a slight elevation in the NAC group (p=0.047). On reperfusion PC 
levels fell gradually in controls while in the NAC group PC levels rose to peak after 2 h 
reperfusion then fell to close to baseline values at 6  h reperfusion.
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Table 7.1: 'HNMR Peak Assignments
Peak Assignments ppm Range of Integration
TSP 0 . 0 -0 .0 2 -0 . 0 2
C-18 bile acids proton peak 0.7 0.61-0.73
Lactate methyl group (CH 3 ) 1.3 1.25-138
Acetate methyl group (CHj) 1.9 1.89-1.95
Pyruvate methyl group (CHj) 2.3 2.34-2.38
PC head group -N +(C H j )j 3.2 3.20-3.27
Anemeric glucose proton peak 5.2 5.20-5.25
ppm: parts per million
TSP: sodium [ d^]- trimethysilylpropionate
PC: phosphatidylcholine
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Table 7.2: Results o f peak integration of'HNIVIR bile spectra. Results arc presented as 
mean ± standard deviation.
Group Baseline Ischaemia 2  h post­
reperfusion
5 h post­
reperfusion.
6  h post 
re perfusion
Lactate I/R 11.73±6.14 12.98±9.02 11.29±6.24 11.32±7.2I 12.88±9.73
NAC 13.84±3.93 17.22±0.75 17.46±3.02 14.34±4.88 I5.16±3.56
P 0.465 0.564 0.117 0.564 0.248
Acetate I/R 1.20±0.40 1.24±0.34 0.77±0.25 0.51 ±0 . 2 1 0.74±0.32
NAC l.07±0.19 0.70±0.01 1.04±0.26 1.24±0.37 1.99±0.36
P 0.754 0.083 0.175 0 . 0 2 1 0 . 0 2 1
Pyruvate I/R 0.98±0.39 1.07±0.53 0.84±0.32 0.57±0.40 0.89±0.43
NAC 1.37±0.19 1.76±0.09 1.86±0.3I 1.39±0.36 1.57±0.82
P 0.175 0.105 0.009 0 . 0 2 1 0.248
PC head 
group
I/R 3.75±1.62 8.38±1.92 5.68±2.22 6.26±5.24 4 .11±2.89
NAC 2.42±0.95 2.58±0.30 4.66±2.62 2.75±0.71 2.62±0.63
P 0.175 0.047 0.347 0.248 0.772
NAC: N-acetylcysteine 
PC: phosphatidylcholine
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Figure 7.8. Proton nuclear magnetic resonance('H NMR) spectra of baseline control bile. 
TSP=sodium trimethyIsily 1-f H4 ]propionatc standard, BA=bile acid, Lact=lactate, 
Ac=acetate, Py=pyruvate, PC=phosphatidylcholine head group, fLCNwater, Gl=glucose
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Figure 7.9. Proton nuclear magnetic resonance ('H NMR) spectra o f acetate levels 
following warm ischaemia-repcrfusion.. 'H NMR spectra o f acetate peaks in representative 
samples from (a) the I/R and (b) NAC group at 6  h post-reperfusion showing significant 
difference.
7.3.7. DHR oxidation
Rhodamine values were significantly lower in NAC group than in l/R group, indicative of 
lower concentration into systemic circulation o f RNS and ROS in the NAC group at 6  h 
post-reperfusion: 1.16 ± 0.28 vs. 2.85 ±1.11 nM, (NAC vs. I/R, p=0.005) (Figure 7.10).
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Figure 7.10. Rhodamine (Rll) in nM at 6 h post reperfusion. Results are presented as 
mean (SD). The RH levels were significantly lower in the NAC group compared to I/R 
(p<0.005).
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7.4 Discussion
This study has shown that NAC administration reduces I/R injury in the steatotic liver 
following a 1 h period of partial inflow occlusion, and the benefit is mainly apparent in the 
late phase o f I/R injury. Although there have been previous in-vitro studies on the effect of 
NAC on hepatic I/R injury (Nakano et al. 1997) this is the first in vivo study to investigate 
the effect o f NAC in warm liver I/R injury in steatotic livers.
Rabbits were fed with high-cholesterol diet (2%) for 8  consecutive weeks in order to induce 
moderate steatosis (Seifalian et al. 2001a). With this model the liver weight and liver 
weight / body weight (LW/BW) ratio are significantly greater in animals with liver steatosis 
compared to lean animals (as shown in chapters 6  and 7) (Seifalian et al. 2001a). Unlike 
the commonly used low-choline methionine diet, which produces periportal fatty 
infiltration (Hui et al. 1994; Teramoto et al. 1994), with this model a central lobular 
deposition o f fat is observed, similar to that found in the majority o f human fatty livers, 
such as in diabetes, obesity and alcoholism (Neuschwander-Tetri and Caldwell 2003). Liver 
steatosis reduces flow in the hepatic microcirculation and mitochondrial ATP generation 
(Selzner and Clavien 2001). Fat accumulation in the cytoplasm o f the hepatocytes causes 
compression or even complete occlusion of the sinusoidal spaces with shunting o f a 
proportion of total hepatic blood flow (THBF) (Teramoto et al. 1993). Our group 
previously demonstrated in an experimental model, that in moderate steatosis, the THBF 
was reduced by 30% and flow in hepatic microcirculation was 50% of normal controls 
(Seifalian et al. 1999).
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A rabbit model was used instead of a rat model since the size of rabbits is more convenient 
for the placement of probes, bile flow measurement and blood uptake at different time 
points. The period of hepatic inflow ischaemia (1 h) is also similar to the warm ischaemia 
time during human liver resection and transplantation. In this model, partial ischaemia was 
obtained by interrupting the blood flow to the median and left lobes of the liver. 
Maintaining splanchnic blood flow through the right and the caudate lobe minimises portal 
vein stasis and intestinal venous congestion, reducing the risk of portal bacteraemia and 
haemodynamic instability (El Desoky et al. 2001; Koo et al. 1992).
Several studies on liver 1/R injury have focused on the initial reperfusion phase (Demir and 
Inal-Erden 1998; Nakano el al. 1995), which is characterised by oxidative stress induced by 
Kupffer cells and occurs in the first 2 h (Jaeschke and Farhood 1991). In the present study 
the observation time was extended to 6  h as a distinct late phase o f warm I/R injury 
develops 4 hours after reperfusion, and is primarily caused by activated neutrophils with 
release of ROS and proteases (Harbrecht et al. 1993; Jaeschke et al. 1990).
NAC was chosen as an antioxidant to modulate hepatic I/R injury as it is routinely 
administered to patients with acute liver failure secondary to acetaminophen (paracetamol) 
overdose (Harrison et al. 1991), and has been used in other clinical conditions where 
oxidant damage was the putative or known mechanism o f injury, such as adult respiratory 
distress syndrome (ARDS) (Suter et al. 1994) and I/R after cardiac ischaemia-reperfusion 
(Ceconi et al. 1988; Tossios et al. 2003) . Recent work from our group has also shown 
beneficial effects of NAC in normal liver following one hour o f lobar ischaemia 
(Glantzounis et al. 2004). The dose of NAC administered is that used in clinical practice to
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treat patients with acute liver failure (Harrison et al. 1991). The beneficial effect of NAC 
was demonstrated by improvement in liver microcirculation, bile production and 
composition, associated with reduced hepatocellular injury.
Several studies have validated the use of LDF to measure changes in hepatic 
microcirculation (Chavez-Cartaya et al. 1994; El Desoky et al. 2001; Seifalian et al. 1998). 
During partial inflow occlusion, parenchymal perfusion was greatly reduced but was still 
recordable. This low level of perfusion has also been reported in other studies and can be 
caused by a random wandering motion of red cells and breathing movements (Vollmar et 
al. 1994). In the NAC group hepatic microcirculation returned to baseline values at the end 
of reperfusion suggesting that NAC has reversed the perfusion failure of the late phase of 
I/R injury. This correlates well with the return of portal blood How rates towards baseline 
at the end o f the reperfusion period in the NAC group.
In order to adequately investigate hepatic injury and function, changes in serum ALT 
activity, bile flow and composition were studied. ALT is relatively liver specific and 
reflects the loss o f membrane integrity and release of cytoplasmic content into the 
circulation (Lemasters et al. 1983). Bile production is a reliable marker o f liver function 
(Bowers et al. 1987). The NAC group had reduced hepatocellular injury as indicated by 
lower ALT values following reperfusion, and improved biliary excretion, an energy 
dependent process, resulting in increased bile drainage volumes. Comparable rise in ALT 
values has been observed during reperfusion in steatotic animals subject to a similar 
ischaemic insult (Nakano et al. 1997).
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This is the first study utilising 'H NMR analysis of bile to study the effect of NAC on 
steatotic livers in a controlled experimental model o f liver 1/R. The use of spin echo spectra 
allowed the interference from broad lipid signals to be reduced and more clearly identify 
and comparatively quantify bile constituents. Continuous bile flow was recorded in both the 
1/R and NAC groups, and 'H NMR spectroscopy revealed fluctuations in the concentration 
of several bile constituents More specifically NAC administration enhanced the biliary 
excretion o f acetate, pyruvate and lactate.
Acetate is produced as a result of fatty acid p-oxidation in the liver (Ambrose and Easty 
1977). This reaction requires ATP at its initiation. Following 1/R injury ATP is consumed 
to clear excess lactate and pyruvate and may not be readily available for fatty acid 
oxidation. The 1/R induced reduction or depletion of ATP may result in a decreased ability 
to utilize P-oxidation causing acetate production to falter. The higher bile acetate levels in 
the NAC treated livers would suggest improved ATP production and energetics. The 
increased excretion o f pyruvate and lactate in the bile o f NAC treated livers is difficult to 
interpret. Steatotic livers have lower ATP levels after stress compared to normal livers and 
mitochondrial injury has been proposed as one o f the causes o f reduced hepatocellular ATP 
stores in steatosis (Neuschwander-Tetri and Caldwell 2003). The main source of PC in the 
hepatocytes is the cell membrane. The increase following ischaemia correlates well with 
the theory of cellular breakdown and membrane lipid peroxidation (Suzuki et al. 2000).
In the present study NAC administration reduced significantly the oxidation o f DHR 123 to 
RH. The formation o f RH is partially peroxynitrite dependent, although other oxidants such
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as hydrogen peroxide in the presenee of horseradish peroxidase and hypoehlorous acid 
(HOCI) can oxidise DHR 123 to RH (Halliwell B and Gutteridge JMC 1999) ROS and 
peroxynitrite can cause cellular injury and necrosis through several mechanisms including 
peroxidation o f membrane lipids, protein denaturation and DNA damage (Halliwell B and 
Gutteridge JMC 1999). Oxidation of DHR 123 to RH has been reported in endotoxemia, 
hemorrhagic shock and splanchnic 1/R (Szabo et al. 1995). Although the protective effect 
of NAC in DHR oxidation has been demonstrated in in-vitro studies (Kooy et al. 1994) 
and in splanchnic artery occlusion (Cuzzocrea et al. 2000a), this is the first report of a 
reduced DHR oxidation by NAC infusion in warm 1/R in steatotic livers.
In conclusion, the administration of NAC, prior to and during reperfusion, reduced the 
extent of 1/R injury in the steatotic liver. This was apparent during the late phase of 
reperfusion and was demonstrated by increased portal blood flow and liver parenchymal 
perfusion. Bile excretion was increased and acute liver injury was reduced. This 
improvement was associated with reduced levels of reactive oxygen and nitrogen species. 
A trial of NAC infusion in patients with hepatic steatosis undergoing liver resection or in 
patients undergoing liver transplantation with steatotic grafts is required to confirm these 
benefits in clinical practice.
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7.6 Chapter summary
Steatotic livers are more susceptible to ischaemia-reperfusion (I/R) injury. Patients with 
hepatic steatosis have increased morbidity and mortality following liver surgery and 
steatotic grafts have higher primary dysfunction after liver transplantation. The aim of the 
present study was to evaluate the in-vivo effect of N-acetylcysteine (NAC) on hepatic 
function in both the early and initial late phase o f warm liver 1/R injury in steatotic rabbits. 
12 New Zealand rabbits were fed with high cholesterol (2%) diet for eight weeks. I/R group 
(n=6 ) underwent lobar liver ischaemia for 1 h followed by 6  h of reperfusion. In the treated 
group (NAC, n=6 ) an intravenous infusion of NAC was administered prior and during the 6  
h reperfusion period. Systemic and hepatic haemodynamics were monitored continuously. 
Alanine aminotransferase activity and bile production were measured. Magnetic resonance 
spectroscopy ('HNMR) was used to analyse bile composition. The oxidation of 
dihydrorhodamine (DHR) to rhodamine (RH) was used as a marker o f production of 
reactive oxygen and nitrogen species.
Histology demonstrated moderate centrilobular hepatic steatosis. NAC administration 
improved significantly portal flow, hepatic microcirculation, bile composition and bile flow 
at 6 th hour of reperfusion. NAC administration was also associated with less hepatocellular 
injury as indicated by ALT serum activity and reduced the oxidation o f DHR to RH after 6  
h of reperfusion.
In conclusion NAC administration reduced the extent of I/R injury on the steatotic liver, 
particularly during the late phase of reperfusion.
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CHAPTER 8
THE EFFECT OF N-ACETYLCYSTEINE ON ENERGY 
METABOLISM AND NITRIC OXIDE ACTIVITY DURING HEPATIC
ISCHAEMIA-REPERFUSION
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8.1 Introduction
N-acetylcysteine (NAC) is a low molecular weight thiol used successfully in the treatment 
of fulminant hepatic failure due to acetaminophen overdose (Aitio 2006; Chyka et al. 2000; 
Prescott et al. 1979). It has also shown beneficial effects in other settings o f acute liver 
failure (Harrison et al. 1991), in chronic obstructive pulmonary disease (Grandjean et al. 
2000; Stey et al. 2000), in human immunodeficiency virus infection (De Rosa et al. 2000), 
in radiocontrast-induced nephropathy (Tepel et al. 2000) and in cardiopulmonary by-pass 
surgery (Fischer et al. 2004; Tossios et al. 2003).
Its main actions are as a glutathione precursor and as a scavenger of reactive oxygen 
(ROS) and nitrogen species (Cotgreave 1997; Glantzounis et al. 2006; Yan et al. 1995). It 
has been shown in chapters 6  and 7 that NAC reduces warm liver ischaemia-reperfusion 
(I/R) injury in both normal (Glantzounis et al. 2004) and steatotic liver (Fusai et al. 2005) 
but the mechanism of action is not completely clear. The use o f antioxidants for 
amelioration o f liver I/R injury requires further study of the mechanism of action.
In vitro evidence suggests that low molecular weight thiols are implicated in nitric oxide 
(NO ) metabolism by interacting with plasma S-nitrosothiols (RSNOs) (Marley et al. 2001). 
It has also been shown that production o f RNS could have a negative effect on cellular 
energy production through inhibition of mitochondrial enzymes such as cytochrome 
oxidase (Cooper 2002; Koeck et al. 2004).
Recent experimental evidence shows that NO synthesis is markedly upregulated with liver 
I/R injury (Serracino-Inglott et al. 2003). It is postulated that following reperfusion NO
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production is reduced but subsequently large amounts of NO are produced due to the 
expression o f inducible NO synthase (iNOS) with potential deleterious effects. NO can 
produce RNS such as peroxynitrite after the reaction with superoxide anion, can form S- 
nitrosothiols or be metabolized to nitrite and nitrates. However the role o f NO in liver I/R 
is still controversial (Glantzounis et al. 2005a).
The aim o f this study was to look at the effects of NAC administration on liver function, 
microcirculation, cellular energy production, NO metabolism and oxidative stress. For this 
reason the experimental rabbit lobar liver I/R model, which has been validated and refined 
in chapter 4 was used. In this model, for continuous monitoring o f arterial blood pressure 
and blood sampling, a cannula is placed in the right ear artery, instead of the femoral artery 
in order to avoid the systemic effects of limb ischaemia. Cellular energy production was 
assessed through the monitoring of changes in the redox state of hepatic cytochrome 
oxidase by NIRS and analysis o f bile composition by proton nuclear magnetic spectroscopy 
('H NMR). NO activity was assessed by measurement of nitrite / nitrate plasma levels with 
capillary electrophoresis, plasma S-nitrosothiols with electron paramagnetic spectrometry 
(EPR) and liver tissue nitrotyrosine by mass spectrometry. The degree o f oxidative stress 
post I/R was assessed through the oxidation of the dye dihydrorhodamine to rhodamine.
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8.2 Materials and methods 
8.2.1 Animal model.
The study was conducted under a license granted by the Home Office in accordance with 
the Animals (Scientific Procedures) Act 1986. New Zealand white rabbits (3.4 ± 0.8 kg, 
n=18) were used. Anaesthetic protocol and surgical procedure are described in section 3.1. 
A radio-opaque catheter 20 gauge (GA) was inserted into the right marginal ear artery for 
monitoring o f arterial blood pressure and collection of blood samples. Ear marginal veins 
were cannulated with radio-opaque catheters (22 GA) for the administration of anaesthetics, 
fluids and medication. Laparotomy was performed through a roof top transverse incision. 
Lobar ischaemia was induced by clamping the vascular pedicles of the median and left 
lobes o f the liver, using an atraumatic microvascular clip. After 60 min o f ischaemia the 
vascular clip was removed and reperfusion was allowed for 7 h. In all groups, 15 ml/kg/h of 
0.9 % NaCl was administered through the ear marginal vein to compensate for 
intraoperative fluid loss.
8.2.2 Experimental groups and protocol
Three groups o f animals were used (n= 6  each). In the NAC group 150 mg/kg NAC 
(Parvolex00; Medeva Pharma, Ashton-under-Lyne, Lancashire, UK) in 20 ml 5% dextrose 
was infused intravenously through the ear vein over the 15 min before reperfusion and 
maintained at 10 mg/kg/h in 5 % dextrose (10 ml/h) during the 7 h reperfusion period. In 
the I/R group 20 ml 5 % dextrose was infused intravenously 15 min before reperfusion and 
continued at a dose o f 10 ml/h during the reperfusion period. Animals in the sham operation 
group underwent laparotomy but no liver ischaemia. Laparotomy and baseline 
measurements were completed over 1 h. In the sham group monitoring continued for the
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equivalent o f the ischaemia and reperfusion periods in treated animals (total monitoring 
period 9 h).
Arterial blood samples (1 ml each) were taken before the induction of liver ischaemia 
(baseline), at the end of ischaemia (60 minutes) and two, five and seven hours after 
reperfusion for measurement of alanine aminotransferase (ALT) activity. Serum was 
separated from the samples and stored at -20°C until assayed (see also section 3.5).
8.2.3 Hepatic microcirculation
Hepatic microcirculation was measured by a surface laser Doppler flowmeter (for details 
see section 3.2).
8.2.4 Measurement of cytochrome oxidase (cyt ox) activity
Changes in cytochrome oxidase redox state during liver I/R were measured by NIRS 
(section 3.3). Briefly, Cyt Ox is the terminal complex o f the mitochondrial respiratory 
chain. It takes electrons from cytochrome c and catalyses the reduction o f oxygen to water 
with the concomitant synthesis o f ATP through the oxidative phosphorylation process 
(Capaldi 1990; Edwards el al. 1991). Cyt Ox has 4 redox active metal sites, which exhibit 
different absorption characteristics depending on their redox state. The copper centers are 
optically active in the NIR light in contrast with the heme centers that absorb visible light 
(Cooper el al. 1994; Jobs is FF 1992). Absorption of the NIR light occurs primarily at the 
CuA center within Cyt Ox. The contribution o f the heme centers to absorption of NIR is 
less than 10 % of the total signal in the reduced oxidised spectrum (Cooper et al. 1994).
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Thus, the signal measured by N1RS is almost entirely due to the C ua center. The signal 
intensity decreases on reduction of this center. The redox state o f Cyt Ox C u A is dependant 
on cellular oxygen availability (Takashima et al. 1995). In the presence of oxygen electron 
transfer occurs and the center becomes oxidised, whereas lack of oxygen results in a 
decreased flow of electrons and the center becomes reduced. Thus, reduction to Cyt Ox 
levels measured by N IRS refers to accumulation o f electrons in the CuA centre of Cyt Ox.
Data are presented as changes in Cyt Ox CuA redox state relative to baseline. Decrease (vs. 
baseline) in the redox state of Cyt Ox CuA indicates that the CuA center becomes reduced 
and electrons accumulate in the CuA center of Cyt Ox . Increase (towards baseline) in the 
redox state of Cyt Ox CuA indicates that the CuA center becomes oxidised and electron 
transfer through the respiratory chain occurs.
8.2.5 Measurement of bile flow and 'H NMR bile spectroscopy
The common bile duct was cannulated with a polyethylene catheter (PE-50, 0.58 mm inner 
diameter, Portex, Kent, UK) for continuous collection o f bile. Bile samples were taken at 
baseline, following 60 min ischaemia and hourly during reperfusion. Bile volume was 
expressed as pL/min/lOOg of liver wet weight.
'HNIVIR analysis was performed on an 11.7 Tesla (500 MHz for protons) spectrometer 
(Varian Unity +; Varian, Palo Alto, CA, USA) al 25°C (see also section7.2.4). Bile was 
thawed at room temperature and placed in 5mm NMR tube. For a field/frequency lock a 
coaxial capillary insert was used (Wilmad, Buena, NJ, USA). This capillary insert was 
filled with a deuterium oxide solution o f sodium [ d4]- trimethysilylpropionate (TSP) that
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acted both as a chemical shift reference and quantification standard. This capillary was 
calibrated by using a series of known concentration solutions o f deoxycholate and a 
calibration curve was obtained. This was then used for quantification of bile components 
(lactate, acetate, pyruvate and phosphatidylcholine) which enabled an accurate comparison 
of bile levels between the groups. One dimensional NMR spectra were obtained at 500 
MHz with a sweep width of 6  kHz. Presaturation of bile was carried out to attenuate the 
intensity o f water signal. The spectra were analysed using software from MestRe-C version
3.1.1 (Universidade de Santiage de Compostela, Spain). All spectra were integrated using a 
fixed range for each peak and published peak assignments (Ellul et al. 1992; Melendez et 
al. 2001; Sequeira et al. 1994; Sequeira et al. 1995) shown in table 7.1.
8.2.6 EPR spectrometry
Blood samples were defrosted just before analysis by EPR spectrometry. The samples were 
analysed using a JEOL JES REIX spectrometer (Jeol (UK) Ltd, Welwyn Garden City, UK) 
equipped with an ES-UCX2 cylindrical mode X-band cavity. Samples were analysed at 
room temperature in a WG-LC-11 quartz flat cell (Wilmad Glass, Buena, NJ, USA). The 
instrument parameters differed for each set o f experiments.
S-nitrosothiols analysis
RSNOs were measured in plasma by EPR spectrometry (Rocks et al. 2005) . With this 
technique the RSNOs are degraded using an alkaline pH of > 10.5 in the presence o f the 
spin trap complex N-methyl-D-glutamine dithiocarbamate (MGD )2  - Fe2+ as described in
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section 3.9. Briefly, blood samples (1 mL) were taken from the ear arterial line at baseline, 
end o f ischaemia, 2nd, 5th and 7th h post-reperfusion or the equivalent time in the sham 
group, into EDTA-coated tubes containing 10 pL of N-ethylmalemide (NEM). Blood also 
was taken at the end o f the experiment from the right hepatic vein.
The samples were centrifuged immediately at 3000 rpm for 10 min. The supernatant was 
aliquoted into small centrifuge tubes and snap frozen in liquid nitrogen. During analysis 
plasma samples were placed in an evacuated glass vial, kept on ice and the concentration of 
RSNOs present was measured the same day, as previously described (Rocks et al. 2005). 
Briefly, 20 mM ammonium ferrous sulphate solution in degassed CAPS (pH 10.5) was 
added to MGD to form the (MGD)2 -Fe2+ complex (final concentrations of MGD and Fe24 
were 50mM and 10 mM respectively). This was then added in a ratio o f 1:1 volume/volume 
to the plasma samples, incubated for 3 min and measured by EPR spectrometry. The 
samples were analysed using a JEOL JES REIX spectrometer (Jeol Ltd, Welwyn Garden 
City, UK) equipped with an ES-UCX2 cylindrical mode X-band cavity. Samples were 
analysed at room temperature in a WG-LC-11 quartz flat cell (Wilmad Glass, Buena, NJ, 
USA). The instrument parameters differed for each set of experiments. The spectra were 
recorded using the SpecESR programme, version 1.0 and the mean peak area was 
determined. Water was taken through the same procedure to act as a control. The EPR 
spectrometer parameters were: microwave frequency 9.45GHz, microwave power 20mW, 
centre field 330 mT, sweep width ± 5 mT, sweep time 250 s, number o f data points 8192, 
time constant 1 s, modulation frequency 100 kHz, and modulation width 0.4 mT. The 
spectra were taken as an average over 3 scans. The concentration of nitrosothiols present
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was determined by comparison to a nitrosoglutathione calibration curve (0, 300, 600, 800, 
and 1000 nM).
8.2.7 Measurement of nitrite (N 02 ) / nitrate (N03 ) by capillary electrophoresis
NO' metabolites, NO2" and NO3 ', concentrations are determined using a capillary 
electrophoresis method (Davies et al. 1999) as described in section 3.8. Briefly, blood 
samples were taken from the ear arterial line at baseline, end of ischaemia, 2nd, 5th and 7th h 
post-re perfusion or the equivalent time in the sham group into EDTA-coated tubes. Blood 
also was taken at the end o f the experiment from the right hepatic vein. The samples were 
centrifuged immediately at 3000 rpm for 10 min. The supernatant was aliquoted into small 
centrifuge tubes, snap frozen in liquid nitrogen and kept in -80 °C until assayed.
Plasma samples were centrifuged at 13000rpm through a Vectrospin Micro 30kDa ultra­
filtration device (Whatman International Limited, Kent, UK) for 30 min. A P/ACE System 
5500 equipped with a P/ACE diode array detector (DAD) and automatic injector, a fluid- 
cooled column cartridge and a System Gold data station was used. Samples were passed 
through a 50 pm x 47 cm (40 cm to detector) fused-silica capillary with an electrolyte 
consisting of 150mM sodium chloride / 5 mM Tris-HCl at pH 7.4 with 2 mM TTAB. The 
analysis was performed at 25°C. The solutions were injected onto the capillary by 
hydrodynamic injection using a pressure injection of 0.5 psi for 15 s. The components in 
the samples were separated using a -  lOkV voltage separation. The DAD was set at 214 nM 
with a bandwidth o f 4 nM. The capillary was rinsed before each injection with 0.1 M 
NaOH and electrolyte for 1 min and 2 min, respectively. Aqueous standard solutions were 
formed using concentrations of 10 to 50 pM sodium nitrate and 2 to 10 pM sodium nitrite.
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8.2.8 Dihydrorhodamine 123 oxidation
Oxidation o f DHR 123 to rhodamine (RH) was measured with the method described in 
section 3.10. Briefly, Seven hours after reperfusion in the I/R group or the equivalent time 
in the sham group animals were injected with DHR 123 (2 pmol/kg in 0.8 mL normal 
saline 0.9 %). Twenty minutes later plasma samples were collected for rhodamine 
fluorescence evaluation. Fluorescence measurements were performed at an excitation 
wavelength of 485 nm and emission wavelength of 538 nm. The concentration of RH 
formation was calculated using a standard curve obtained with authentic RH (1 to 40 nM) 
prepared in plasma obtained from untreated rabbits.
8.2.9 Histology
Formalin fixed paraffin embedded blocks of liver were cut at 4 microns and stained with 
haematoxylin and eosin (H&E) and reviewed by a pathologist, blinded to the treatment of 
the animals. The tissue was semiquantitatively scored for the number of polymorphs in a 
high powered field, using an Olympus BX50 microscope at x 400 magnification. A score 
was devised; a score of 0-3 was given to the number of single PMNs in sinusoids (1 = 1-5, 
2=5-20, 3=>20); a score of 0-3 for aggregated PMNs (1 = 1-2 clusters, 2=2-5, 3=>5). This 
system was validated with a quantitative system where the total number o f polymorphs 
counted in 50 hpfs and the average then given; this was compared to the semiquantitative 
system. A comment was also made if the aggregated PMNs were associated with 
hepatocyte necrosis. The presence or absence o f apoptosis, judged by shrunken, darkly 
stained hepatocytes, was also made in a semiquantitative manner. Comment was made on 
presence or absence of Kupffer cell hyperplasia and if there were any other changes to
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hepatocytes, taking particular note of any zones alTected. Immediately subcapsular areas 
and foci around large hepatic veins were not counted, as these would have shown a 
disproportionate amount of PMN infiltrate.
8.2.10 Data collection and statistical analysis
Data from the pulse oximeter, blood pressure monitor, LDF and NIRS were collected 
continuously on a labtop computer. The data were averaged for 2 min before the induction 
of ischaemia (baseline), at the end of ischaemia and at the end of each h o f a 7-h 
reperfusion period. Changes in Cytochrome oxidase activity at the end o f each period were 
calculated relative to baseline. Bile spectroscopy values are expressed as a percentage of 
baseline values. Data were presented as mean (SD). Student's t test for paired samples and 
one-way ANOVA with Bonferroni adjustment for multiple comparisons were used for 
statistical analysis. P < 0.050 was considered statistically significant.
8.3 RESULTS
8.3.1 Systemic haemodynamics
In all three groups systemic mean arterial blood pressure fell during the experiment 
compared to baseline. There were no haemodynamic differences between NAC and I/R 
groups during the whole experiment. However MABP was significantly higher in the sham 
group compared to NAC and I/R after the 3rd h o f reperfusion (Figure 8 . 1).
Pulse rate remained stable in all groups throughout the experiment. There were no 
statistically significant differences between the groups (Figure 8.2).
Oxygen saturation (Sa0 2 ) remained stable through the experiment in all groups.
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Figure 8.1 Mean arterial blood pressure (MABP) during ischaemia and reperfusion. Values 
are mean (SD). MABP fell during the experiment compared to baseline in all groups. This 
reduction was more obvious in the NAC and I/R groups. *p < 0.05 versus NAC and I/R 
group. NAC, N-acetylcysteine, I/R: ischaemia-reperfiision
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Figure 8.2 Pulse rate during ischaemia and reperfusion. Values are mean (SD). There 
were no significant differences between groups. NAC, N-acetylcysteine, l/R, ischaemia- 
reperftision.
8.3.2 Liver function tests
Mean serum ALT activity at baseline was within the normal range, with no significant 
differences between the three groups (Figure 8.3). After reperfusion, the mean ALT activity 
in the NAC and I/R groups was significantly higher than that in the sham operated group. 
The serum ALT activity was lower in the NAC group compared to the I/R group at 2 h (p = 
0.02), 5 h (p -  0.04) and 7 h (p = 0.01) post reperfusion (Figure 8.3).
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Figure 8.3 Serum alanine aminotransferase (ALT) activity during ischaemia and 
reperfusion. Values are mean (SD). *p < 0.050, 1/R vs. NAC, *p < 0.05, Sham vs. NAC. 
NAC, N-acetylcysteine, I/R, ischaemia-reperfusion.
8.3.3 Hepatic microcirculation
There was no significant change in the hepatic microcirculation over the 9-h sham 
operation. Following I/R, flow in the microcirculation was reduced in the NAC and I/R 
groups. NAC treatment was associated with an increased flow in the hepatic 
microcirculation during reperfusion compared to the 1/R group; this difference became 
significant after the 3rd h (p=D.04) (Figure 8.4).
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Figure 8.4 Hepatic microcirculation during ischaemia and reperfusion. Values are mean 
(SD). There were no significant differences in the hepatic microcirculation during the 
experiment in the sham-operated group. Microcirculation in the I/R group was significantly 
lower compared to the NAC group after the 3rd h of reperfiision *p<0.05 vs. NAC group. 
NAC, N-acetylcysteine, I/R, ischaemia-reperfusion.
8.3.4 Cyt Ox activity
During ischaemia Cyt Ox redox state decreased significantly compared to baseline and 
sham (Figure 8.5). During the early phase of reperfiision cytochrome oxidase redox state 
returned towards baseline in the I/R group, but subsequently decreased again. In the NAC 
group, cyt ox redox state was significant better compared to I/R group during the late phase
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of reperfusion (5th h: p=0.04, 6th h: p=0.03, 7th h: p=0.03). Of note cyt ox redox state 
decreased also in the sham group during the experiment compared to baseline (figure 8.5).
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Figure 8.5 Changes in the redox state of cytochrome oxidase (cyt ox) during ischaemia and 
reperfusion. Values are mean (SD). There was a significant difference in the redox state of 
cyt ox between NAC and I/R group during the late phase o f reperfusion (after the 5 th h). *p 
< 0.05 vs. NAC group. NAC, N-acetylcysteine, I/R, ischaemia-reperfusion.
8.3.5 Bile flow and composition
Bile Flow: Bile flow remained stable in the sham group over the experiment. Bile flow in 
the I/R group was similar to sham at baseline but reduced significantly during ischaemia
1 9 9
(Figure 8.6). It increased again during reperfusion but did not return to baseline values. 
NAC administration ameliorated the decrease during reperfusion. However the difference 
compared to 1/R group did not reach significance.
'H NMR spectroscopy of bile:
’H NMR gave a characteristic signal for analysis o f bile composition (Figure 8.7). The 
results o f the integration of the area under curve for the assigned peaks are shown in table 
8.1. 1/R produced significant alterations to bile composition, with an increase to lactate 
levels (Table 8.1) and reduction in acetate (Table 8.1) during reperfusion. NAC 
administration ameliorated the increase in bile lactate and the decrease in bile acetate levels 
(Table 8.1). The differences were significant at 5 h and 7 h post reperfusion respectively.
During ischaemia there was an increase in phosphatidylcholine (PC) levels in both groups. 
PC levels continued to rise in controls for 5 h post-reperfusion. In the NAC group, PC 
levels rose to peak at 2 h post-reperfusion then fell to less than baseline values at 7 h post­
reperfusion. PC levels were consistently lower in the NAC group than in I/R (P^0.0055).
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Figure 8.6 Bile flow (pL/min/lOOg) during ischaemia and reperfusion. Values are mean 
(SD). Bile flow remained stable through the experiment in the sham group. It decreased 
significantly from baseline in the I/R and NAC groups. Although NAC administration was 
associated with better flow during reperfiision compared to I/R group; this difference did 
not reach significance.
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Figure 8.7 'H NMR spectrum of baseline control bile. TSP=sodium trimethyIsilyI-
2
f fUlpropionate standard, BA=bile acid, Lact=lactate, Ac=acetate, Py=pyruvate, 
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Table 8.1: Results o f peak integration of'H N M R bile spectra
G r o u p B a s e l in e I s c h a e m ia 2 h r  R e p e r f . 5  h r  R e p e r f . 7 h r s  R e p e r f .
PC  h e a d  g r o u p I/R 1 .8 8 ± 0 .8 5 2 .1 8 ± 1 .18 2 .9 0 1 1 .1 3 2 .9 7 1 0 .5 4 1 .6 2 1 0 .5 7
NAC 1.0410 .21 1 .5 5 1 0 .1 7 2 .3 6 1 0 .2 9 1 .3 2 1 0 .2 4 0 .8 9 1 0 .0 9
P 0 .0 9 1 4 0 .4 0 4 8 0 .3 8 4 2 0.0005 0.0417
L a c ta te I/R 5 .2 8 ± 1 .74 10 .0 5 ± 4 .6 4 9 .4 0 1 3 .0 9 1 6 .0 8 l8 .4 1 2 6 .2 8 1 7 .8 8 3
NAC 6 .8 5 ± 0 .2 0 7 .2 7 1 0 .7 9 8 .4 6 1 1 .1 9 8 .2 1 1 0 .9 1 8 .6 0 1 0 .3 5
P 0 .1 1 8 7 0 .3 5 3 0 0 .5 8 8 1 0 .1 6 2 5 0.0069
A c e ta te I/R 2 .3 2 ± 1 .87 5 .3 8 1 6 .4 8 0 .9 7 1 0 .1 3 1 .7 8 H .6 1 3 .6 5 1 3 .0 3
NAC 4 .5 3 1 0 .3 7 4 .3 5 1 0 .1 6 2 .6 4 1 1 .2 2 5 .2 4 1 1 .5 9 7 .8 9 H .1 8
P 0 .0 5 0 9 0 .7 9 9 0 0.0341 0.0186 0 0 5 7 5
P y r u v a te I/R 0 .6 3 1 0 .3 0 0 .6 8 1 0 .4 3 0 .6 9 1 0 .1 1 0 .8 4 1 0 .2 1 0 .8 0 1 0 .5 5
NAC 0 .9 6 l0 .1 8 1 .10 1 0 .1 1 1 .0 9 1 0 .1 3 1 .5 2 1 0 .3 2 1 .6 1 1 0 .0 9
P 0 .1 0 7 0 0  1652 0.0040 0.0176 0 .0 5 7 5
G l u c o s e I/R 0 .5 4 1 0 .4 4 1 .4 7 1 0 .1 2 2 .6 7 H .7 1 2 .8 1 l1 .2 4 0 .7 9 1 0 .3 6
NAC 0.7 7 1 0 .5 1 0 .5 4 1 0 .2 6 2 .6 3 1 1 .9 1 0 .9 8 1 0 .4 5 1 .0 5 1 0 .4 5
P 0 .4 6 0 7 0 .2 1 4 0 0 .9 7 9 1 0.0471 0 .3 6 3 9
NAC: N-acetylcysteine, PC: phosphatidylcholine
8.3.10 S-Nitrosothiols
The (MGD)2 -Fe2f nitrosothiol adduct gave a three line signal (aN=1.28mT, g-2.04) when 
analysed by EPR spectrometry (Figure 8 .8 ). A signal was observed in the majority of 
samples. The mean peak area of the signal was determined from the last two peaks. T he 
RSNOs concentration was calculated using the equation of the nitrosoglutathione standard 
curve. The plasma RSNOs concentrations were plotted as mean concentration and standard 
deviation (SD) (Figure 8.9). There was no significant difference in plasma S-nitrosothiol 
levels during the experiment in the sham group. The RSNOs levels increased significantly 
in the I/R group during reperfusion compared to baseline, and this increase reached
203
significance at the 5th hour post reperfusion and at the 7th hour post reperfusion (hepatic 
vein sample). NAC administration prevented the increase in RSNOs. The difference (NAC 
vs I/R) was significant at 5h post reperfusion in plasma samples taken from the ear arterial 
line and at 7 h post reperfusion in samples taken from the the right hepatic vein (p < 0.05).
in
Figure 8.8. A typical nitrosothiol EPR spectrum of in a plasma sample from a sham rabbit 
5 hours after reperfusion. After the plasma sample has been added to the spin trap 
complex, (MDG)2-Fe2+, a three-line signal can be seen when analyzed by EPR 
spectrometry, indicated by shaded boxes, with aN^l.28 mT and g=2.04.
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Figure 8.9 Plasma nitrosothiols (RSNOs) concentration (nM). Results are presented as 
mean ± SD. The RSNOs levels increased significantly in the I/R group during reperfusion 
compared to baseline, and this increase reached significance at the 5th h post reperfusion. 
NAC administration prevented the increase in RSNOs. The difference (NAC vs I/R) was 
significant at 5h post reperfusion in plasma samples taken from the ear arterial line and at 7 
h post reperfusion in samples taken from the the right hepatic vein. (*p<0.05: I/R vs NAC 
and sham).
8.3.11 Nitrite, nitrate, NOx activity
N 0 3 and NO2 were measured using a capillary electrophoresis method, as described 
above, in all samples. NO3 ' was eluted at 3.9 min, whilst NO2 " was eluted at 3.7 min, as 
shown in Figure 8.10. The mean and SD were plotted for NO2" and NO3 as well as the 
NOx concentrations for each group (as shown in Figures 8 . 1 1 , 8 . 1 2  and 8.13, respectively). 
There was no significant difference in nitrite levels, during the experiment in the sham 
group. Nitrites increased significantly during ischaemia and reperfusion in the I/R group.
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NAC administration prevented this increase and this difference reached significance at 2 h 
post reperfusion and at 7 h post reperfusion (hepatic vein). Nitrate levels decreased during 
the experiment in the sham group. They decreased also significantly during reperfusion in 
the I/R group. In the NAC group they increased significantly from baseline at 2 h post­
reperfusion and then decreased.
M
3.00 4.000.00
Figure 8.10 A typical electropherograph showing the elution of NO3 ' and NO2 from a 
sham rabbit plasma sample at end of ischaemia. NO3 is shown to elute at 3.9 min, whilst 
NO2" elutes at 3.7 min.
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Figure 8.11 Plasma nitrite (NO2 ) concentration (pM). Results are presented as
mean ± SD. Nitrite levels increased significantly during ischaemia and reperfusion in the
I/R group. NAC administration prevented the increase in nitrites. *p<0.050: I/R vs NAC.
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Figure 8.12 Plasma nitrate (NO3 ) concentration (pM). Results are presented as mean ± SD. 
Nitrate levels decreased significantly during reperfiision in the I/R group. *p<0.050 vs. 
baseline.
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Figure 8.13 The mean NOx (sum of NO;,' and NO;') concentration in plasma samples. 
Results are presented as mean ± (SD). NOx concentration did not differ significantly from 
baseline at any time point in either o f the three groups. There were also no differences 
between the three groups during the experiment.
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8.3.12 Dihydrorhodaminc 123 oxidation
Liver ischaemia caused a significant increase in the RH fluorescence of plasma, consistent 
with the oxidation o f DHR 123 by RNS and ROS during the reperfusion phase. RH values 
were significantly higher in the I/R group compared to the sham group (Figure 8.14).
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Figure 8.14 Plasma reactive nitrogen species production as assessed by oxidation o f 
dihydrorhodamine 123 to rhodamine (mean ± SD). Liver I/R caused a significant increase 
in the rhodamine fluorescence o f plasma, 7 h post reperfiision compared to sham group, 
while NAC administration ameliorated the increase (*p<0.05: control vs NAC and sham).
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8.3.13 Liver tissue nitrotyrosine
Liver I/R caused a decrease in liver tissue nitrotyrosine levels. This decrease was not 
significant compared to baseline. However if we look at the nitrotyrosine / tyrosine (NT/T) 
there is a significant decrease at 7 h post reperfusion compared to baseline (Figure 8.15). 
NAC administration ameliorated this increase (Figure 8.15) (*p<0.05 vs baseline).
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Figure 8.15 Liver tissue nitrotyrosine / tyrosine (NT/T) ratio (pg/ng) measured by 
mass spectrometry. Results are presented as mean ± SEM. Liver 1/R caused a significant 
decrease in NT/T ratio at 7 h post reperfusion compared to baseline. NAC administration 
ameliorated this increase (*p<0.05 vs baseline).
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8.3.14 Histopathology
The histological semiquantitative score regarding the number of single PMNs in sinusoids 
was 9 for the sham group, 14 for the I/R group and 12 for the NAC group. The score 
regarding the aggregated PMNs was 2 for the sham group, 11 for the I/R group and 9 for 
the NAC group.
There was no evidence of necrosis, Kupffer cell hyperplasia or apoptosis in the sham group.
Hepatocellular necrosis, apoptosis and Kupffer cell hyperplasia was more severe in the I/R 
group compared to the NAC group (Figures 8.16 and 8.17). The average number of PMNs / 
hpf (quantitative score) was: 11 ± 7 for the sham group, 38 ± 33 for the I/R group and 18 ± 
9 for the NAC group.
2 1 1
Figure 8.16 Representative photomicrographs o f liver histology at 7 h post- reperfiision in 
the I/R group. It shows prominent numbers o f aggregated neutrophils within sinusoids and 
associated degenerate hepatocytes (H&E x40).
Figure 8.17 Representative photomicrographs o f liver histology at 7 h post- reperfusion in 
the NAC group. It shows moderate numbers of neutrophils within sinusoids, some o f which 
are aggregated. Little hepatocyte damage is apparent (H&E x40).
2 1 3
8.4 Discussion
The present study investigated the effect of NAC administration on cellular energy 
production and NO activity in a liver lobar I/R model. Our previous experimental studies in 
rabbits with normal (chapter 6) and steatotic livers (chapter 7) undergoing lobar I/R injury 
(Glantzounis et al. 2004; Fusai et al. 2005) have shown that continuous NAC 
administration improves liver function and reduces liver injury. The beneficial effects were 
more obvious during the late phase of reperfusion injury. However, the mechanism of this 
improvement was not established. It is well known that NAC is a precursor o f glutathione, 
and also can act as a direct scavenger of free radicals (Cotgreave 1997; Yan et al. 1995). 
Previous in vitro studies have shown that NAC is also involved in NO metabolism and 
undergoes transnitrosation reactions with S-nitrosothiols (RSNOs) leading to RSNOs 
decomposition (Jourd'heuil et al. 2000;Marley et al. 2001). There is also evidence that GSH 
can inhibit peroxynitrite formation (Nakamura et al. 2000).
This study aimed to evaluate RNS formation following I/R and the in vivo effects of NAC 
on cellular energetics and NO metabolism. A rabbit model of liver lobar I/R was used. The 
time period chosen has allowed haemodynamics, hepatic function and changes in 
bioenergetics and NO metabolism to be evaluated in both the early and initial late phase o f 
liver I/R injury. The duration of general anaesthesia was similar to that for major human 
liver surgery (liver resection and transplantation).
During reperfusion significant changes occurred in bile production and composition. Bile 
formation is an active secretory process involving bile salt-dependent and -independent 
mechanisms (Bowers et al. 1987). Bile level may reflect the degree o f ATP degradation
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during the ischaemia period. Bile excretion is used as an indicator o f liver function and 
recovery following ischaemia in experimental studies (Bowers et al. 1987; Jamieson el al. 
1988; Nakano et al. 1997; Terajima et al. 2000) and clinical liver transplantation (Adam et 
al. 1992; Anthuber et al. 1996; Fisher et a l 1999; Sumimoto et al. 1988).
However, little is known about changes in bile composition during liver ischaemia and 
following reperfusion and less is known about the effect of therapeutic strategies to 
ameliorate I/R injury. This is the first study utilizing 'H NMR analysis of bile to study the 
effect of NAC on normal rabbit livers in a controlled experimental model of warm liver I/R. 
The use o f spin echo spectra allowed the interference from broad lipid signals to be reduced 
and more clearly identify and comparatively quantify bile constituents. Continuous bile 
flow was recorded in both the I/R and NAC groups, and *H NMR spectroscopy revealed 
fluctuations in the concentration of several bile constituents despite there being no 
significant differences in bile flow at during ischaemia and reperfusion between I/R and 
NAC group More specifically, NAC administration enhanced the biliary excretion of 
acetate and pyruvate and reduced the excretion of PC.
Biliary lactate was higher in the I/R group during reperfusion compared to the I/R group. 
This difference was more prominent during the late phase of reperfusion which 
corresponds to a large burst of neutrophil activity (Clavien 1998; Jaeschke et al. 1990). It 
has been observed that the injury produced during the initial part o f the late phase is a more 
extensive hepatocellular injury in comparison to the early phase (Clavien 1998; Harbrecht 
et al. 1993; Jaeschke et al. 1990). Moreover, an element of neutrophil sequestration, 
sinusoidal narrowing (Vollmar et al. 1994) and vasoconstriction (Pannen 2002) combine to
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form a ‘no-reflow paradox’ where by hepatocytes are subjected to a further perfusion 
deficit and persistent ischaemia (Menger et al. 1992). This may explain the observed peak 
in lactate at this late time-point especially since lactate levels have been shown to become 
elevated in bile even when they are not elevated in serum (Nishijima et al. 1997). Acetate is 
produced as a result of fatty acid p-oxidation in the liver (Ambrose and Easty 1977). This 
reaction requires ATP at its initiation. Following I/R injury ATP is consumed to clear 
excess lactate and pyruvate and may not be readily available for fatty acid oxidation. The 
I/R-induced reduction or depletion of ATP may result in a decreased ability to utilize p- 
oxidation causing acetate production to falter. The higher bile acetate levels in the NAC 
group would suggest improved ATP production and energetics. The increased excretion of 
pyruvate in the bile of NAC treated livers is difficult to interpret although this has been 
reported also in our study with steatotic liver (chapter 7) (Fusai et al. 2005). Pyruvate is 
transported in the mitochondria, and after an oxidative decarboxylation, it is transformed 
into acetyl coenzyme A and used for the citric acid cycle. There could be a relationship 
between the increased of pyruvate and acetate in the NAC group and better mitochondrial 
preservation.
The main source of PC in the hepatocytes is the cell membrane. The increase following 
ischaemia and again at 2 and 5 h post-reperfusion correlates well with the theory of cellular 
breakdown and membrane lipid peroxidation (Suzuki et al. 2000). This rise coincides with 
hepatocellular injury during ischaemia with the ‘no-reflow period’. PC levels at these time- 
points were reduced in the NAC treated group. Increased PC has also been observed in 
association with poor graft function (El Desoky et al. 1999; Fusai et al. 2005). During I/R 
injury membrane phospholipids are degraded and glycogen is broken down. This study
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demonstrates increasing loss of these compounds in bile with increasing severity o f injury. 
The presence of biliary glucose and its increase following I/R has been noted recently 
(Habib et al. 2004).
In this study Cyt Ox redox state decreased significantly during ischaemia, subsequently 
recovered partially during the early phase and decreased further during the late phase to 
levels below the ischaemic values. NAC prevented the reduction in Cyt Ox during 
reperfusion and this could explain the beneficial effects to the energy dependent process of 
bile flow.
The current study showed that liver I/R decreased significantly the redox state o f Cyt Ox, 
increased the levels of RSNOs and decreased liver tissue nitrotyrosine, markers o f NO 
activity. NO can regulate mitochondrial respiration by inhibiting Cyt Ox (Cooper 2002). 
This inhibition is reversible at low concentrations of NO . However, Cyt Ox inhibition at 
high NO levels leads to increased formation o f superoxide, which then reacts with NO 
leading to the formation of other RNS such as peroxynitrite. Peroxynitrite at high levels 
can cause irreversible damage to Cyt Ox. This probably occurs via the combination of 
tyrosine nitration and damage to prosthetic groups (Cooper 2002; Aulak et al. 2004; Koeck 
et al. 2004). Furthemore, formation of ROS and RNS is enhanced under conditions o f 
hypoxia (Turrens 2003).
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In the present study significant oxidation of DHR 123 to RH occurred in the I/R group 7 h 
post reperfusion. At this time point a significant increase in RSNOs formation was noted 
while the redox state of Cyt-ox Cua was significantly decreased and hepatic 
microcirculation was also reduced. The underlying mechanism could be that NO produced 
by iNOS induction and superoxide anion produced by activated neutrophils during the late 
phase of reperfusion lead to production o f peroxynitrite. Peroxynitrite and hypoxia 
generated by low flow cause reduction in Cyt Ox, and mitochondrial dysfunction which 
results in increased mitochondrial RNS and ROS formation. These oxidants possibly 
contribute to further deterioration in microcirculation and liver injury. The decrease in liver 
nitrotyrosine post-reperfusion, found in the present study, is not what we would expect, 
since nitrotyrosine formation is regarded as a marker of peroxynitrite. It seems that the 
reactions between N O , RNS and proteins are complex and probably increased proteolytic 
activity occurs during I/R. NO mediated hepatotoxicity has already been observed in 
chronic liver inflammatory conditions such as ethanol induced hepatotoxicity, where 
induction o f iNOS seems to play a major pathogenetic role (McKim el al. 2003; 
Venkatraman et al. 2003).
NAC administration prevented the decrease in the redox state of Cyt Ox and liver tissue 
nitrotyrosine, the increase in RSNOs and ameliorated the oxidation of DHR 123 to RH. 
This is the first in vivo study in liver I/R showing the interaction between NAC and plasma 
RSNOs. In vitro evidence suggest that there is a dynamic interaction between S-nitroso- 
albumin and low molecular weight thiols in plasma in controlling vascular tone and 
function (Marley et al. 2001). Both high and low molecular weight thiols can be S-
218
nitrosated in plasma by reaction with NO or inter-converted by trans-nitrosation reactions. 
Peroxynitrite can also generate S-nitrosothiols through an oxygen independent reaction 
(Marley et al. 2001).
Low molecular weight thiols enhance the decomposition o f S-nitrosoalbumin which is the 
main high molecular weight thiol in plasma. The exact reaction mechanisms by which 
thiols promotes rapid metabolism of plasma RSNOs is not clear, although both 
transnitrosation and reductive reactions have been reported (Jourd'heuil et al. 2000; Marley 
et al. 2001).
This study would suggest that NAC exerts its beneficial effects on liver I/R, through 
inhibition of formation of RNS such as peroxynitrite and the continuous maintenance of 
mitochondrial activity. Modulation of NO metabolism could be a potential target for 
ameliorating I/R injury.
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8.5 C hapter summary
N-acetylcysteine (NAC) reduces warm liver ischaemia-reperfusion (I/R) injury but the 
mechanism of action is not clear. The present study has investigated the effect o f NAC 
administration on cellular energy production and nitric oxide metabolism in the rabbit lobar 
I/R model.
Lobar liver ischaemia was induced for 60 min, followed by 7 h of reperfusion. In the NAC 
group (n=6) 150 mg/kg/h o f NAC was administered iv, over the 15 min before reperfusion 
and maintained by continuous infusion at a dose o f 10 mg/kg/h during the reperfusion 
period. Control groups were I/R alone (I/R group, n=6) and sham laparotomy (Sham group, 
n=6). Cellular energy production was assessed through the measurement of liver 
cytochrome oxidase redox state (Cyt Ox) by near-infrared spectroscopy, and by analysis o f 
bile composition using proton nuclear magnetic resonance (*H NMR) spectroscopy. Nitric 
oxide metabolism was assessed through measurement o f plasma S-nitrosothiol levels by 
electron paramagnetic resonance spectrometry, nitrite and nitrates through capillary 
electrophoresis. Reactive nitrogen species formation was studied by measuring liver tissue 
nitrotyrosine with mass spectrometry and through the oxidation of the fluorescent dye 
dihydrorhodamine (DHR) 123.
In the I/R group Cyt Ox redox state decreased significantly during reperfusion compared 
to baseline and sham, while bile lactate levels were significantly increased and bile acetate 
levels were decreased.. Plasma S-nitrosothiol levels were significantly increased at 5 h post 
reperfusion (p<0.05, I/R vs sham) and oxidation o f DHR 123 was significantly increased 7 
h post reperfusion (p<0.05, I/R vs sham,). NAC administration ameliorated the decrease in 
tissue Cyt Ox redox state, decreased bile lactates and plasma nitrosothiol levels and 
increased bile acetate levels (all p<0.05 at 5 h post reperfusion, NAC vs I/R). Furthermore 
NAC decreased the oxidation of DHR 123 and prevented the reduction in liver 
nitrotyrosine (p<0.05, NAC vs. I/R).
In conclusion, the protective effect displayed by NAC in warm liver I/R involves inhibition 
o f reactive nitrogen species formation and maintenance o f mitochondrial activity.
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CHAPTER 9
THESIS DISCUSSION,
CONCLUSIONS AND FUTURE WORK
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9.1 Methodological considerations
9.1.1 The experimental model
Liver I/R injury has major clinical importance in different clinical settings such as liver 
resections for liver tumours, liver transplantation, haemorrhagic shock with fluid 
resuscitation, cardiac by-pass surgery, laparoscopic surgery. The study and the clarification 
o f the pathophysiology will facilitate the understanding o f the complicated mechanisms 
involved in the pathogenesis o f reperfusion injury. Then, the effect o f therapeutic strategies 
to ameliorate liver I/R should be assessed. Experimental models are very useful for the study 
of the mechanisms o f liver I/R and the assessment of the effectiveness o f therapeutic 
strategies, since they provide controlled conditions which allow the researchers to study the 
effects o f an intervention on a single homogenous population.
The experimental model used in this study offered the opportunity to assess both 
haemodynamic and functional parameters in the rabbit liver, in sham operated animals and in 
animals submitted to liver I/R (control and treated groups). For maintenance of anaesthesia 
an inhaled agent (Isoflurane) was used which is mainly metabolised in the lungs rather than 
the liver. This avoids cumulative effects and is also less hepatotoxic compared to other 
inhaled agents such as halothane (Stachnik 2006). The animal selected for the experimental 
procedures was rabbit. This was done mainly due to the size, which allows application of a
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proper anaesthetic protocol and maintenance of metabolic stability with long anaesthesia. It 
allows also the easy placement of probes, continuous measurement of bile flow by 
cannulation of the common bile duct and blood withdrawal at different time points with 
maintenance of the haemodynamic stability. The anatomy of the rabbit liver with separate 
lobes makes easier the identification of vascular elements and selective interruption of the 
blood supply.
The sham group allowed the effects of prolonged anaesthesia and surgical trauma alone to be 
evaluated. The duration o f general anaesthesia was similar to that for major human liver 
surgery (liver resection and transplantation).
One o f the main criticism of the liver lobar I/R model is that it does not simulate the clinical 
conditions o f total liver ischaemia, which occur in liver transplantation or in liver resections 
when Pringle manoeuvre is applied. However, work from our group showed that 30 min of 
total hepatic ischaemia is poorly tolerated by the rabbits, resulting in cardiac arrest due to 
severe reduction in MABP and metabolic acidosis (Kanoria et al. 2004). Also, acute portal 
venous occlusion causes venous congestion in the mesenteric bed and compromise of the 
intestinal mucosa, resulting in bacterial translocation and onset of systemic inflammatory 
response syndrome (Koo et al. 1992). In the present study blood flow to the medial and left 
lateral lobes is interrupted leaving the right and caudate lobes with normal circulation. Lobar 
ischaemia maintains splanchnic blood flow and prevents the haemodynamic instability
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associated with mesenteric congestion and portal bacteraemia found with total inflow 
occlusion (Koo el a l 1992). Ischaemic time is similar to time used in liver resections.
The current model may be preferable also to a liver transplant model for the study o f liver 
I/R, because in contrast with preservation of organs at low temperatures, normothermic 
ischaemia produces rapid liver injury, with the option o f in-vivo study without the systemic 
effects of transplantation. The technical difficulty of re-establishing portal and arterial 
blood flow, the denervation o f the organ, artefacts due to organ cooling and the possibility 
of immunological involvement make experimental liver transplantation a complex 
experimental model. Normothermic ischaemia of the liver is to some extent a simulation of 
the circulatory and metabolic conditions of transplantation, being nevertheless a simple, 
reproducible and efficient experimental method with low mortality and morbidity.
This model was further refined with the cannulation of the ear artery instead o f the femoral 
artery for monitoring o f arterial blood pressure and blood withdrawal. A set o f experiments 
showed that the cannulation of the femoral artery causes remote hepatic injury. The 
mechanism for this injury was not investigated, but it is possible that low flow reperfusion 
injury and the release of mediators such as cytokines could be the cause. Although the 
remote effect of limb I/R injury was studied only on liver function, it is plausible to assume 
that prolonged femoral artery cannulation causes remote injury to other organs such as lung, 
heart, kidneys. Experimental studies focusing on the application of an intervention and study 
o f specific organ function should avoid femoral artery cannulation.
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One of the limitations of the model is that it is not appropriate for recovery and thus can not 
assess the effect of NAC in later time points where organ failure, morbidity and mortality 
could be evaluated.
In the present study a model of steatosis induced by high cholesterol diet was used for the 
study o f the effect of NAC in fatty livers. High-cholesterol feeding induces the formation o f 
steatotic livers in which there is accumulation of triacylglycerol (triglyceride) and cholesterol 
in the liver (Lee and Ho 1975; Mastai et al. 1996; Wanless et al. 1996). Animals models 
used for the study of non alcoholic fatty liver disease (NAFLD) are divided into two broad 
categories: those caused by genetic mutation and those with an acquired phenotype produced 
by dietary or pharmacological manipulation. The genetic leptin-deficient or leptin resistant is 
the most popular model and the dietary methionine / choline deficient model is the most 
commonly used in the second category (Anstee and Goldin 2006). However, neither these 
two models has reproduced either the phenotype or the pathogenic mechanism of human 
steatosis-steatohepatitis (Anstee and Goldin 2006).
The high cholesterol diet model produces a central lobular deposition of fat, similar to that 
found in the majority o f human steatotic livers. The liver weight and the liver weight (LW) / 
body weight (BW) ratio are increased significantly compared to rabbits with normal liver. 
Macroscopically the liver is enlarged, yellowish in colour with rounded edge and firm 
consistency. Microscopically there is moderate steatosis with macro vesicular fat 
accumulation and inflammatory cell infiltrate. Biochemically there is elevated bilirubin,
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elevated transaminases, low albumin, high cholesterol and slightly high triglycerides. 
Although it has characteristics similar to the human steatosis, it is not the ideal model, since 
the steatosis is produced by high cholesterol diet and mainly leads to significant 
hypercholesterolemia and mild hypertriglyceridemia. Probably the development o f combined 
models of genetically modification along with high fat diet will produce a situation similar to 
the human steatosis.
9.1.2 Laser Doppler Flowmetry (LDF)
The measurement o f micro circulatory blood flow is of major importance in the study o f the 
pathophysiology of liver I/R injury and its modulation by therapeutic strategies. There is 
experimental and clinical evidence that changes in microcirculation during the immediate 
reperfusion period in liver transplantation correspond directly with the maximum 
postoperative enzyme release from the liver (Klar el al. 1997), and are of value in assessing 
and predicting the degree o f liver injury (Pannen 2002). The sinusoidal flow is actively 
regulated and redistributed at the level of the microcirculation through a balance between 
vasoconstrictive substances such as endothelin and vasodilatory agents such as NO and 
carbon monoxide.
In the present study, laser doppler flowmetry was used to measure blood in capillaries and 
sinusoids rather than in major vessels running deeply inside the liver substance, thus the 
described range o f penetration was considered sufficient to study blood flow in a liver lobe 
with a maximum thickness of less than 10 mm. This method does not measure the 
microcirculatory blood flow of the liver as a whole, which would be ideal. However, the
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location of the probe in a fixed point of the liver surface, throughout the experiment, allows 
the continuous record of the flow signal. This can be considered representative o f the 
microcirculatory changes on that point during the different stages of the procedure, using the 
same place as control.
During the application of LDF in the experiments a few problems were encountered. One 
being motion artefact. The laser Doppler monitor can produce artefact signals due to 
vibration or other movements of the fiberoptic probe itself and due to relative movements 
between the probe and the explored tissue. With the rabbit liver there is considerable amount 
o f respiratory movement. In the current experiments it was possible to reduce significantly 
the artefact signals with a good level of anaesthesia, good mobilisation o f the liver to avoid 
diaphragmatic movements and placement of the probe loosely in contact with the liver 
allowing it to move with it.
A baseline recording o f flow as a standard (100%) was used in each individual experiment 
and expressed in arbitrary "Perfusion Units". This is because the backscattered light varies 
from one organ to another depending on factors including light absorption and red cell 
fraction on different tissues and it is not possible to translate the values into a unit o f flux that 
can be utilised for different organs; nevertheless, when applied to the same organ the signal 
is reproducible within a narrow range of variation. Another factor which affects the baseline 
measurements is the type o f probe used in the experiments. This could explain the difference
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in baseline found in two different experimental procedures (femoral artery group and ear 
artery group, normal liver) where different probes were used in each set of experiments.
9.1.3 Near infrared spectroscopy (NIRS)
During NIRS application in the experiments a few problems were noticed. The interference 
by the effect of operating lights on the measurement requires covering of the probes with 
lightproof back cloth. Variation in measurements were found with the re-application of the 
probes even on the same site of measurement which may be caused by variation of the 
optical properties of the area under investigation which are tested and accounted for by the 
spectroscopy with the initial setting. This problem restricts the NIRS application as the 
probes must be applied and maintained in the same site without movement during the whole 
procedure, which may be impractical in clinical situation. However, in the present study 
recording of cytochrome oxidase (Cyt Ox) data was not affected from the re-application of 
probes and accurately represented the redox state of the enzyme which correlated with the 
changes in microcirculation and transaminases, as well as the changes in bile composition. 
The measurement of cytox with NIRS has been validated against other techniques, by our 
group, such as nuclear magnetic resonance spectroscopy (Seifalian el al. 2001b) and partial 
oxygen pressure (El Desoky el al. 2000). NIRS is a powerful method of obtaining 
information about mitochondrial activity and cellular energy production. This has major 
importance as clinical evidence shows that the degree in impairment of the hepatic 
mitochondrial redox state determines the survival rate o f patients after haemorrhagic shock 
and resuscitation (Nakatani el al. 1995).
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9.1.4 Histology
The semiquantative histological score used in this study provides enough information in 
order to detect differences between two experimental groups. However, when the differences 
are not very significant then the use of a quantitative score will detect differences which the 
semi quantitative score is not able to detect.
9.1.5 Proton nuclear magnetic resonance (*HNMR) spectroscopy and electron 
paramagnetic resonance (EPR) spectrometry
Proton NMR spectroscopy demonstrated significant changes in bile composition during liver 
ischaemia-reperfusion. It can be used also as a marker for the assessment of the effectiveness 
of different therapeutic strategies such as antioxidants. The quantitative measurement 
provides more precise information compared to the measurement of the changes relative to 
baseline. The further development of bile analysis with proton NMR spectroscopy could 
have clinical application in the postoperative assessment of liver graft function and early 
diagnosis of dysfunction.
EPR provides quantitative measurement of stable free radicals such as ascorbyl radical, but 
also of bio molecules such as S-nitrosothiols (RSNOs) which come from reaction o f free 
radicals with thiols. Measurement of RSNOs by EPR has previously validated against an 
established chemiluminenescence method (Rocks et al. 2005). This is a quick and sensitive 
technique that, due to the nature o f EPR spectrometry, is not directly affected by other NO
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metabolites. The samples do not require pre-treatment (e.g. to be deproteinised). This allows 
both high and low molecular weight RSNOs to be analyzed, which includes S- 
nitrosoalbumin. Our results suggest that S-nitrosothiols plasma levels are a good marker of 
nitrosative stress. EPR could have potential clinical applications in the measurement of 
oxidative stress in biological fluids or tissues and also assessment of the effectiveness of 
therapeutic strategies against oxidative stress.
9.2 Role of nitric oxide in liver I/R
The role o f NO in liver I/R is still ambivalent. Under physiological conditions only 
constitute endothelial NOS is present in the liver. Low levels of NO regulate hepatic 
perfusion by maintaining a balance with vasoconstrictors such as endothelin. NO also 
prevents platelet adhesion, thrombosis, polymorphonuclear cell accumulation and secretion 
of inflammatory mediators (Gauthier et al. 1994; Mittal et al. 1994). During reperfusion 
initially NO levels decrease, but afterwards large amounts are produced through induction of 
iNOS. There is experimental evidence that iNOS messenger RNA expression starts 1 h post 
reperfusion with increased iNOS activity at 5 h post -reperfusion (Hur et al. 1999). Induction 
of iNOS may have either toxic or protective effects. Different studies have shown inducible 
nitric oxide synthase inhibition to be either beneficial or detrimental. Furthermore, the use of 
a selective iNOS inhibitor showed beneficial effects in experimental models with 
endotoxaemia (Thiemermann et al. 1995; Wang et al. 1998), but not with liver I/R (Majano 
et al. 2005).
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The toxic effects of NO are linked with the production of peroxynitrite, which is the product 
o f 0 2' and N O . Peroxynitrite can cause cell injury through multiple pathways, such as 
initiation of lipid peroxidation, direct inhibition of mitochondrial respiratory chain enzymes, 
inhibition of membrane Na+/K+ ATPase activity, or oxidative protein modification such as 
formation of nitrotyrosine (Doulias et al. 2001; Hon el al. 2002; Szabo 2003). Whether NO 
will act as a cytoprotective or cytotoxic agent depends on a number o f factors, such as NOV 
superoxide anion ratio, hepatic stores of reduced glutathione and duration of ischaemia.
The present study has shown that during the late phase of reperfusion large amounts of nitric 
oxide are produced, as indicated by the rise in nitrites and RSNOs. However at this point 
significant liver injury occured as indicated by the increase in ALT activity, the reduction in 
bile flow, in microcirculation, the changes in Cyt Ox redox state and histology. There was 
also evidence o f significant oxidative stress during that period, as shown by the increased 
oxidation of dihydrorhodamine to rhodamine which is partially peroxynitrite dependent. The 
major factor which can contribute to this injury could be RNS and ROS. Peroxynitrite could 
be one o f the major factors responsible for this increase. The current study showed also that 
increased NO levels in the late reperfusion period is associated with a reduction in the 
parenchymal perfusion. The reduced flow could be secondary to the detrimental effects of 
RNS in microcirculation.
Experimental evidence suggests that NO controls oxygen consumption by inhibiting cyt ox. 
Although in small concentrations of NO this inhibition has a regulatory role in cell function,
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in large concentrations o f NO can be detrimental. Further studies are required to elucidate 
the role of NO and mitochondrial activity in liver I/R.
9.3 Role of NAC in liver I/R
N-acetylcysteine is an agent with a wide spectrum of effects and minor side effects such as 
anaphylactic reaction (skin rash). It can be administered instead of L-cysteine which can be 
toxic. Due to its small size it can overcome the problems associated with the administration 
o f the endogenous anti-oxidant glutathione.
Its beneficial role has been well established in the fulminant liver failure due to paracetamol 
overdose. In this field there are several randomised controlled clinical trials which have 
shown a clear benefit (Chyka et al. 2000). However, there is controversy about its role in 
fulminant liver failure due to other causes. The mechanism postulated for the protective 
effect in liver failure due to paracetamol overdose is inhibition of peroxynitrite. However, we 
should bear in mind that the mechanisms of injury are different between liver I/R injury and 
other forms of hepatic injury. Acute adenosine triphosphate depletion occurs with ischaemia 
but not in chronic liver disease. Also the signalling pathways and the mechanisms of cell 
death are different in settings of acute liver injury and chronic disease.
The therapeutic role o f NAC in human diseases has been reviewed recently. Although 
beneficial effects were demonstrated in conditions associated with oxidative stress such as 
AIDS, cancer and I/R injury; the current evidence does not support routine application (Aitio 
2006).
232
The studies on NAC in this thesis were planned due to the lack of previously controlled 
experimental data, on the role o f continuous NAC infusion on liver function during the early 
and late phase of hepatic I/R injury. The effect of NAC was evaluated using a controlled 
model where both phases o f liver I/R could be studied. The dose of NAC used was similar to 
that used for patients with fulminant liver failure due to paracetamol overdose. This thesis 
has provided significant information on the timing of the maximum protective effect of NAC 
and also on the mechanism of action. It seems that the protective effect becomes apparent 
when the oxidative stress reaches a maximum. This seems to occur after the 5th h o f 
reperfusion. In addition, the modulation of NO metabolism with NAC administration 
provides further new information. We have showed that large amount of NO is produced 
during the late phase o f reperfusion and associated with significant liver injury. NAC 
administration reduced NO production ameliorated liver injury and maintained 
mitochondrial activity and cellular bioenergetics.
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9.4 Overall conclusions arising from the thesis and suggestions for future work
The major findings of the study were:
1. Cannulation of the femoral artery induces remote liver injury and should be avoided in 
studies focusing on liver function. The use of the ear artery instead o f the femoral 
avoided the remote hepatic injury. Studies focusing on the study of specific organ 
function after application of an intervention should avoid femoral artery cannulation.
2. Lobar liver I/R caused significant decrease in hepatic microcirculation, liver tissue 
oxygenation and energy metabolism as was expressed by changes in the redox state of 
cytochrome oxidase and bile composition. It also caused significant alterations in NO 
metabolism during the late phase, as indicated by the increase in plasma nitrates, plasma 
S-nitrosothiols and decrease in liver tissue nitrotyrosine. Further studies should clarify 
further the relationship between mitochondrial activity, NO metabolism and liver I/R 
injury. Also, the use of proton NMR spectroscopy for bile analysis and o f EPR for 
measurement of S-nitrosothiols and free radicals could have applications in clinical 
studies.
3. Continuous infusion of N-acetylcysteine in rabbits with normal liver significantly 
improved hepatic microcirculation, intracellular oxygenation and reduced liver 
transaminases. The main protective effect o f NAC was more obvious during the late 
phase o f reperfusion (after the 5th h). Similar results were obtained in rabbits with 
moderate hepatic steatosis.
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4. The protective effect of NAC was associated with improved cellular energy metabolism 
(maintenance of mitochondrial activity, decreased lactates in bile) and with significant 
modification of nitric oxide metabolism (reduction in plasma nitrites, S-nitrosothiols and 
RNS).
The above conclusions suggest a protective role for N-acetylcysteine in liver I/R injury. This 
protective effect should be further investigated in recovery models, where NAC could be 
administered continuously through an implantable pump and assess outcome in terms of 
morbidity, mortality and organ failure. The administration of more powerful thiols, such as 
bucillamine, should also be investigated as they may have a major role in I/R injury (Amersi 
et al. 2002).
However, we should bear in mind that the body response to liver resection is very complex 
and that the oxidative stress produced by I/R injury is only one part o f the pathway. 
Experimental evidence suggests that Kupffer cell activation and the subsequent release of 
cytokines such as tumour necrosis factor-a (TNF-a) and intereukin-6 (IL-6) play a pivotal 
role in liver regeneration and prevention of liver failure (Shiratori et al. 1996). Also 
induction o f iNOS may have a role in liver regeneration (Garcia-Trevijano et al. 2002;Rai et 
al. 1998;Ronco et al. 2004). In order these areas to be further clarified, it is important 
recovery models to be established; where both modulation o f liver I/R injury and the 
influence on liver regeneration can be studied.
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In clinical practise evidence suggests that patient age and underlying liver disease (cirrhosis, 
steatosis) increase significantly the risks for postoperative liver failure leading to increased 
morbidity and mortality (Helling 2006). Clinical studies have shown a significant increase in 
mortality after the age of 65, mainly with extended liver resections (Koperna, Kisser, and 
Schulz 1998). One o f the main factors seems to be susceptibility to liver ischaemia and 
oxidative stress.
Also, hepatic steatosis and steatohepatis have been reported worldwide and are increasingly 
recognised as the leading cause for liver dysfunction and cirrhosis in the non-alcoholic, viral 
hepatitis negative population in Europe and North America. Steatotic livers are very 
susceptible to oxidative stress leading to high rates of liver failure after liver resection and in 
primary non-function or dysfunction following liver transplantation both in cadaveric 
(Selzner and Clavien 2001) and living donor liver transplantation (Soejima el al. 2003). 
Hence there may be an increased role for antioxidant therapies.
Clinical trials have produced conflicting results regarding the use of antioxidants in liver 
transplantation. One o f the reasons for this inconsistency in the results is that small groups of 
relatively young patients with normal underlying liver function or good graft function were 
studied. The main protective effect would be anticipated in older patients with diseased livers 
(post chemotherapy, steatosis) undergoing liver resection and in patients undergoing liver 
transplantation with marginal grafts. Clinical trials need to be designed accordingly.
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